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Abstract 
Transcranial direct current stimulation (tDCS) is a popular non-invasive brain stimulation 
technique, which has the potential to modulate cortical excitability. The effects of tDCS 
are known to outlast the stimulation period, and in some cases, repeated applications 
have been found to produce long lasting clinically relevant effects. The primary aim of 
this thesis was to explore the reliability and therapeutic potential of this technique.  
In Chapters 3 and 4 transcranial magnetic stimulation (TMS) was used to measure tDCS 
effects. These experiments revealed substantial variability regarding the way in which 
healthy adults responded to stimulation. Notably, there were differences between 
participants regarding the direction and magnitude of change in cortical excitability. 
Furthermore, even when group level effects were found reliably, there was substantial 
intra-subject variability across repeated testing sessions.  
Subsequent experiments in Chapters 5 and 6, explored the biological and behavioural 
effects of tDCS in individuals with Gille de la Tourette’s syndrome (GTS). GTS is a 
neurodevelopmental disorder characterised by motor and phonic tics which have been 
linked to hyper excitability within motor-cortical regions. Therefore, these experiments 
aimed to reduce cortical excitability of targeted regions in the hope that this would 
impact on tics. Disappointingly, no such effects were found immediately after a single 
session of tDCS (Chapter 5). Consequently, it was hypothesised that repeated 
applications may be necessary for significant reductions in tics to occur. This was 
investigated in Chapter 6 using an in-depth case study. The results were encouraging, in 
particular there was a substantial drop in tics following 10 days of tDCS at 1.5mA 
intensity. The stimulation was well tolerated and the treatment regimens were closely 
adhered to, despite tDCS being delivered in the participants own home with remote 
supervision. A weaker stimulation intensity was not as effective. The findings of 
Chapters 3-6 highlight that the optimal stimulation parameters may vary from person to 
person, and that exploration of individual data is critical in therapeutic contexts. The 
results also suggest that tDCS may be helpful as a treatment for GTS and furthermore 
highlight the feasibility of home use stimulation.  
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 General Introduction 
 
Key words: transcranial direct current stimulation (tDCS), electroconvulsive 
therapy (ECT), transcranial magnetic stimulation (TMS), long term potentiation 
(LTP), long term depression (LTD), supplementary motor area (SMA), magnetic 
resonance spectroscopy (MRS), Gilles de la Tourette’s syndrome (GTS), cortical 
excitability.  
 
In this thesis, a number of studies are discussed in which the effects of 
transcranial direct current stimulation (tDCS) were explored in neurologically 
typical individuals and individuals with Gille de la Tourette’s syndrome (GTS). This 
thesis also explores the relationship between different methods used to measure 
neurotransmitter function including Gamma-Aminobutyric Acid (GABA) and 
glutamate.  
1.1 A brief history of therapeutic brain stimulation 
 
The use of electrical stimulation to influence and study the brain is not 
new. In fact, there are historical references dating as far back as 131-401 AD 
which document the uses of fish with electrical properties to alleviate headaches 
(Priori, 2003). Although these early examples exist, prior to the 17th century little 
was understood about the body’s natural relationship with electricity. An 
individual who is often credited with greatly enhancing our understanding of this 
is Luigi Galvani. Galvani revolutionized scientific thinking by demonstrating that 
lifeless bodies could be made to move using electrical stimulation (Piccolino, 
1998). In doing so he was the first person to identify the electrical nature of 
muscle contraction and nerve conduction (Piccolino, 1998).  Galvani’s nephew 
Giovanni Aldini developed this by conducting experiments in which electrical 
currents were applied to the heads of executed prisoners to induce muscular 
contractions (Piccolino, 1998).  Aldini also applied electrical currents to the heads 
of living individuals as a treatment for complaints such as ‘melancholia’ (Priori, 
2003). These experiments are arguably the origin of modern therapies using 
electrical stimulation to treat neuropsychiatric disorders.   
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Throughout the 17th century understanding and experimentation with 
electrical stimulation grew, and with it, application of electrical currents to treat 
mental health conditions increased (Elliott, 2014). During this time perhaps one 
of the most important developments was the use of electro convulsive therapy 
(ECT) to treat patients under psychiatric care. Initially ECT was used to treat a 
range of conditions, however, with improved psychiatric care and the 
introduction of psychotropic drugs in 1950s and 1960s it’s use began to decline 
(Fink, 2001). Today ECT is still used to successfully alleviate symptoms in 
conditions such as severe treatment resistant depression (Fink, 2001), however, 
it is not without side effects or complications. Even with the use of general 
anaesthesia and more efficient use of electrical wave forms the treatments can 
result in memory impairment and other cognitive deficits (Sackeim et al., 2007).  
The nature of the technique makes it unpopular with many and has heavily 
restricted its therapeutic use. Nevertheless, ECT provides a powerful 
demonstration of the potential of electrical stimulation in treating the symptoms 
of psychiatric illness.   
A number of less invasive brain stimulation techniques have since emerged 
which use electrical currents to influence the brain. These include transcranial 
magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS).  
1.2 Modern day methods: Transcranial Direct Current 
Stimulation (tDCS) 
 
tDCS is a non-invasive brain stimulation technique which has been shown 
to effectively modulate cortical excitability in humans. The application of tDCS 
involves running a low density electrical current between two electrodes – at 
least one of which is placed on the scalp (see Figure 1.1). The intensity of the    
currents used are typically 1-2mA, which is substantially below those found to be 
safe in animals (Mccreery et al. (1990) Liebetanz et al. (2009)).  The electrodes 
used are typically made from conductive rubber and are connected to a battery 
powered device capable of delivering continuous current. When the device is 
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switched on direct current flows from one electrode (Anode) to the other 
(Cathode); some of this current will be shunted by the scalp and cerebral spinal 
fluid (CSF), however, a proportion will penetrate through to reach the cortical 
surface of the brain (Moreno-Duarte et al., 2014).  
 
Figure 1.1. Illustration of tDCS application. 
Within the tDCS literature the two electrodes are often referred to as 
‘active’ and ‘reference’ rather than anode and cathode.  The active electrode is 
typically placed on the scalp above the area of interest, whereas the reference 
electrode can be placed in a number of different locations (including on the 
contralateral forehead, opposite hemisphere or at an extra-cephalic location 
such as the shoulder). It is important to note that the term ‘reference’ is 
somewhat misleading, as the current will affect tissue at this location in addition 
to at the active electrode and areas between.  It should also be noted that when 
researchers refer to anodal or cathodal stimulation they are typically referring to 
the electrode placed above the area of interest i.e. the ‘active’ electrode.  
tDCS is a particularly interesting technique as it has the ability to both 
increase and decrease cortical excitability depending on the electrode polarity. A 
number of studies have demonstrated that cortical excitability typically 
decreases in the areas under the cathode and increases in areas beneath the 
anode (Jacobson et al., 2012). These induced changes in excitability are typically 
short lived, lasting up to 120 minutes following stimulation cessation (Batsikadze 
et al., 2013). However, more long term effects may be achievable with repeated 
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applications through activation of long term potentiation (LTP) and long term 
depression (LTD) type changes in plasticity. The potential to induce longer lasting 
changes in cortical excitability with minimal adverse effects has led to a dramatic 
increase in interest of the technique’s therapeutic potential, particularly in 
recent years (Brunoni et al., 2012).  
tDCS has a number of additional advantages over other forms of 
stimulation which make it an appealing tool for therapeutic use. The machine 
itself is small, portable and relatively easy to use which makes home use 
possible. This is particularly advantageous when compared with other non-
invasive brain stimulation techniques such as TMS, as these often involve 
repeated visits to a clinic for treatment which may be inconvenient and/or 
distressing.  
When recognised guidelines are followed, tDCS is considered to be a safe 
and low risk technique (see Fregni et al. (2014)) with considerably less adverse 
effects reported than those occurring as a result of other forms of stimulation or 
psychoactive medication. An extensive review carried out on 567 tDCS sessions 
in healthy controls and individuals with symptoms of migraine, tinnitus or stroke, 
found the most common side effect was tingling under the electrode; moderate 
fatigue and an itching sensation were also reported by some during stimulation. 
Reported side effects occurring after stimulation included headache which was 
reported by approximately 11.8%, nausea which was reported in less than 2% 
and insomnia which was reported by less than 1% (Poreisz et al, 2007). It is 
possible that some of these effects may be circumstantial and unrelated to tDCS 
itself. A more recent review revealed that although side effects such as tingling 
and itching sensations below the electrodes were slightly higher in active 
stimulation conditions, this was not significantly different to sensations reported 
during sham. In addition to this, reports of headache, burning sensation or 
discomfort were similar for the two conditions (Brunoni, Amadera, et al., 2011).  
A number of studies have highlighted the potential effectiveness of tDCS 
in treating a range of conditions including depression (Boggio et al., 2008; 
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Brunoni, Ferrucci, et al., 2011; Fregni, Boggio, et al., 2006), and schizophrenia 
(Brunelin, 2012). tDCS has also been found to be helpful in reducing chronic pain 
(Antal et al., 2010), pain caused by fibromyalgia (Fregni, Gimenes, et al., 2006)  
and reducing fatigue caused by multiple sclerosis (Tecchio et al., 2014). Small 
scale case studies also suggest that tDCS may be helpful in reducing seizure in 
individuals with epilepsy (Yook et al., 2011) and in reducing tics in Tourette’s 
syndrome  (Carvalho et al., 2015; Mrakic-Sposta et al., 2008).  
Although the reports of therapeutic application are generally positive, 
they are limited in number and, therefore, few extensive reviews of their 
effectiveness have been carried out. Studies into the effects of tDCS within 
healthy neurologically typical individuals reveal a somewhat mixed picture. 
Although many studies report that tDCS is able to influence cortical excitability 
and behavioural outcomes, this is not always found. In a recent meta-analysis 
Horvath et al. (2015) made the claim that tDCS has little or no reliable 
neurophysiological effects beyond changes in specific TMS measures (Horvath et 
al., 2015). This claim and the methodology used in reaching it has been met with 
a strong backlash and criticism (for example see Antal et al. (2015)). However, it 
does serve to highlight that tDCS effects are not always simple and predictable.      
In the excitement surrounding tDCS and its clinical potential, important 
factors have often been ignored and there are a number of unexplored issues 
which require attention in order to build stronger conclusions about its 
effectiveness. In particular, there is uncertainty about the exact mechanisms 
underlying the effects (although see section 2.3). There is also little 
understanding of the effectiveness of stimulation across and within participants, 
and regarding issues relating to parameter selection and the setup of stimulation 
protocols.  
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1.3 Gilles de la Tourette Syndrome 
 
Gilles de la Tourette syndrome (GTS) is a childhood onset disorder, 
characterized by the presence of motor and phonic tics which are present for a 
minimum of 1 year (Leckman, 2002). Tics are involuntary, brief, stereotyped 
behaviours of a limited duration and can involve movement (motor tic) or the 
production of sound (phonic tic). The disorder is thought to affect approximately 
1% of children and has been reported almost globally (Robertson, 2008). GTS 
often follows a time course whereby tics are typically at their worst aged 10- 12 
years; for three quarters of children these will then diminish by early adulthood 
with over a third becoming seemingly tic free adults (Bloch & Leckman, 2009). 
Many individuals with GTS will also have a co-occurring diagnosis such as 
Attention Deficit Hyperactivity Disorder (ADHD) or Obsessive Compulsive 
Disorder (OCD). Estimates suggest that approximately 86.5% of children with GTS 
have also met the criteria for one or more additional diagnoses, with ADHD being 
the most common (Bitsko et al., 2014).   This can make understanding the 
aetiology of GTS particularly complex, as instances of ‘pure GTS’ are less 
common.  
The most common forms of treatment for GTS are behavioural therapies 
such as ‘habit reversal training’ and pharmacological interventions including 
antipsychotics. Although these work for some, they are not always ideal. In 
particular, the side effects associated with antipsychotics make them 
unappealing for many. For example, a study of 51 participants with GTS who 
were prescribed the antipsychotic Haloperidol found that 41% discontinued its 
use due to intolerable side effects (Silva et al., 1996). There is a clear need for the 
development of additional treatments and it is possible that non-invasive brain 
stimulation techniques may play an important role.     
The aetiology and neurobiology of Tourette syndrome is not yet fully 
understood, however, genetic factors are implicated and differences in the 
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structure and function of different brain regions are also likely to be involved. 
Although the evidence is far from conclusive, a number of structures and circuits 
have been identified including the basal ganglia (Worbe et al., 2012), corpus 
callosum and caudate nucleus (see Albin & Mink (2006) for review). Thinning in 
motor cortical areas has also been reported (Worbe et al., 2010), and 
dysfunction in the cortico-striato-thalamo-cortical circuits suggested (Mink, 
2001).  
1.4 Non-invasive brain stimulation and Tourette Syndrome 
 
In order for tDCS to be a developed as a potential treatment for GTS, it is 
important that an appropriate stimulation site can be identified. As previously 
discussed a number of different regions have been implicated, however, some of 
these such as the basal ganglia are deep within the brain. Direct stimulation of 
these deep sub-cortical structures using a standard 1-2mA intensity is not 
possible as the current density is strongest at the cortical surface and rapidly 
decreases with distance from the electrodes. However, a number of studies have 
suggested that it may be possible to reach these structures using stimulation 
which targets cortical areas connected to structures of interest  (Kadosh, 2015).  
Fortunately, one cortical area seems to be particularly implicated in the 
production of tics. This location known as the supplementary motor area (SMA), 
has been found to have altered metabolic activity in individuals with Tourette’s 
syndrome (Eidelberg et al., 1997). In addition to this, levels of an inhibitory 
neurotransmitter known as Gamma-Aminobutyric Acid (GABA) within the SMA 
have been found to correlate with tic scores (Draper et al., 2014). The 
connectivity of this area also makes it an appealing target for stimulation, as it 
has extensive connections to areas relating to motor control and cognitive 
processing (Picard & Strick, 2001). 
To date, it seems that non-invasive stimulation may be useful in reducing 
tics when applied to the SMA. Application of repetitive TMS (rTMS) using pulse 
configurations known to reduce cortical excitability has been found to reduce tic 
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severity scores over a 12 week period following 10 sessions of stimulation (Kwon 
et al., 2011). A similar finding was published by Le et al. (2013) who reported an 
improvement in tic symptoms following 20 days of rTMS which lasted up to 6 
months in some participants; and by Mantovani et al. (2007) who reported 
significant reductions in self-reported measures of tics following 10 days of 
stimulation.  The application of cathodal tDCS to the SMA also shows therapeutic 
promise, Carvalho et al. (2015) found that tic severity and frequency reduced 
significantly following 10 sessions of cathodal tDCS. These effects were still 
present at a 6 month follow up and changes in the resting state network of the 
brain were also identified. Finally a study by Mrakic-Sposta et al. (2008), reported 
a significant reduction in tics following 5 days of cathodal tDCS that was greater 
than that which occurred following a sham condition.  
These results are all very promising, but, with the exception of Mrakic-
Sposta et al. (2008) none were sham controlled, which makes possible placebo 
effects difficult to distinguish from those due to stimulation. Furthermore, the 
studies have often focused on a limited pool of outcome measures (for example 
self-report alone) therefore making it impossible to draw strong conclusions 
about how the effects may be occurring.  
1.5 Research aims and summary 
 
Through a series of experiments my aim was to better understand the 
effects of tDCS in order to explore its potential as a therapeutic intervention for 
reducing tics in individuals with Tourette’s syndrome. The initial two studies 
(Chapters 3 and 4) were designed to investigate the neural effects of tDCS in 
neurologically typical individuals to establish and identify patterns of response 
relating to different parameter selections. In the third study (chapter 5) I 
explored the neural and behavioural changes related to cathodal stimulation of 
the SMA in individuals with Tourette’s syndrome. This was expanded into 
experiment four (Chapter 6) in which the effects of prolonged application were 
investigated in a single case. Finally, an experiment investigating the use of 
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magnetic resonance spectroscopy was conducted (Chapter 7) to explore what 
neurochemical markers are being measured by the technique and how this 
relates to previous findings about the neurobiology of tDCS effects.  
 
In this thesis the following questions are addressed: 
 
1.  What is the time course of the effects of a single session of tDCS? Does 
this differ depending on the intensity and polarity of stimulation used? 
 
2. How stable are the effects of tDCS within and between individuals? 
 
3. Does a single session of tDCS applied to the SMA influence cortical 
excitability or tics in individuals with Tourette’s syndrome?  
 
4. Does 10 days of tDCS applied to the SMA have any short term or lasting 
effects on tics in an individual with Tourette’s syndrome. 
 
5. What do past studies using MRS tell us about the biological underpinnings 
of tDCS? How do we know what MRS is measuring?  
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 Non-invasive stimulation and investigation 
of the human motor cortex 
 
Key words: transcranial direct current stimulation (tDCS), transcranial magnetic 
stimulation (TMS), direct waves (D-wave), indirect waves (I-wave), corticospinal 
neurones (CSNs), pyramidal tract neurones (PTNs), motor evoked potential 
(MEP), motor threshold (MT), input output curve (IO curve) short interval 
intracortical inhibition (SICI), long interval intracortical inhibition (LICI), 
intracortical facilitation (ICF), magnetic resonance spectroscopy (MRS). 
 
In recent years a number of different techniques have been used to explore 
the physiological effects of tDCS.  One of the most popular is transcranial 
magnetic stimulation (TMS) which can be used to make inferences about cortical 
excitability within the motor cortex.  This technique is used throughout the 
experiments discussed in this thesis and is therefore covered in depth in this 
section. Other methods including animal work and pharmacological 
manipulations have also been important; as has work conducted using Magnetic 
Resonance Spectroscopy (MRS).  
2.1 Transcranial Magnetic Stimulation 
 
Transcranial Magnetic Stimulation (TMS) is a 
safe, non-invasive stimulation technique which 
was first demonstrated in 1985 (Barker et al., 
1985). This was five years after Merton and 
Morton (1980) demonstrated that areas of the 
human motor cortex could be stimulated 
through the intact scalp using a brief high 
voltage electric shock. The development of 
TMS as a technique revolutionised the field of 
non-invasive brain stimulation as, in comparison 
to its predecessors, it causes minimal 
discomfort. This is because it is not necessary to 
Figure 2.1. Illustration of TMS 
application. Black arrows indicate 
electrical current flow, red dashed 
line indicates magnetic field. 
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apply high currents directly to the scalp (which can cause strong and unpleasant 
sensations at high intensities); instead TMS works via the principles of electro-
magnetic induction. 
  During stimulation a brief but strong electrical current is delivered from 
an electrical capacitor to the TMS coil. The TMS coil contains windings of copper 
wire which conduct the current. Different TMS machines are capable of 
delivering this current using two main pulse configurations, known as mono and 
biphasic.  A monophasic pulse involves the production of a strong initial current 
which is then balanced by a dampened return current. Whereas a biphasic pulse 
is characterised by an initial current rise followed by a reverse in current and 
then again by a subsequent increase, meaning the direction of the current is 
reversed twice (Rossini et al., 2015). Both of these pulses are capable of inducing 
a fluctuating magnetic field which is perpendicular to the coil. The resultant 
fluctuating magnetic fields (which can be at strengths of 1-2 Tesla (Rossini et al., 
2015) are able to pass through the scalp and skull relatively unaltered to induce 
an electrical current in the brain. This induced current is able to interact with the 
neuronal tissue and influence electrical signalling of neuronal populations; in 
particular the induced current can depolarize neurones or their axons (Hallett, 
2000).   
The effects of TMS are dictated by a number of important factors, 
including properties relating to the hardware such as the coil type (L. G. Cohen et 
al., 1990), pulse configuration (Brasil-Neto et al., 1992; Kammer et al., 2001) and 
possibly even differences between stimulator models (Kammer et al., 2001). 
These factors can easily be controlled within studies, although may cause some 
issue when comparing across them.    
 The shape of the TMS coil influences the magnetic field generated, which 
in turn influences the strength and localization of the induced electrical current 
below. The two most prototypical coils are single round coils and figure-of-
eight/’butterfly’ coils (See Figure 2.2). Single round coils create the strongest 
induced electrical field at the circumference, whereas the peak field strength for 
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figure of eight coils is created at the intersection between the two round 
components (L. G. Cohen et al., 1990); this makes figure-of-eight coils more focal 
than round coils.  In addition to coil shape, the size of the coil is also important, 
with smaller coils resulting in more spatially restricted electrical fields (L. G. 
Cohen et al., 1990).   
 
 
 
 
 
As previously noted the nature of the TMS pulse (mono or biphasic) can 
also influence the effects of the stimulation (Brasil-Neto et al., 1992; Kammer et 
al., 2001). A TMS pulse results in a minimum of two phases (dependant on the 
pulse configuration), which are positive when the current in the coil is increasing 
and negative when the current is decreasing (Brasil-Neto et al., 1992). The 
differences in the wave forms appears to result in differences in the optimal coil 
orientation for stimulation of the motor cortex (Brasil-Neto et al., 1992; Kammer 
et al., 2001), and differences in motor threshold (Kammer et al., 2001).  It is, 
therefore, important to maintain these as constants within any study and be 
mindful when comparing between.   
2.1.1 TMS and the motor cortex 
TMS can be used to study a range of cortical areas and functions; 
however, by far the most popular area of study is the motor cortex. This is 
because of the relative ease by which reliable indicators of TMS effects can be 
obtained by measuring motor evoked potentials (MEPs). MEPs are cortically 
driven muscle contractions (induced by stimulating the motor cortex) that can be 
Figure 2.2. Illustration of figure of eight coil (left) and single round coil 
(right) with peak magnetic field shown as heat map. 
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measured using electromyography (EMG) from electrodes attached to a target 
muscle. MEPs provide a non-invasive quantifiable measure of induced activity, 
without the need for specially designed cognitive tasks or invasive procedures. 
Although this approach can be used to gain insights about various facets of 
motor cortex excitability (discussed in depth in 1.2.3 and 1.2.4), it does not allow 
for more detailed and direct information about neuronal responses.  Therefore, 
in order to discuss the biological underpinning of TMS it is necessary to first 
discuss research using single cell recording. In this method small electrodes are 
placed directly into epidural or subdural space in the spinal cord, from which 
electrical impulses traveling down the fibres can be recorded. This procedure is 
invasive and much less accessible than MEP recording, although it does offer 
some critical insights into the effects of TMS delivered to the motor cortex.   
It should be noted that the relationship between single cell recordings 
and MEPs are not straight forward. This is because even a focal TMS pulse can 
excite many corticospinal neurones (CSNs) within the stimulated area, and of 
those excited only a small proportion may be destined to influence the motor 
neurone pool of the muscle from which the MEP response is being recorded via 
EMG (Di Lazzaro et al., 2008). Nevertheless, MEPs are a well-established and 
popular research tool for exploring cortical excitability which have been greatly 
informed by research carried out with single cell recordings.  
2.1.2 Biological underpinnings 
Early studies conducted in the 1930s and 1950s using animals such as cats 
and non-human primates, revealed that when a single electrical stimulus was 
applied directly to the motor cortex a number of high frequency waves were 
detectable via electrodes placed in the medullary pyramid or the dorsolateral 
surface of the cervical spinal cord (Adrian & Moruzzi, 1939; Patton & Amassian, 
1954). Two types of waves were distinguished following a single stimulation 
which were termed direct waves (D-wave) and indirect waves (I-wave) (Patton & 
Amassian, 1954). The D-wave appeared to stem directly from excitation of the 
fast conducting corticospinal neurones (CSN), whereas the I-waves were found to 
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be largely dependent on the integrity of the cortical grey matter and were 
thought to originate indirectly via trans-synaptic activation of the CSN (Patton & 
Amassian, 1954).  These early findings in animals have proved to be robust, and 
have since been found in human participants and in response to transcranial 
stimulations.    
 Some of the first studies investigating 
the effects of modern electrical 
stimulation in humans were conducted 
with patients under anaesthetic during 
surgery. These studies revealed that a 
strong electrical currents (up to 750v) 
delivered by anodal transcranial electrical 
stimulation (TES), or induced via 
monophasic transcranial magnetic stimulation (TMS), evoked a series of 
transcending waves down the corticospinal tract which resembled D and I-waves. 
Although both stimulation types resulted in recordable volleys, the properties of 
the waves differed between them. In particular Berardelli et al. (1990) found that 
the initial waves generated by TMS were of slightly longer latency and smaller 
amplitude than those generated by TES. Similar effects have been found from 
epidural recordings in non-anaesthetised humans (Di Lazzaro, Oliviero, et al., 
1998; Nakamura et al., 1996), however, the findings have not always been 
consistent. For example, Burke et al. (1993) reported that the threshold for D-
waves produced using TMS was lower than for I-waves. This has not been found 
in subsequent studies and may be due to confounding effects of anaesthesia (Di 
Lazzaro, Oliviero, et al., 1998). Overall these studies provide strong evidence that 
various forms of transcranial electrical stimulation can successfully influence the 
motor cortex, leading to distinctive patterns of activity that can be measured 
further down the spinal cord. The different patterns of the descending volleys 
suggest differences in how the underlying tissue responds to the electrical field. 
However, the complex nature of these interactions means that even within a 
single stimulation type such as TMS, there are variations in the patterns of 
Note: 
The terms Pyramidal Tract Neurone 
and Cortico Spinal Neurones are both 
used by researchers to describe 
biological underpinnings. 
The terms are somewhat 
interchangeable as the majority of 
PTNs project onto the corticospinal 
tract  (Di Lazzaro et al., 2008). 
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response. For TMS these effects seem to be particularly dependent on factors 
such as intensity of stimulation and direction of current flow.    
Further research into the effects of TMS gave rise to the characterization 
of different I-waves evoked from a single monophasic pulse, resulting in the 
categorization of early and late I-waves. These appear to be influenced by the 
intensity of the TMS pulse, and suggest that the threshold for activation and 
consequently the mechanisms of action differ. Low TMS intensities using a 
posterior to anterior (P-A) current flow result in a single descending volley 
termed the I1-wave, which is thought to be produced by indirect activation of 
corticospinal cells (via activation of monosynaptic cortical-cortical connections 
projecting onto CSNs). At higher TMS intensities, later volleys known as late I-
waves are measurable; it has been suggested that these arise from complex 
mechanisms which result in repetitive discharge to pyramidal tract neurones 
(PTNs) (Di Lazzaro, Profice, et al., 2012). Manipulations of the inhibitory 
neurotransmitter GABA using the benzodiazepine Lorazepam found that the 
drug did not affect threshold levels of stimulation, or the I1-wave, but caused 
pronounced suppression of later I-waves (Di Lazzaro et al., 2000). This has been 
interpreted as further evidence to suggest that these late I-waves are generated 
by networks which are presynaptic to CSN (Di Lazzaro et al., 2008).  If the TMS 
intensity is increased even further, this can result in the production of D-waves. 
These do not appear to be altered by experimentally manipulated changes in 
cortical excitability and are therefore thought to be generated by the direct 
activation of corticospinal axons some way away from the cell body (Di Lazzaro, 
Profice, et al., 2012; Di Lazzaro et al., 2008). 
Another insight gleaned from experiments using direct recording is that 
the effects of stimulation are influenced by the direction in which the current is 
traveling.  Nakamura et al. (1996) found that orientating the TMS coil in a way 
which induced posterior to anterior (P-A) current flow using a monophasic pulse 
resulted in preferential production of I-waves. Conversely orientating the coil to 
induce lateral-medial (L-M) current flow resulted in preferential production of D-
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waves.  A similar effect was found by Kaneko et al. (1996), who suggested that P-
A stimulation preferentially stimulates the corticospinal tract trans-synaptically 
resulting in I-waves, whereas L-M current flow preferentially influences the 
corticospinal tract via non-synaptic activity which results in D-waves. Similar 
effects have also been found using lower TMS intensities (Di Lazzaro, Oliviero, et 
al., 1998).  
The findings relating to coil orientation suggest that different neuronal 
populations have different selective sensitivities to the direction of current flow.  
Variation in cortical folding and orientation of neurones is likely to be one of a 
number of factors which causes individual variability reported in a number of 
studies (Berardelli et al., 1990; Burke et al., 1993; Di Lazzaro et al., 2001; 
Houlden, Schwartz, Tator, Ashby, & MacKay, 1999).  
The complex nature of the interactions between the induced current and 
the underlying cortical tissue make it incredibly difficult to pinpoint exact 
mechanisms of TMS, and there are still aspects which are not well understood. 
Nevertheless, single cell recordings have provided valuable insights and highlight 
the importance of careful consideration of factors such as TMS intensity and coil 
angle in experimental use.   
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2.1.3 Single pulse measures 
Single pulse TMS involves the application of a TMS pulse in isolation. 
Although a number of pulses may be applied, the temporal gap between them is 
typically thought to be too long to induce any interactive effects; therefore, the 
pulses can be seen as independent from each other. There are various methods 
in which single pulse TMS can be used to assess cortical excitability. Of particular 
interest are motor threshold and input-output curves, both of which involve 
measuring MEPs.  
MEPs can vary in both size and shape, even in response to identical 
stimulation (Ellaway et al., 1998). As a result, the measurement of IO curves, 
motor threshold (MT) and other techniques typically involve the measurement of 
multiple MEPs in response to the same stimulation. These responses are then 
averaged to give an estimate of MEP amplitude in response to given parameters.  
The variability of MEPs is likely to stem from a combination of factors, including, 
Key points:  
 TES and TMS can induce descending corticospinal volleys in subtly 
different ways.  
 TMS intensity influences responses. Lower intensities produce I1 
waves associated with indirect activation of CSNs via monosynaptic 
corticocortical connections. Higher intensities produce late I waves 
which are associated with repetitive discharge to CSNs via presynaptic 
networks.  
 Coil orientation can critically influence the effect of the TMS pulse. In 
particular, P-A current flow preferentially produces I-waves. Whereas 
L-M currents preferentially produce D-waves.  
 The effects of a single TMS pulse on the human motor cortex are 
highly complex and relate to properties of the induced current and the 
structural arrangement of neural circuits.  
32 
 
the number of recruited motor neurones in the spinal cord, the number of motor 
neurones discharging more than once to a stimuli, and the synchronization of the 
TMS-induced motor neurone discharges (Rosler & Magistris, 2008). As these 
effects are particularly difficult to predict or account for, the use of averaged 
MEP amplitude in response to stimulation has become standard practice and is 
used in the measurement of all the following methods.  
Motor threshold (MT) 
A critical advantage of applying TMS to the motor cortex is the ability to 
individualize the intensities used; this can be achieved by calibrating intensities 
to what is known as an individual’s motor threshold (MT). MT is defined as the 
amount of stimulation needed (expressed as a percentage of maximal stimulator 
output) to reliably generate a MEP of a predefined magnitude (typically 50-100 
µV). This can be measured in a muscle at rest (resting motor threshold RMT) or 
during a slight contraction (active motor threshold AMT) (Devanne et al., 1997). 
AMT is typically lower than RMT and also results in a shorter delay between 
pulse delivery and MEP production (Hess et al., 1987). MT is lower in intrinsic 
hand muscles and increases in proximal muscles occurring in the lower limbs, 
arms and trunk (Chen et al., 1998).  
MT (measured using a standard monophasic P-A TMS pulse) is thought to 
largely reflect the effects of the I1-wave (Hallett, 2007), and is considered to be 
predominantly reflective of indirect activation of corticospinal neurones (CSNs) 
(via activation of monosynaptic cortical-cortical connections) (Di Lazzaro, Profice, 
et al., 2012). Therefore, MT is thought to reflect the excitability of the main 
corticospinal projections to the target muscle with the lowest excitation 
threshold  (Hallett, 2007).  
Pharmacological studies have found that voltage-gated sodium channel 
blockers such as carbamazepine increase MT (Menzler et al., 2014; Ziemann, 
Lonnecker, et al., 1996). Voltage-gated sodium channels are known to be critical 
in regulating the excitability of axons, therefore these results provide further 
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support that MT reflects the excitability of cortical-cortical fibre axons excited by 
TMS (Ziemann, 2013). Glutamatergic mechanisms may also be important. 
Ketamine, which is a NMDA receptor antagonist and indirectly increases 
glutamate via α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors (Du et al., 2007), has been found to decrease motor threshold (Di 
Lazzaro et al., 2003). This may suggest that MT also reflects fast ionotropic 
glutamatergic neurotransmission via the synapses connecting these fibres to 
corticospinal neurones (Ziemann, 2013). 
MTs are known to be highly variable between, but not within individuals 
(Mills & Nithi, 1997). They also appear to have a genetic component, as the MTs 
of siblings have been found to be highly correlated (Wassermann, 2002). This 
correlation may reflect the heritability of factors such as skull density or 
potentially even intrinsic neuronal properties.  A strong predictor of MT is scalp 
to cortex distance (Cukic et al., 2009; Herbsman et al., 2009; Kozel et al., 2000; 
McConnell et al., 2001; Stokes et al., 2005). It has been estimated that for every 
1mm away from the TMS coil it is necessary to increase the stimulator output by 
approximately 3% to induce the equivalent amount of stimulation within the 
motor cortex (Stokes et al., 2005). The orientation of white matter fibres has also 
been found to be predictive of MT (Herbsman et al., 2009). Taken together scalp-
cortex distance and white matter fibre orientation in the corticospinal tract have 
been estimated to predict up to 82% of the between subjects variance in MT 
(Herbsman et al., 2009). Some studies have reported a correlation with age 
suggesting that aging increases MT (Rossini et al., 1992; Smith et al., 2009), 
however, this appears to be somewhat unreliable as other studies have found no 
association (Herbsman et al., 2009; McConnell et al., 2001; Wassermann, 2002). 
The effects of handedness may also contribute to variation in MT, however, as 
with age, the evidence is mixed. Some studies report that MT is significantly 
lower in response to stimulation of the dominant hemisphere (Macdonell et al., 
1991; Triggs et al., 1994), but this has not always been found to be the case 
(Civardi et al., 2000; Rossini et al., 1992; van der Kamp et al., 1996). Interestingly 
even when MT was not found to be significantly different, the stimulated area 
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which could produce an MEP has been found to be larger in the dominant 
hemisphere (Triggs et al., 1999).   
Input output (IO) curves  
Another common method of assessing cortical excitability is to calculate 
input output (IO) curves (also sometimes known as recruitment curves or 
stimulus response curves). IO curves are measured by recording MEP amplitudes 
evoked from various intensities of TMS; typically, these intensities are 
individualized for each participant using percentages of their MT (see Figure 2.3 
for example).  
Compared with MT, IO curves can measure activity from neurones which 
are spatially further away from the centre of activation. They can be used as an 
index of excitability within a wider region of the cortex and are thought to reflect 
the strength of corticospinal projections (Chen, 2000). Evidence from a range of 
pharmacological studies suggests that there are important differences between 
the mechanisms for MT and those which mediate MEPs evoked from higher 
stimulation intensities (Ziemann, 2013). As IO curves measure a range of 
intensities they encompass different physiological processes at different parts of 
the curve.  
35 
 
 
The IO curve contains two distinctive components: the bias level (also 
known as the threshold) and the gain/slope (Devanne et al., 1997).  In addition to 
this, IO curves may also show a plateau, which is characteristic of their sigmoidal 
shape in which MEP amplitude increases steeply close to MT and then eventually 
plateaus at higher intensities (Devanne et al., 1997; Hess et al., 1987).  As 
previously noted, low intensities of TMS (delivered with a P-A current flow) 
appear to elicit a single I-wave, whereas stronger intensities result in the 
production of additional late I-waves (Di Lazzaro et al., 2008). It has been 
suggested that these later I-waves are likely to occur through the activation of 
corticospinal interneurons via excitatory interneurons which are controlled by 
many neurotransmitters (see (Ziemann, 2013) for review). In addition to this the 
higher TMS intensities have also been found to elicit D-waves resulting from 
direct activation of the corticospinal tract (Di Lazzaro et al., 2001). As a result of 
Figure 2.3 A. Example of EMG recording showing increasing MEP amplitude resultant of 
increased TMS intensity. Arrows indicate passing of time. B. IO curve data with slope 
fitted to median values for each intensity (red circles). 
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the different underlying mechanisms the slope and intercept of IO curve should 
be examined separately.  
Unlike MT there is evidence that IO curves may be effected by participant 
age. Pitcher et al (2002) found that although the maximum amplitude of MEPs in 
older and younger subjects was similar, it took higher stimulator intensities to 
achieve this in the older participants. This is an important factor to consider 
when conducting studies with a large age range.    
When measuring IO curves it is standard protocol to measure each 
intensity multiple times in order to address variability within the MEP response. 
This can be done by measuring the response to stimulation in a ramped (blocked 
trials of ascending or descending intensity) or in a randomized fashion. The 
method chosen may have a significant effect on the data collected, particularly 
when short inter-trial-intervals (ITIs) such as 5 seconds (s) are used. Moller et al. 
(2009) found that measuring IO curves using increasing intensity strengths 
resulted in shallower curves than when stimulation was decreased; the effect of 
randomized pulses resulted in a curve between the other two.  This was found 
for 5s ITIs but not when 20s was used. Pearce et al. (2013) also found no 
significant differences between ramped and randomized pulses when ITI was set 
at 6-20s.  Therefore, when short ITIs are used, the order of stimulus intensity 
should be randomized.   
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2.1.4 Paired pulse measures 
Another method of assessing cortical excitability using TMS involves the 
use of paired pulse protocols. These techniques use a conditioning-test paradigm 
in which the first pulse modulates the second. The two pulses are typically 
delivered to the same location with a set Inter-Stimulus-Interval (ISI) between 
them, the duration of which determines 
whether the effects are excitatory or 
inhibitory (see Figure 2.4). Short ISIs of 1-5 
milliseconds (ms) typically lead to an 
increase in inhibition, whereas longer ISIs of 
8-30ms have been found to lead to 
facilitation (O'Shea & Walsh, 2007). 
Interestingly, increasing the ISI to 50-200ms 
has also been found to lead to inhibition, 
however, for these long ISIs to become 
inhibitory it is necessary to use a different 
conditioning stimulus intensity than used for 
1-5ms protocols. Some notable paired pulse 
techniques are short interval intracortical 
inhibition (SICI), intracortical facilitation (ICF) 
and long interval intracortical inhibition 
(LICI). 
Short interval intracortical inhibition (SICI) 
One of the most established paired pulse techniques is short interval 
intracortical inhibition (SICI), which involves the application of a sub-threshold 
conditioning stimulation (CS) followed by a supra-threshold test stimulation (TS) 
delivered through the same coil after an ISI of 1-5ms (Hanajima & Ugawa, 2008). 
SICI was first documented by Kujirai et al. (1993) in the human motor cortex, and 
has since been studied extensively in both healthy subjects (Garry & Thomson, 
2009; Roshan et al., 2003) and patient populations (Cantello et al., 2002; 
Figure 2.4. Example EMG readout 
for various TMS measures. 
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Daskalakis et al., 2002; Gilbert et al., 2011; Ridding et al., 1995; Ziemann et al., 
1997). The subthreshold conditioning stimuli used in SICI is not thought to 
influence excitability in the spinal cord, as these intensities do not appear to 
produce recognisable epidural volleys when tested alone (Di Lazzaro, Restuccia, 
et al., 1998). At present it is widely thought that the conditioning pulse causes a 
short lasting inhibitory postsynaptic potential in corticospinal neurones via the 
activation of a low-threshold cortical inhibitory circuit. The engagement of this 
circuit is then thought to inhibit the action potentials generated in the same pool 
of corticospinal neurones in response to the test stimulus (see Ziemann (2013) 
for a review).  
Animal models and pharmacological studies have suggested that the 
effects of SICI are strongly mediated by activity linked to the inhibitory 
neurotransmitter gamma-aminobutyric acid (GABA), in particular GABA-A 
receptors appear to be heavily implicated (Hanajima & Ugawa, 2008). For 
example, a number of pharmacological studies have found that administration of 
benzodiazepines (thought to positively modulate GABA-A receptors) increases 
levels of SICI (see Ziemann (2013) for a review).  In addition the exploration of 
the effects of other drug manipulations on SICI suggest that the effect is more 
related to the receptor subtypes a2- and a3-GABA-A rather than a1-GABA-A  
receptors (Ziemann, 2013).  GABA-B receptors have also been implicated, for 
example, the GABA-B receptor agonist baclofen has been found to significantly 
decrease the effect (McDonnell et al., 2006).  The effects of GABA-B modulation 
have been linked to activation of presynaptic GABA-B receptors which are 
effective in reducing GABA release. It has been proposed that it is this process 
that influences SICI (McDonnell et al., 2006).  
Interestingly the effects of SICI may be non-uniform. Although SICI is 
noted to occur using ISIs of 1-5ms, SICI resulting from 1ms ISIs appears to have 
different properties than those occurring at later time points (Cengiz et al., 2013; 
Fisher et al., 2002; Roshan et al., 2003). Initially it was proposed that the effects 
of 1ms ISIs may be due to refractory periods of cortical-cortical axons (Fisher et 
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al., 2002), however, this was cast into doubt by later research which found that 
levels of inhibition were increased when higher TS were used (Roshan et al., 
2003). Roshan et al. (2003) argued that if refractory periods were responsible 
then increasing the intensity of the TS would lead to a reduction in inhibition. 
This is because TS intensities at increasing strengths would lead to the 
recruitment of non-refractory interneurons in addition to those in refractory 
states caused by the CS. Based on this, conclusions were made that 1ms SICI 
cannot be explained by axonal refractory periods alone, and that synaptic 
inhibition may also contribute (Roshan et al., 2003). These findings have been 
supported by some (for example, Vucic et al. (2009)), however, there are others 
who favour the refractory period theory as an explanation of their findings. For 
example, a study by Stagg et al. (2011) found a correlation between levels of 
GABA measured using magnetic resonance spectroscopy (MRS) and the amount 
of inhibition that was found using a 1ms SICI protocol. No correlations were 
found between MRS measured GABA and SICI measured using a 2.5ms ISI. The 
authors speculated that MRS may measure extra-synaptic, tonic GABA, which has 
the effect of depolarizing neuronal axons (via increases in chloride ions) leading 
to the lengthening of the refractory periods. This may seem counter-intuitive at 
first as increased tonic GABA would typically be expected to cause 
hyperpolarization of the cell membrane, however, the authors argue that 
differences between the concentrations of chloride ions between the cell body 
and axon can account for these results. Research using transcranial Direct 
Current Stimulation (tDCS) by Cengiz et al. (2013) also supports a distinction 
between the mechanisms of early and late SICI. The effects of tDCS were found 
to influence the early component of SICI in the opposite direction to that of SICI 
measures with ISIs of 2.5-5s.  However, although both Stagg et al. (2011) and 
Cengiz et al. (2013) suggest refractory periods as possible mechanisms of 1ms 
SICI, neither are able to test this directly. Therefore, the origins of the response 
still remain somewhat elusive.  
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Intracortical facilitation (ICF) 
ICF is measured using a similar condition-test protocol to SICI, but with 
longer intervals of 7-20ms between the two pulses (Kujirai et al., 1993). Although 
the mechanisms of ICF are less well understood, there is a general consensus 
that ICF tests the excitability of an excitatory neuronal motor network which is 
distinctive to the SICI network (Ziemann, 2013).  Differences have been found 
between the threshold and optimal coil angle for the two measures (Ziemann, 
Rothwell, et al., 1996). In addition to this, the profile of effects of various drugs 
on ICF are very different to the pattern seen for SICI (Ziemann, 2013). Both N-
methyl-D-aspartate (NMDA) receptor antagonists and manipulations that 
positively modulate GABA-A receptors have been found to reduce ICF (Ziemann, 
2013). This suggests that ICF is in part modulated via processes that involve 
glutamatergic and GABAergic mechanisms. Positive modulators of 
norepinephrine have been found to consistently enhance ICF, which suggest a 
strong modulating effect (for review see Ziemann, 2013). 
Long Interval Intracortical Inhibition (LICI) 
Long interval intracortical inhibition (LICI) is a paired pulse protocol which, 
like SICI, leads to inhibition of the size of MEPs evoked from a test pulse.  LICI can 
be measured using two supra-threshold pulses separated by 50-200ms (Claus et 
al., 1992; Di Lazzaro et al., 2002; Valls-Sole et al., 1992), and is thought to be 
mediated by GABA-B receptors. Direct evidence for this comes from the findings 
that the GABA-B receptor agonist baclofen has been found to strongly increase 
the effects of LICI (McDonnell et al., 2006). Although baclofen has also been 
found to effect SICI (McDonnell et al., 2006), the two mechanisms are distinct. In 
particular SICI is thought to be strongly mediated by GABA-A receptors and is 
influenced by the administration of the GABA-A agonist lorazepam (Di Lazzaro et 
al., 2006; Teo et al., 2009) whereas LICI is not affected by this manipulation (Teo 
et al., 2009).  In addition, increasing the test pulse strength has been found to 
increase SICI effects but reduce those of LICI (Sanger et al., 2001). Increasing the 
intensity of the test stimuli is thought to result in the recruitment of neurones 
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spatially further away from the site of action and/or with higher thresholds. The 
evidence suggests that these neurones are more sensitive to SICI than LICI 
protocols and, therefore, provide evidence that the effects are mediated by 
distinct cell populations. 
While LICI is reported to occur using ISIs of 50-200ms, it appears that the 
exact ISI used exerts a subtle influence over the effect. Di Lazzaro et al. (2002) 
found that LICI occurring at ISIs of 100 and 150ms caused a reduction in MEP 
amplitude and also supressed I2 and later waves, which are thought to be of 
cortical origin. Within the same participants, ISIs of 50ms were also found to 
reduce MEP amplitudes, however, the amplitude of late I-waves was increased. 
This suggests that the inhibitory effects of 50ms LICI may occur at subcortical 
locations such as the spinal cord. As a result of this finding much subsequent 
research has used ISIs of 100ms and longer to measure LICI.  
2.2 Magnetic Resonance Spectroscopy 
 
Proton MRS (1H MRS) is a non-invasive neuroimaging technique which can 
be used to quantify levels of metabolites within a predefined location. Unlike 
TMS the MRS technique allows neurotransmitters such as GABA and glutamate 
to be measured in various brain regions and is not restricted to the motor cortex. 
This is done through the placement of a small Volume of Interest (VOI), for 
example a 2*2*2cm voxel cube, within a predefined location during scanning. 
Levels of metabolites within this location are then measured by detecting 
radiofrequency signals that arise from hydrogen nuclear spins within the tissue. 
The signals produced by different metabolites have chemically specific 
frequencies caused by the chemical environment of the hydrogen spins (Puts & 
Edden, 2012). Once acquired, the resulting MRS signals can be separated into a 
spectrum known as the chemical shift, from which it is possible to quantify levels 
of metabolites present in the voxel.  
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Although MRS has proven to be a useful research tool, it is not clear 
exactly where the signals it detects are produced. For example, GABA can be 
present intracellularly within both neurones and glia, in addition to being present 
in extracellular locations. Furthermore, GABA is part of a complex metabolic 
cycle and is largely synthesised from glutamine via glutamate, therefore at any 
one time point only a fraction of MRS-GABA will be neurotransmitter (Rae, 
2014). This is a complex and important issue. In the instance of the 
neurotransmitter GABA, these different pools can lead to subtly different 
processes known as tonic and phasic inhibition. GABA present at the synapse is 
associated with phasic inhibition. This involves the release of GABA within 
synaptic vesicles which then diffuses across the synaptic cleft to occupy 
postsynaptic GABA receptors. This process is very quick as the receptors have a 
low-affinity meaning the molecules only occupy the cleft for a very brief period 
of time, resulting in a brief postsynaptic conductance change (Brickley & Mody, 
2012). Extra synaptic ambient levels of GABA are associated with tonic inhibition, 
which occurs via extra synaptic GABA acting on related extra synaptic receptors. 
These receptors have a high-affinity and, therefore binding here can result in 
persistent conductance and longer lasting inhibition (Brickley & Mody, 2012). 
As previously noted, MRS measures the total concentration of 
neurochemicals within a predefined area, in doing so it is not possible to 
distinguish separate functional pools, however, it is possible to examine 
correlations between other measures such as TMS to help understand the origin 
of the signal. Tremblay et al. (2013) found SICI and LICI were not significantly 
associated with MRS measured levels of GABA; this was also found by Stagg et al. 
(2011), albeit with subtly different parameters. These findings suggest that the 
GABA measured by MRS is not predominantly of synaptic origin. Stagg et al. 
(2011) identified a significant relationship between MRS measured GABA and 
SICI measures using a 1ms ISI. The mechanisms by which 1ms SICI works are still 
somewhat elusive, however, it is possible that it may reflect refractory periods 
occurring at the axon, which may suggest an involvement of tonic GABA levels. 
On the basis of this, Stagg et al. (2011) have suggested that MRS measured GABA 
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reflects extra-synaptic inhibitory tone. This should be viewed with caution as the 
finding is highly speculative and yet to be replicated. Stagg et al. (2011) also 
found that the slope of IO curves was significantly correlated with measures of 
MRS glutamate, which suggests this reflects pre-synaptic levels of glutamate. 
However, IO curves were also correlated with MRS measured GABA, whereby 
higher levels of GABA were associated with steeper slope. This is counter 
intuitive as steeper slopes are indicative of higher cortical excitability. The 
authors speculate that this relationship is probably driven through the close 
biochemical relationship between the two neurotransmitters as the majority of 
GABA is metabolised from glutamate. A further complication is the fact that it is 
not always possible to separate out individual metabolites. For example, the 
ability to separate glutamate and glutamine is dependent on properties relating 
to the scanner and also the scanning sequence as a result a number of studies 
report a composite measure known as glx. These factors should be considered 
when reviewing MRS findings across studies.  
2.3 Transcranial Direct Current Stimulation 
 
As outlined in Chapter 1, tDCS is a non-invasive stimulation technique, 
which has the ability to effectively modulate cortical excitability. The underlying 
mechanisms of tDCS have been explored using a range of different methods 
including animal models, TMS and MRS. Key findings are discussed below.  
2.3.1 Insights from animal research 
As previously mentioned in Chapter 1, findings from early animal work 
have provided a fundamental starting point for understanding the influence of 
electrical stimulation in the human brain. With regard to tDCS this research has 
been particularly important for understanding polarity specific effects.  Two 
notable studies which address this were conducted by Bindman et al. (1964)  and  
Creutzfeldt et al. (1962) using direct cellular recordings from anesthetised 
animals. Using these techniques, it was found that spontaneous neuronal 
discharges were increased by surface positive current and decreased by surface 
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negative current. Interestingly the polarity specific effect did not appear to be 
true for all neurones. At deeper levels of the cortex (more than 3mm deep) 
Creutzfeldt et al. (1962) found positive currents had an inhibitory effect and vice 
versa for negative currents. In addition to this, research by Purpura and 
McMurtry (1965) revealed that both non-pyramidal tract neurones and 
pyramidal tract neurones were sensitive to different current densities, with non-
pyramidal tract neurones being stimulated at lower total charge than pyramidal 
neurones (which were not influenced by charge densities of 40-80µV/mm). 
These findings suggest that interneuron populations may be more sensitive to 
the low intensities of stimulation typically applied during tDCS (1/2mA) than 
pyramidal tract neurones.     
These findings have important implications for studies in humans. They 
indicate that the orientation of neurones relative to the electrical field is likely to 
be critical to the response. They also highlight that tDCS may stimulate different 
populations of neurones and that the effects may differ depending on the 
intensity of the stimulation used and the depth of the neurones stimulated. 
Another important finding from the animal literature is that the effects of 
electrical stimulation are present both during and after current application 
(Bindman et al., 1964; Purpura & McMurtry, 1965). These findings have since 
been explored in humans and are typically referred to as ‘online’ and ‘offline’ 
effects. The so called offline effects of tDCS may be dependent on long term 
depression (LTD) and long term potentiation (LTP) type plasticity, whereby 
synaptic connections are strengthened or weakened in response to previous 
activity. Some direct evidence for this is provided by Fritsch et al. (2010) who 
found evidence of LTP-like plasticity in an in vitro mouse study, where an anodal 
stimulation was passed through a slice preparation of the motor cortex. This was 
found to be dependent on the neurotrophic brain-derived neurotrophic factor 
(BDNF), which is implicated in synaptic plasticity and is thought to be dependent 
on NMDA receptor activation (Fritsch et al., 2010).   
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With the exception of a handful of invasive studies (for example, Dymond 
et al. (1975)), tDCS research in humans has been carried out using non-invasive 
methods with lower intensities than those used in the animal research. The 
current is applied to the scalp which differs from many early animal studies   
(Bindman et al., 1964; Creutzfeldt et al., 1962; Purpura & McMurtry, 1965)  in 
which the current was applied directly to the surface of the cortex. Applying the 
current to the scalp results in a less focal stimulation as the current flow can 
become distorted by a number of factors including the conductivity of the 
different tissue types it passes through (Sadleir et al., 2010). This is important to 
consider when comparing between animal and human studies. Further insights 
into the mechanisms underlying tDCS effects in humans come from studies using 
pharmacological manipulations, TMS and brain imaging techniques such as MRS. 
These studies have revealed differences between online and offline effects and 
will therefore be discussed separately.  
2.3.2 Insights from pharmacology, TMS and MRS 
Online effects of tDCS 
Findings from pharmacological and TMS research suggest that the online 
effects  of tDCS are largely mediated by changes in membrane potential rather 
than changes in synaptic plasticity (Stagg & Nitsche, 2011). Nitsche, Fricke, et al. 
(2003) found that when calcium-gated ion channels were blocked using 
Flunazine (FLU) anodal stimulation did not change cortical excitability. The 
blocking of sodium-gated ion channels using Carbamazepine (CBZ) also 
prevented any effects of online anodal stimulation. Interestingly the online 
effects of cathodal stimulation were not influenced by FLU or CBZ; this could be 
due to cathodal stimulation hyperpolarizing the neuronal membrane which 
would make it insensitive to the effects of both FLU and CBZ (Nitsche, Fricke, et 
al., 2003).  Evidence that online anodal tDCS does not influence glutamatergic or 
GABAergic interneurons comes from the finding that the TMS measures of ICF  (a 
measure of glutamatergic interneurons) and SICI (a measure of GABAergic 
interneurons) are not significantly influenced by the stimulation (Nitsche et al., 
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2005).  Blocking of glutamatergic NMDA receptors using dextromethorphan 
(DMO) also did not influence the effects (Nitsche, Fricke, et al., 2003). 
Interestingly the effects of cathodal stimulation appear to be subtly different to 
those of anodal. Although blocking of NMDA receptors using DMO did not 
influence effects (Nitsche, Fricke, et al., 2003), online cathodal stimulation has 
been found to reduce the effects of ICF and also to alter the slope of IO curves 
(Nitsche et al., 2005). The changes in ICF appear to suggest an involvement of 
glutamatergic interneurons. However, the changes in IO curves provide further 
support that the effect occurs by modulating the membrane potential of 
glutamatergic interneurons rather than synaptic activity, because changes in IO 
curves are typically thought to represent changes in interneuronal activity  
(Stagg, 2014).  
 
Offline effects of tDCS 
Residual offline effects of tDCS are commonly found after stimulation, 
and have been known to last from a few minutes to a number of hours. The 
strength and duration of these effects appears to be dependent on the duration 
and intensity of the stimulation used, however, for the most part the 
mechanisms underlying these effects appears to be similar.  
 
The after-effects of anodal tDCS are thought to reflect changes in synaptic 
strength and appear to be dependent on membrane depolarization. 
Pharmacological blocking of calcium and sodium channels using CBZ and FLU 
prevented the occurrence of any observable alterations in cortical excitability 
(Nitsche, Fricke, et al., 2003). Evidence from TMS studies (see Table 2.1) suggests 
that offline anodal effects are likely to involve widespread interneurons, as they 
have been found to influence IO curves but not motor thresholds (Nitsche et al., 
2005). It also seems likely that the effects involve synaptic modulation and, in 
particular, GABAergic and glutamatergic systems may be influenced. The effects 
of SICI have generally been reported to reduce following anodal stimulation 
(Batsikadze et al., 2013; Kidgell et al., 2013; Nitsche et al., 2005), which strongly 
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suggests the involvement of GABA-A receptors. In addition, studies using MRS 
measured levels of GABA have reported a significant reduction in the stimulated 
area following anodal stimulation (Kim et al., 2014; Stagg et al., 2009). ICF has 
also been found to increase after anodal tDCS (Batsikadze et al., 2013; Nitsche et 
al., 2005) and a trend towards increase in Glx (a composite of glutamate and 
glutamine) has been reported in an MRS study following stimulation (Stagg et al., 
2009). In addition, pharmacological blocking of N-methyl-D-aspartate (NMDA)-
receptors (which are glutamate sensitive) using DMO has been found to prevent 
after-effects (Liebetanz et al., 2002; Nitsche, Fricke, et al., 2003). The 
involvement of NMDA receptor activity is particularly interesting as these 
receptors have known involvement in cortical neoplastic mechanisms like LPT 
and LTD (Bennett, 2000). Pharmacological manipulations have also revealed that 
the after-effects may be influenced by neuromodulators such as norepinephrine, 
dopamine and serotonin. In particular, the effects of dopaminergic systems may 
have an important role due to their involvement in synaptic plasticity (see Stagg 
(2014) for review).   
 
The after-effects of cathodal stimulation appear to be less dependent on 
membrane polarization than those of anodal. Pharmacologically blocking of 
sodium and calcium channels using CBZ and CBU does not appear to influence 
the effects (Nitsche, Fricke, et al., 2003). However, it is possible that this is due to 
measurement issues (as discussed for online effects) and, therefore, it is not yet 
possible to conclude that membrane polarization changes are not at least in part 
involved. As with anodal stimulation there is evidence that a wide pool of 
interneurons may be involved in the effect. This evidence comes from the finding 
that although motor thresholds are not influenced, the slope of IO curves has 
been found to decrease (Nitsche et al., 2005) as has the size of MEPs evoked 
from TMS intestines which previously resulted in 1mV MEP 
amplitudes(Furubayashi et al., 2008; Nitsche & Paulus, 2000). Cathodal after-
effects also appear to be in part dependent on the modulation of glutamatergic 
synapses. ICF was significantly reduced following stimulation (Nitsche et al., 
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2005) and blocking of NMDA receptors using DMO has been reported to abolish 
after-effects (Nitsche, Fricke, et al., 2003). Evidence from MRS work also 
supports the role of glutamate; in a study by Stagg et al. (2009) glutamate 
concentration was found to reduce following cathodal stimulation. Taken 
together the evidence seems to support a strong role of the modulation of 
glutamatergic activity, however, the results of pharmacology studies have not 
always been consistent and some attempts to modify glutamate have failed to 
impact on after-effects (see Stagg (2014)). Evidence for the involvement of 
GABAergic mechanisms are also somewhat mixed between the different 
methods. TMS research using SICI has found that SICI appears to be increased 
following cathodal stimulations of less than 2mA (Batsikadze et al., 2013; Nitsche 
et al., 2005). A reduction in GABA concentration has also been reported using 
MRS (Stagg et al., 2009), however, the evidence from pharmacology studies is 
more mixed. The variations found between the different methods may be due to 
their different sensitivities and the possibility that they are 
measuring/influencing neurotransmitters at different sites (such as synaptic and 
extra synaptic levels). In addition, some of the complex findings from 
pharmacological studies may relate to the close association which exists 
between glutamate and GABA (Stagg & Nitsche, 2011).  
Overall the mechanisms underlying the effects of anodal tDCS both online 
and offline appear to be clearer than those of cathodal stimulation. 
Nevertheless, we are coming closer to understanding how the effects truly work 
which can only be beneficial in understanding their future uses, particularly as 
therapeutic interventions.  
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Table 2.1. Notable TMS investigations of tDCS effects.  
TMS Measure Protocol Mechanisms Anodal after 
effects 
Cathodal after 
effects 
Resting motor 
threshold 
(RMT)  
Intensity 
needed to 
induce an MEP 
of a predefined 
amplitude 
(typically 50-
100µV).  
Corticospinal tract (CSP) 
neurones and closely 
associated intracortical 
neurones. 
Neuronal membrane 
excitability (Ziemann, 
Rothwell, et al., 1996). 
Not effected 
(Batsikadze et al., 
2013; Nitsche et al., 
2005; Quartarone et 
al., 2005; Scelzo et 
al., 2011) 
Generally not effected 
(Batsikadze et al., 2013; 
Di Lazzaro, Manganelli, 
et al., 2012; Nitsche et 
al., 2005; Quartarone 
et al., 2005). However 
one study did find a 
difference in 
individuals with 
schizophrenia and 
matched controls 
(Hasan et al., 2012).  
Single pulse 
MEPs (at 1mV 
or over) 
Single pulse 
TMS, multiple 
pulses at the 
same intensity.  
CSP neurones and 
intracortical inter-
neurones over a wider 
area. Neuronal membrane 
excitability but also 
GABAergic involvement 
(Boroojerdi et al., 2001), 
particularly at higher 
intensities.  
With a few 
exceptions (Priori et 
al., 1998), generally 
found to increase 
MEP amplitude 
(Batsikadze et al., 
2013; Furubayashi et 
al., 2008; Kidgell et 
al., 2013; Nitsche & 
Paulus, 2000) 
With a few exceptions 
(Priori et al., 1998), 
generally found to 
decrease MEP 
amplitude (Furubayashi 
et al., 2008; Nitsche & 
Paulus, 2000)when 
intensities of less than 
2mA are used 
(Batsikadze et al., 
2013). No effects found 
by Strube et al. (2016).  
Input- output 
curve (IO curve) 
Single TMS 
pulses delivered 
at increasing 
intensities.  
See single pulse MEPs.  
 
Slope increase 
(Nitsche et al., 2005), 
although not always 
found (Batsikadze et 
al., 2013; Strube et 
al., 2016). 
Slope decrease 
reported (Nitsche et al., 
2005) although not 
always found to be 
significant (Batsikadze 
et al., 2013). 
Short 
intracortical 
inhibition 1ms 
(SICI) 
Paired pulse 
technique. First 
pulse sub 
threshold, 
second supra. 
ISIs of 1ms.  
Unclear, potentially 
refractory periods (Fisher 
et al., 2002) and/or 
synaptic inhibition 
(Roshan et al., 2003). 
Offline effects 
unknown. 
Increase in inhibition 
found during 
stimulation (Cengiz et 
al., 2013).  
Offline effects 
unknown.  
Decrease in inhibition 
found during 
stimulation (Cengiz et 
al., 2013).  
Short 
intracortical 
inhibition (SICI) 
Paired pulse 
technique. First 
pulse sub 
threshold, 
second supra. 
ISIs of 1.5-5ms. 
 GABAA ergic 
interneurones (Ziemann, 
2013) 
 
 
Reduce inhibition 
reported (Batsikadze 
et al., 2013; Cengiz et 
al., 2013; Kidgell et 
al., 2013; Nitsche et 
al., 2005) 
Increased inhibition 
reported (Nitsche et al., 
2005), opposite effects 
reported when 2mA 
stimulation used 
(Batsikadze et al., 
2013) 
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Long 
intracortical 
inhibition (LICI) 
Paired pulse 
technique, both 
pulses supra 
threshold. ISI of 
50-200ms.  
GABAB receptors 
(McDonnell et al., 2006). 
No significant effects 
reported (Antal et al., 
2010) 
 
Intracortical 
facilitation (ICF) 
Paired pulse 
technique. First 
pulse sub 
threshold, 
second supra. 
ISIs of 7-20ms. 
Glutamatergic and 
potentially GABAergic 
interneurons (Liepert et 
al., 1997; Ziemann, 
Lonnecker, et al., 1996) .  
Increased facilitation 
(Batsikadze et al., 
2013; Nitsche et al., 
2005) 
Decreased facilitation 
(Nitsche et al., 2005), 
opposite effects 
reported with 2mA 
stimulation (Batsikadze 
et al., 2013). 
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 Exploring the temporal effects of tDCS 
 
Key words: transcranial direct current stimulation (tDCS), transcranial magnetic 
stimulation (TMS), resting motor threshold (RMT), input output curve (IO curve). 
 
3.1 Introduction 
 
As discussed in the previous chapter, much of the past research into the 
effects of tDCS suggests the existence of a well-established pattern of responses, 
whereby anodal currents increase and cathodal currents decrease excitability. It 
is also established that tDCS has both online and offline effects which are 
mediated by partially distinct mechanisms. Online effects are thought to arise 
from changes occurring at the neuronal membrane, whereas the offline effects 
appear to occur primarily through changes in synaptic plasticity (Stagg & Nitsche, 
2011).  
The duration of the offline effect is thought to be dependent on the 
duration and intensity of the stimulation used, for example, intensities of 1mA 
appear to induce longer lasting effects than those occurring following intensities 
of 0.8mA and below (Nitsche & Paulus, 2000). On the basis of these findings it is 
tempting to assume that stronger intensities applied for longer durations will 
lead to more prolonged effects; however, this assumes that the effects follow a 
linear stimulus-response type pattern. Research by Batsikadze et al. (2013) 
highlights that this is not always the case. Batsikadze et al. (2013) found that 
although 20minutes of 1mA cathodal stimulation applied to the motor cortex 
caused a reduction in cortical excitability, 2mA stimulation caused an unexpected 
increase. This reversal of effects at higher intensities was not found for anodal 
stimulation which appears to be more stable. Interestingly the reversal following 
cathodal tDCS only became significant 90 minutes after stimulation ended. This is 
a critical finding as it suggests that the effects of tDCS are at least partially non-
linear; it also highlights that the optimal time for measuring change may not 
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always be immediately following stimulation. The findings have added 
importance as 2mA intensities have become increasingly popular in behavioural, 
cognitive and clinical studies (Batsikadze et al., 2013; Nitsche & Paulus, 2011). If 
these findings can be replicated, it would strongly suggest that caution is 
warranted when using cathodal stimulation in therapeutic contexts, particularly 
if 2mA is applied with the aim of reducing cortical excitability. At the time of 
writing, the findings of Batsikadze et al. (2013) have yet to be replicated.  One 
notable study conducted by Wiethoff et al. (2014) found that, overall, 2mA of 
cathodal stimulation had no discernible effect on cortical excitability. However, 
methodological differences between the two studies may account for the 
discrepancy. In particular Wiethoff et al. (2014) used a stimulation duration of 10 
minutes and only measured effects immediately after stimulation, therefore any 
effects occurring at later time points would have been missed.   
The mechanisms underlying the effects of 2mA cathodal stimulation are 
unknown. However, similar instances of non-linear effects have been reported as 
a result of increased intensity using stimulation protocols such as theta burst 
TMS (Doeltgen & Ridding, 2011),  transcranial random noise stimulation (tRNS) 
and transcranial alternating current stimulation (tACS) (V. Moliadze et al., 2012).  
It is speculated by Batsikadze et al. (2013) that these reversal effects may relate 
to the amount of calcium influx caused by the respective stimulations. This 
would stand to reason for offline tDCS effects, as these are known to be 
somewhat dependent on calcium channel mechanisms (Nitsche, Fricke, et al., 
2003).  These changes in calcium channel mechanisms could relate to different 
populations and parts of neurones being stimulated. In early animal studies 
Purpura and McMurtry (1965) found that non pyramidal tract neurones and 
pyramidal tract neurones were sensitive to different current densities. Therefore, 
there is a possibility that increasing stimulation intensity leads to stimulation of 
different parts of the neurone present at different depths, or even different 
types of neurone, and that this results in distinctive response patterns.     
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A further possible explanation for the reversal of cathodal effects 
following 20 minutes of stimulation at 2mA relates to the engagement of 
homeostatic type processes. This was also argued by Batsikadze et al. (2013) as a 
potential reason for the delayed response following 2mA of stimulation. 
Homeostasis refers to the properties of a system which allow it to remain stable 
within certain limits. These regulatory mechanisms have been proposed to 
maintain neuronal activity within a useful and effective range, and have been 
identified as playing an important role in stabilizing properties of neuronal 
circuits (Siebner et al., 2004). Compelling evidence for the influence of these 
mechanisms in the human motor cortex comes from studies in which two 
periods of non-invasive stimulation are applied in close temporal proximity to 
each other (Fricke et al., 2011; Monte-Silva et al., 2010; Siebner et al., 2004).   In 
these studies, TMS or tDCS is used to pre-condition the motor cortex; shortly 
following this a second period of stimulation is given and changes in cortical 
excitability are measured. If homeostatic mechanisms are not engaged, an 
additive effect may be expected in which two periods of inhibitory or excitatory 
stimulation simply lead to more inhibition/ excitation. However, this does not 
seem to be the case; in fact in all three of these studies a reversal of the initial 
effect was found. It is possible that the reversal of the expected effects of 
cathodal stimulation found by Batsikadze et al. (2013) relates to these 
mechanisms.  
If homeostatic mechanisms play an important role in moderating the 
effects of tDCS, baseline excitability is likely to be an important factor. This is 
supported by the finding that baseline MEP amplitudes and responses to 2mA 
anodal tDCS have been found to be significantly correlated (Wiethoff et al., 
2014). Wiethoff et al. (2014) also found that the relationship between baseline 
and 2mA cathodal stimulation approached significance.  However, a sham 
condition was not included which makes it difficult to draw strong conclusions 
from these findings.  
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The following experiment was conducted to investigate changes in cortical 
excitability caused by anodal, cathodal or sham stimulation applied at 1mA 
(experiment 1) or 2mA (experiment 2) for 20 minutes to the motor cortex. The 
effects of stimulation were explored at various time points for 90 minutes. The 
study aimed to add to the original single pulse TMS findings of Batsikadze et al. 
(2013); in particular the finding that 2mA cathodal increased cortical excitability 
whereas 1mA cathodal decreased it. In order to assess changes in cortical 
excitability IO curves were measured. Batsikadze et al. (2013) found significant 
effects using SI 1mV measures but failed to find any significant change in IO 
curves. However, it is possible that this is due to the fact that they only measured 
IO curves immediately after stimulation. In this study the decision not to 
measure SI 1mV was made as IO curves typically encompass effects similar to 
those measured by SI 1mV in addition to capturing change in excitability within a 
wider population of neurones. This is because IO curves measure change in MEP 
amplitudes in response to a range of stimulator intensities, whereas SI 1mV only 
measures responses to one.  
3.2 Method 
 
3.2.1 Participants 
A total of 22 healthy participants who did not smoke were recruited, of 
these 11 completed both experiment 1 and experiment 2 (Table 3.1). 
Participants were right-handed as measured by an adapted, shortened version 
(M. S. Cohen, 2008) of the Edinburgh handedness inventory ( Oldfield 1971).  All 
were free from CNS active medication and had no counter indications to TMS 
(Rossi et al., 2009). Participants gave informed written consent prior to the study 
and received financial compensation for participation. All experimental 
procedures were approved by the University of Nottingham Research Ethics 
Committee.  
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Table 3.1. Subject characteristics. Data are presented as mean ± SD; N= number 
of participants; F= Female; M=Male; RMT= Resting Motor Threshold. 
 
3.2.2 Design 
In Experiment 1 a within-subjects design was used to investigate changes 
in cortical excitability over a period of time following anodal, cathodal or sham 
stimulation applied at 1mA intensity to the motor cortex. Time of measurement 
(0, 30, 60 and 90 minutes) and tDCS condition (anodal, cathodal or sham) acted 
as independent variables. Change in MEP amplitude as measured by IO curves 
served as the dependent measure.  
Experiment 2 closely followed the design of experiment 1, however, a 
stronger tDCS intensity of 2mA was used.  
3.2.3 tDCS of the motor cortex 
tDCS was delivered via a NeuroConn DC- stimulator (GmbH, Ilmenau, 
Germany) with a maximum stimulation output of 4.5mA. Stimulation was applied 
using surface sponge electrodes each measuring 35 cm² to the area representing 
the first dorsal interosseous (FDI) muscle in the hand (identified using TMS) and 
to the contralateral right orbit. The electrodes were soaked in saline solution of 
up to 154mM to increase conductance whilst attempting to limit participant 
discomfort (Dundas et al., 2007). The current was run between the electrodes for 
a total of 20 minutes at 1 mA (experiment 1) or 2 mA (experiment 2). The current 
was ramped up over 8 seconds in the 1mA condition, followed by an 8 second 
ramp down period. The ramp up/ ramp down periods were increased to 15 
seconds in the 2mA condition for participant comfort. The intensity under the 
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electrodes correspond to current densities of 0.028 mA cm² in the 1mA condition 
(1mA/35cm²) and 0.057 mA cm² in the 2mA condition (2mA/35cm²). 
Sham stimulation mimicked the timings used by Batsikadze et al. (2013); 
20 second ramp up, 30 seconds of stimulation and a 10 second ramp down 
period. The current was ramped up to 1mA in both experiments because 1mA 
has previously been found to create reliable sham effects in participants (Ambrus 
et al., 2012), and was, therefore, considered sufficient. To limit any potential 
effects of sham polarity, this was counterbalanced, hence for half of the 
participants a cathodal electrode arrangement was used, whereas for the other 
half an anodal arrangement was utilized. Subjects participated in all three 
conditions (anodal, cathodal and sham stimulations), with a minimum of a week 
separating active stimulations. The order of experimental session was 
counterbalanced within each experiment.  
3.2.4  TMS measurements and EMG recording 
TMS stimulation was delivered using a Magstim 200 (Magstim, 
Whiteland, Dyfed, UK) with a figure of 8 magnetic coil (diameter of one winding 
70mm). The coil was held tangentially to the scalp and positioned 45° from the 
midline. The optimal location for stimulation (‘hot spot’) of the contralateral FDI 
was defined as the location over the left motor cortex which when stimulated 
consistently resulted in the largest MEP. This was marked lightly with adhesive 
tape to inform tDCS electrode placement.  
MEPs were recorded using disposable, Ag-AgCl surface electrodes 
attached to the right FDI muscle in a belly tendon montage. Alcohol wipes were 
used to prepare the skin prior to application of the electrodes. The signals were 
amplified and bandpass filtered (10Hz- 2kHz, sampling rate 5kHz) and digitalized 
using Brainamp ExG (Brain Products GmbH, Gilching, Germany) controlled by 
Brain Vision Recorder (Brain Products GmbH, Gilching, Germany). Participants 
were encouraged to maintain their hand in a relaxed position on a table directly 
in front of them. Resting motor threshold (RMT) was determined as the lowest 
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intensity needed to yield an MEP response of >100µV in the relaxed FDI muscle 
in a minimum of 5 of 10 trials.  
A neural navigation system (Brainsight, Rogue Research Inc., Montreal 
Quebec, Canada) was used to track coil position in relation to the participants 
head and the location of the identified hotspot. This was done using a template 
which was constructed from a consenting individuals anatomical brain scan. 
Individuals head were registered to this template as individual anatomical scans 
were not available. A chin rest was used during stimulation to maintain the 
position of the participant’s head. Participants were informed that they could 
take breaks if necessary and move if uncomfortable.  
IO curves were measured using TMS intensities of 95, 100, 105, 110, 115, 
120, 125 and 130% RMT. Each block was presented 10 times; hence participants 
experienced 80 TMS pulses during a single IO curve measurement. The order of 
the stimuli was randomized (using Matlab) as opposed to using a ‘ramped’ 
procedure (whereby stimuli are measured in steps from high to low intensity).  
This was chosen to avoid any potential order effects, however this precaution 
may have been unwarranted as the effects of these different methods have since 
been found to show no statistical differences (Pearce et al., 2013). Each TMS 
pulse was separated by an inter stimulus interval (ISI) of 5 seconds.  
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3.2.5 Procedure 
 
 
Figure 3.1. Experimental protocol for each testing session. Arrow demonstrates the 
passage of time over an experimental testing session. 
 
Experiment 1: 1mA tDCS 
After gaining informed consent, participants were seated in a 
comfortable chair with their head positioned in a chin rest and their right hand 
placed in a relaxed position in front of them. The location of the participant’s 
head was then registered to a template using the Brainsight system (Rogue 
research Inc., Montreal Quebec, Canada), and disposable electrodes were 
attached to the hand. Following this, the hotspot for FDI stimulation was 
identified using TMS, which was then mapped onto the template brain to aid coil 
localization and marked lightly on the scalp with mildly adhesive tape. RMT was 
then determined and baseline IO curves recorded. 1mA anodal, cathodal or sham 
tDCS was then applied to the identified hotspot for 20 minutes, which was 
ramped up for 8 seconds at the start of stimulation and down for 8 seconds 
following the end of stimulation. Participants were blind to the stimulation 
polarity, however due to constraints on resources the researcher was not. IO 
curves were then re-measured following tDCS; on average this occurred 6.30 ± 
3.05 minutes after the end of stimulation due to re-localization of the TMS coil 
and removal of the tDCS electrodes. As this was the first time point collected this 
is hereafter referred to as time point 0 or the time immediately following 
stimulation. IO curves were also measured at 30, 60 and 90 minute intervals post 
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tDCS (see Figure 3.1). RMT was kept constant and not adjusted over the course of 
a testing session.  
Participants were asked to get a good night’s sleep before each 
experimental session and watched films during the experiment in an attempt to 
reduce fatigue and maintain alertness. This method was used as fatigue and its 
subsequent effects on alertness have previously been found to increase cortical 
excitability (De Gennaro et al., 2007; Huber et al., 2013) resulting in increases in 
RMT and both low and high threshold measures using TMS. The order of 
experimental conditions was counterbalanced between participants to avoid 
potential order effects. The time of testing was held constant whenever possible 
for each participant to limit any potential influences of the time of day and 
circadian rhythms, as these may influence cortical excitability (Huber et al., 
2013).  
Experiment 2: 2mA tDCS 
The experimental protocol for experiment 2 was identical to experiment 
1, with the exception that 2mA of intensity was used and that the ramp up/ ramp 
down times were increased to 15 seconds. Sham protocol remained the same as 
in experiment 1. The first IO measure started on average 6.34 ±2.39 minutes 
after tDCS.    
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3.2.6 Analysis and statistics 
 
Figure 3.2. Schematic of data analysis with key aspects highlighted. 
MEP data was analysed by measuring peak-to-peak amplitudes using an 
in-house Matlab script. Any trials in which there was evidence of pre-contraction 
of the FDI muscle in the period prior to the TMS pulse were excluded as this is 
known to inflate the MEP response. For each individual, the data was further 
processed by calculating the median MEP amplitude for each of the 8 intensities 
measured during each IO curve. Median rather than mean was used in an 
attempt to limit the effect of outliers. 
For completeness the resultant data was analysed using three 
methodologies (see Figure 3.2). Only one method will be discussed in depth 
here, however, further information regarding the other statistical analyses 
performed is available in Appendix.i, Appendix.ii and Appendix.iii. These analyses 
were all initially carried out for each polarity respectively (anodal, cathodal, 
sham) to allow for in-depth exploration of effects within a given testing session. 
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However, further analysis in which polarity is also entered into the model is 
included for completeness, as this allows more direct comparisons between the 
measures to be made.  
Analysis of tDCS effects on RMT 
The potential effects of tDCS on RMT were explored using paired samples 
t-tests to compare any changes in MEP amplitudes evoked by the 100%RMT 
condition. The stimulator intensity used to measure RMT was held constant over 
the course of each testing session, therefore, change in MEP amplitude can be 
used as a proxy to suggest a change in threshold.  
Analysis of tDCS effects on IO curve slope 
 
The data was analysed by fitting a linear trend of best fit to the median 
MEP values of intensities from 100-130% RMT. 95% RMT was not included 
because for many participants this was subthreshold and resulted in no 
measurable MEPs (See Figure 3.3 for example IO curve).  Linear fitting was 
deemed appropriate based on visual inspection of the data which showed no 
clear evidence of high or low end slope plateau. Average fitting for Experiment 1 
was good (mean R²=0.86) as was fitting for Experiment 2 (mean R²= 0.86). 
By using slope fits the need to include intensity as a variable is removed. 
This makes it possible to more easily explore the data further by normalizing 
Figure 3.3. Example IO curve slope fit. Black circles indicate individual MEP amplitudes, 
purple diamonds show median values for each intensity. 
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slope values to their respective baselines to provide an indication of the 
magnitude and direction of change in IO curve slope following stimulation. This 
approach was used to address naturally occurring differences in baseline slopes 
between individuals. Without exploring the data using this method, differences 
in baselines could skew the results as a seemingly small increase in slope can 
involve a larger proportion of change for some individuals than others. 
Normalized values were entered into repeated measures ANOVAs to assess any 
effects of time. This was done separately for each polarity and intensity.  
To explore the potential effects of baseline cortical excitability on the 
magnitude and direction of change following stimulation, correlational analyses 
were conducted in which baseline slope was correlated with the normalized 
slope values (post/pre) at each time point for each condition. 
  
63 
 
3.3 Results 
3.3.1 Effects of tDCS on RMT 
 
Experiment 1: 1mA 
RMT was held constant throughout each testing session, therefore, 
change in MEP amplitudes evoked by TMS pulses at RMT can be used as a proxy 
for change. As any significant change in MEP amplitudes would suggest that a 
change in RMT had occurred. Paired sampled t-tests revealed no significant 
differences in MEP amplitude at RMT between baseline and measures taken 
after 1mA anodal tDCS (all p> .7).  No significant differences from baseline were 
found following cathodal stimulation (all p>.07) or sham stimulation (all p>.13). 
Experiment 2: 2mA 
MEP amplitudes at RMT were not significantly altered from baseline 
immediately, 30 and 60 minutes following anodal stimulation (all p>0.34). A 
significant difference was found between baseline and 90 minutes (t(15)=2.23, 
p=.04), however, this did not survive correction for multiple comparisons. No 
significant differences were found following cathodal stimulation (all p>0.16) and 
there were no significant changes immediately, 30 and 90 minutes following 
sham stimulation (all p>0.13). A significant difference was found between 
baseline and 60 minutes post sham stimulation (t(15)=-2.63, p=0.02) although 
this effect did not survive correction for multiple comparisons.  
3.3.2 Effects of tDCS on IO curve slope 
Repeated measures ANOVAs were used to assess change in IO curve 
slope across the different time points using ratio data (post tDCS/ baseline). This 
was done to control for subtle variations in baseline between conditions.  1mA 
cathodal and sham conditions violated the assumption of sphericity, therefore, 
Greenhouse-Geisser correction was applied.  
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Experiment 1: 1mA 
Time of measurement (baseline, 0, 30, 60 , 90 minutes) did not 
significantly influence IO curve slope for the 1mA anodal F(4,68)=.21, p=.93, the 
1mA cathodal F(2.3,38.45)=.1.43, p=.25, or the 1mA sham conditions 
F(4,44.47)=.21, p=.07. Average IO curves can be seen in Figure 3.5. 
Experiment 2: 2mA 
The 2mA anodal condition was significantly influenced by time of 
measurement F(4,56)=3.55, p=.01. Exploration of this effect using paired sample 
t-tests revealed that this effect arose from differences between baseline and 30 
minutes post stimulation t(14)=2.4, p=.03 measures. The difference between 
baseline and 60minutes post stimulation was also significant t(14)=2.23, p=.04. 
However, neither effect survived correction for multiple comparisons using the 
Bonferroni method. There was no significant effect of time of measurement for 
the 2mA cathodal F(4,56)=.62, p=.65 or sham condition  F(4,56)= 1.03, p=.4.  
Averaged IO curves can be seen in Figure 3.6. 
  Change in slope over the different time points can be seen in Figure 3.4. 
This illustrates the individual variability within conditions even when the effects 
are found to be significant at group level.  
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Ratio values showing change in slope following 2mA anodal 
stimulation. Each colour represents an individual participant’s data set. Black line 
indicates no change from baseline. 
65 
 
Figure 3.5. Mean and SEM of average MEP amplitudes at each given TMS 
intensity pre and post stimulation for A: 1mA Anodal, B: 1mA Cathodal, C: 1mA 
Sham. 
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Figure 3.6. Mean and SEM of average MEP amplitudes at each given TMS 
intensity pre and post stimulation for A: 2mA Anodal, B: 2mA Cathodal, C: 2mA 
Sham.  Indicated significant difference from baseline.   
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3.3.3 Correlational analysis: baseline relationships with slope change 
The results of Pearson’s correlation analysis are shown without correction 
for multiple comparisons. However, in the case of correlation coefficients 
reaching conventional statistical significance (p=<0.05) the Bonferroni correction 
was applied and is discussed. Figure 3.7 and Figure 3.8 show spider plot diagrams 
of Pearson’s correlation coefficient for slope change at each time point and 
respective baseline; filled circles indicate correlations that reach conventional 
levels of statistical significance (p=< .05).  
Experiment 1: 1mA 
Baseline slope was not related to slope change following 1mA anodal 
tDCS at any time point (all p > 0.44) as is shown in Figure 3.7A. Change in slope 
following 1mA cathodal stimulation (Figure 3.7B) was not found to be related to 
baseline at any time point (all p>0.36). Baseline slope was associated with slope 
change following sham stimulation (Figure 3.7 C) immediately following 
stimulation (r=-0.48, p=0.04), post 30 minutes (r=-0.55, p=0.02), post 60 minutes 
(r=-0.55, p=0.02) and post 90 minutes (r=-0.62, p=0.00). However, when the 
Bonferroni correction for multiple comparisons is applied only the correlation 
between baseline and 90 minute follow up remained statistically significant (r=-
0.62, p=0.02).    
 
Figure 3.7. Uncorrected Pearson’s correlation coefficients of baseline slope with 
slope change at the four time points for A: 1mA anodal; B: 1mA cathodal and C: 
1mA sham condition. Filled circles indicate significant correlations (p=<0.05).  
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Experiment 2: 2mA 
Baseline slope was not related to slope change following 2mA anodal 
tDCS at any time point (all p>0.16) as shown in Figure 3.8 A.  However, baseline 
slope was correlated with change in slope immediately following 2mA cathodal 
stimulation (r=-0.57, p=0.03), marginally correlated with slope 30 minutes after 
stimulation (r=-0.57, p=0.05) and correlated with slope measures 60 minutes 
following stimulation (r=-0.55, p=0.03). Baseline was not correlated with slope 
measures 90 minutes following stimulation (r=-0.47, p=0.08), see Figure 3.8 B. 
Baseline slope was also not found to be significantly correlated with slope 
following sham stimulation at any time point (all p=>0.11), see Figure 3.8 C.  
 
Figure 3.8. Uncorrected Pearson’s correlation coefficients of baseline slope with 
slope change at the four time points for A: 2mA anodal; B: 2mA cathodal and C: 
2mA sham conditions. Filled circles indicate significant results (p=<0.05).  
 
3.3.4 Effects of tDCS type and time on IO curve slope  
 
Experiment 1: 1mA 
In order to compare the effects of the different polarities more directly, 
additional repeated measures ANOVAs were calculated using the slope ratio data 
from all conditions. This analysis was also conducted using raw slope values, 
details of which can be found in Appendix.iii.  Slope change was entered as the 
dependent variable. Polarity (3 levels) and time of measurement (5 levels) served 
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as independent factors. The Greenhouse-Geisser correction was used to correct 
for any significant violations of sphericity.   
No significant effects of tDCS polarity were found in the analysis of the 
1mA data (Table 3.2). There was no significant interaction between time and 
polarity; however, a significant main effect of time was revealed F(4,56)= 2.73, 
p=.04. Post hoc tests using the Bonferroni correction revealed a single significant 
difference between slope change from baseline at the 0 minute measurement 
(p=.02), which showed a general increase across all tDCS measures at this time 
point.  This can be seen in part in Figure 3.5 (in which baseline as indicated in 
red, is always below 0min measure indicated in green).  
 
Table 3.2. Results of repeated measures ANOVAs calculated for 1mA data in which the 
effects of time, and polarity on IO curve slope are explored 
 
 
 
Experiment 2: 2mA 
No significant effects of polarity were found in the analysis of 2mA data 
(Table 3.3). The interaction was also not found to be significant, however, as in 
the 1mA condition there was a significant main effect of time, F(4,56)=3.24, 
p=.02. Post hoc Bonferroni tests revealed a significant difference between 
baseline and slope change 60 minutes after stimulation (p=.02). Inspection of the 
data shown in Figure 3.6 suggests that this effect is primarily driven by the 
anodal and sham conditions.  
 
Factor df F P p² 
Polarity 2,28 1.08 .35 .06 
Time 4,56 2.73 .04* .14 
Polarity*Time  4.44,75.44 .63 .66 .04 
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Table 3.3. Results of repeated measures ANOVAs calculated for 2mA data in which the 
effects of time, and polarity on IO curve slope are explored. 
 
 
3.4 Discussion 
 
Changes in cortical excitability following 1mA tDCS  
In line with previous studies there was no evidence of either 1mA anodal, 
cathodal or sham conditions significantly effecting RMT (Batsikadze et al., 2013; 
Nitsche et al., 2005; Quartarone et al., 2005; Scelzo et al., 2011).   
Extensive analysis of change in IO curve slope following 1mA tDCS failed 
to reveal any significant differences from baseline for either anodal, cathodal or 
sham conditions. This was true of measurements taken immediately following 
stimulation and at each subsequent time point measured. The lack of an effect is 
somewhat at odds with previous literature (Nitsche et al., 2005), as the IO curve 
measures in this study show no evidence of significantly increased cortical 
excitability following anodal stimulation, nor decrease following cathodal 
stimulation. In addition to this there was no evidence that anodal, cathodal and 
sham stimulations influenced IO curves in distinct ways. If anything there was a 
tendency towards a slight increase in IO curve slope over the course of each 
experimental session regardless of tDCS type.  
Correlational analysis revealed that change in IO curve slope following 
sham stimulation was significantly correlated with baseline at all time points. 
However, only the relationship between baseline and 90 minutes post 
stimulation survived the adjustment for multiple comparisons. Baseline slope 
Factor df F P p² 
Polarity 2,28 .184 .833 .013 
Time 4,56 3.239 .018* .188 
Polarity*Time  8,112 .939 .487 .063 
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was not found to significantly correlate with change in IO curves for either 
anodal or cathodal stimulation.  
Changes in cortical excitability following 2mA tDCS 
2mA cathodal tDCS was not found to have any significant influence on 
RMT, however, a significant difference was identified between RMT measured at 
baseline and the 90 minutes following anodal stimulation. This finding is 
somewhat novel and not supported by previous literature (Batsikadze et al., 
2013), however, the effect did not survive correction for multiple comparisons, 
and may be due to methodological issues/natural fluctuation over time rather 
than an effect of tDCS. This view is partially supported by the finding of a 
significant difference between baseline and 60minute follow up in the sham 
condition, although this also failed to survive the correction for multiple 
comparisons.  It is possible that the use of a slightly higher threshold criteria 
(>100µV rather than 50-100 µV ) may also have contributed to these effects.  
Analysis of the 2mA anodal data revealed a significant increase in IO 
curve slope from baseline at 30 and 60 minutes following stimulation; however, 
neither of these effects were strong enough to survive the multiple comparison 
correction. 2mA cathodal and sham stimulation failed to have any significant 
effect on slope at any time point. It is theoretically possible that significant 
cathodal differences may have been observed at a later time point, as effects 
were previously found up to 120 minutes post stimulation (Batsikadze et al., 
2013). However, this seems unlikely as the 2mA anodal effects found in the 
present experiment were actually found earlier (30 at 60 minutes post 
stimulation) than those found by Batsikadze et al. (2013) who reported 
significant effects only after 60 minutes. It is unclear why 2mA anodal effects 
would show an earlier time course, while cathodal effects would be more 
delayed within the same sample of participants.   
In depth analysis of the data suggests that the effects on IO curve slope 
following 2mA anodal stimulation are largely driven by changes occurring in 
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MEPs evoked from the strongest 130%RMT pulses. This is apparent upon visual 
inspection of the data and also in analysis in which the effects on individual TMS 
intensities were explored (discussed in Appendix.i and Appendix.ii). This may 
relate to the total amount of neurones stimulated by each TMS intensity and the 
focality of tDCS stimulation.  The amount of current reaching the cortical surface 
as a result of tDCS is thought to be varied and widespread (Datta et al., 2012; 
Miranda et al., 2006), particularly when standard rectangular electrodes are used 
(Datta et al., 2012).  As a result, higher stimulation intensities, such as 130% RMT 
(which recruits neurones more widely than lower intensities), may be more able 
to capture changes induced by tDCS. Although it is possible that in the present 
study higher intensities may have revealed more effects, it should be noted that 
previous studies have successfully identified changes in MEP amplitudes using SI 
1mV intensities (Batsikadze et al., 2013; Furubayashi et al., 2008; Kidgell et al., 
2013; Nitsche & Paulus, 2000). In the current data set this would generally reflect 
responses to TMS intensities from 115% RMT and upwards, yet significant 
differences are only apparent at 130%.  
Although the independent analyses revealed some support that anodal 
tDCS, but not sham or cathodal stimulation, significantly altered IO curve slope, 
no significant differences between polarities were found in the group analysis. 
This suggests that the effect is somewhat weak and contrasts with many studies 
which have reported significant differences between MEP amplitudes following 
different polarities of tDCS and sham conditions (Batsikadze et al., 2013; Fricke et 
al., 2011; Nitsche et al., 2007; Nitsche & Paulus, 2000). It is unclear why the 
findings using IO curve would be so different to those measuring MEPs from a 
single TMS intensity, nevertheless it is worth noting that despite many studies 
using SI 1mv only a few have used IO curves. Of those studies using IO curves one 
reported a significant change depending on stimulation type (Nitsche et al., 
2005) however another failed to replicate this  (Batsikadze et al., 2013).  
The potential impact of baseline cortical excitability on the amount and 
direction of subsequent change following stimulation was also explored for the 
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2mA condition. This was done by calculating correlational values between 
baseline slope values and ratios of change at each time point. Interestingly, 
although in the 1mA condition baseline slope was correlated with changes 
following sham stimulation, the same was not found in the 2mA data set. Here 
neither baseline slope for sham nor anodal stimulation were significantly related 
to subsequent change. For the 2mA cathodal condition, baseline slope was 
significantly related to change at 0 and 90 minutes following stimulation, 
however, neither of these correlations survived correction for multiple 
comparisons. These results differ to those found in the sham condition for 
experiment 1, hence making clear interpretation difficult.  
The results of the correlations also appear to differ from a recent 
experiment conducted by Wiethoff et al. (2014) in which baseline MEP amplitude 
correlated with changes following 2mA anodal tDCS. Wiethoff et al. (2014) also 
identified a trend between baseline and change following 2mA cathodal 
stimulation, a finding which is weakly implicated at specific time points in the 
current data set. A number of methodological differences between the studies 
may account for the lack of effects in this study, in particular, the sample size 
which was much larger (n=53) in the study by Wiethoff et al. (2014), and 
differences between the TMS protocols used.  
A final point of interest is the finding that even in the 2mA anodal 
condition, in which there is some evidence of change in cortical excitability, there 
is substantial variability between participants. At the time of starting this study 
(in 2013) there was little published research exploring this issue, however, since 
then a number of articles have been published which show that the effects of 
tDCS are not as clear cut and polarity specific as initially believed. In particular, 
the study by Wiethoff et al. (2014) revealed that in a large sample of 53 
participants, 50% showed only minor or no response to stimulation. In addition, 
the direction of responses was mixed, with some participants showing increased 
excitability in response to both anodal and cathodal stimulation (2mA) and 
others showing increase following anodal and decrease following cathodal.  This 
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variability is an interesting issue and warrants further exploration if tDCS is to 
fulfil its potential as both a research tool and therapeutic technique.  
Limitations 
As with most, the design of this study is not perfect and it cannot be ruled 
out that methodological issues may have contributed to the findings. In 
particular, TMS coil placement and the ability of participants to watch films 
during the study may have contributed.  
Although neural navigation software was used throughout the 
experiment, this involved registering the participants to a template head, as 
individual anatomical scans were not available. Although useful this process is 
not exact, and therefore there is a possibility that the TMS coil was not always 
localized in exactly the same area each time. As a result, this could influence MEP 
amplitudes and thereby add error into the measure.  
Another potential source of variability within the experiment was 
differences in participant mood and arousal level as a result of the films they 
chose to watch. Although horror and comedy films were excluded (to limit 
participants’ movements from laughter/ startle responses) participants were 
broadly allowed to choose what to watch. Previous research has found that 
viewing highly emotive static picture stimuli (both pleasant and unpleasant) 
increases MEP amplitudes in comparison to neutral stimuli (Coombes et al., 
2009; Hajcak et al., 2007). It is, therefore, possible that some variability within 
the data could relate to the material participants were viewing, although the 
effects of such viewing material are likely to differ from the static, high valence 
images used in previous studies. In addition, it is not clear if the effects of 
fatigue, boredom and natural changes in emotional state would have had an 
impact had there not been something for participants to watch and engage in.  
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Conclusions 
With the exception of the 2mA anodal condition, the study largely failed to 
replicate previous findings. Unlike past research, 1mA anodal tDCS did not 
significantly increase cortical excitability, nor did 1mA cathodal stimulation 
decrease it. The study also failed to replicate the increase in cortical excitability 
found  by Batsikadze et al. (2013) following 2mA cathodal stimulation.   As the 
methods used are not identical to previous published works it cannot be ruled 
out that methodological issues contributed to the lack of significant effects. 
However, thorough inspection of the data revealed high variability with regard to 
the direction and magnitude of change seen for each individual. This is even 
apparent when the effects are significant at a group level (see Figure 3.4). It is, 
therefore, suggested that natural variability occurring between participants may 
also have contributed to the lack of effects. This issue is explored in depth in the 
next chapter.  
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 Exploring intra and inter-subject reliability 
and stability in response to tDCS 
 
Some of this work has been previously reported in: Dyke, K., Kim, S., Jackson, G. 
M., & Jackson, S. R. (2016). Intra-Subject Consistency and Reliability of Response 
Following 2 mA Transcranial Direct Current Stimulation.  Brain Stimulation 9(6), 
819-825. 
Key words: transcranial direct current stimulation (tDCS), transcranial magnetic 
stimulation (TMS), resting motor threshold (RMT), input output curve (IO curve), 
short interval intracortical inhibition (SICI), long intracortical inhibition (LICI), 
intracortical facilitation (ICF), intra-subject variability, inter-subject variability.  
 
4.1 Introduction 
Chapter 3 reported studies in which the effects of various tDCS parameters 
were explored using single pulse TMS. These studies failed to replicate previous 
findings of polarity specific effects following 1mA stimulation (Nitsche et al., 
2005), and also were unable to replicate the reversal of cathodal effects when 
delivered at 2mA (Batsikadze et al., 2013). The only significant effect observed 
was the finding that 2mA anodal stimulation significantly increased cortical 
excitability 30 and 60 minutes following tDCS application.   
In tDCS studies a number of factors are known to influence outcomes, 
including the intensity and duration of stimulation used (Batsikadze et al., 2013; 
Monte-Silva et al., 2013), the measures used to quantify effects (Horvath, 2014; 
Jacobson et al., 2012) and the electrode montage used (Miranda et al., 2006; 
Nitsche & Paulus, 2000). Although these factors are important, they cannot 
explain the variability found within studies. For example, Wiethoff et al. (2014) 
found substantial inter-subject variability in response to both 2mA anodal and 
cathodal stimulation.  The studies discussed in Chapter 3 also show high 
variability between individuals, even when the group level effects are significant.  
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This issue of variability between participants in response to stimulation is 
not unique to tDCS. Variability has also been reported in response to other non-
invasive brain stimulation methods such as Paired Associative Stimulation (PAS) 
and intermittent Theta Burst Stimulation (iTBS) (Fratello et al., 2006; Hamada et 
al., 2013; Lopez-Alonso et al., 2015; Muller-Dahlhaus et al., 2008). Given 
individual differences in anatomy, including skull shape, thickness and density, 
and additional factors such as baseline neuronal states, it is perhaps not 
surprising that these techniques do not yield identical results across individuals. 
However, developing an understanding of the factors that may predict this 
variability is a critical step in increasing the reliability and usefulness of such 
techniques for use within both research and therapeutic contexts.  
To date, a number of inter-subject factors have been identified as 
influencing tDCS including: anatomical structure (Bikson et al., 2012; Datta et al., 
2012), age (Fujiyama et al., 2014; V Moliadze et al., 2014), and potentially even 
genetic profile (for review see Li et al. (2015)). These factors can be useful in 
explaining differences occurring between participants, however, less is known 
about the reliability of the effects within individuals. A few notable studies have 
explored these issues for anodal stimulation at 1mA (Horvath et al., 2016; Lopez-
Alonso et al., 2015) and at 0.5mA (Chew et al., 2015). Interestingly, although 
1mA anodal tDCS was found to have a reasonable level of inter-subject reliability 
(Lopez-Alonso et al., 2015) the same was not true of 0.5mA (Chew et al., 2015). 
Furthermore, even when reliability has been explored using the same intensity 
the results are conflicting.  Horvath et al. (2016) found that reliability across 
sessions was poor, which contrasts with the findings of Lopez-Alonso et al. 
(2015). It is possible that the differences between the studies reflect the 
different methodologies used.  A few notable and potentially influential 
differences include electrode size, duration between testing sessions, duration of 
stimulation, use of neural-navigation and the amount of sessions tested. Less 
research exists exploring the reliability of cathodal stimulation, with the notable 
exception of a study at 1mA by Horvath et al. (2016) in which consistency was 
found to be poor.  
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Of the three studies which explored intra-subject consistency, only one 
reported the effects of tDCS on paired pulse TMS measures. These measures can 
provide more specific information about the biological underpinnings of tDCS 
effects. For example, while MEP amplitudes evoked from relatively high TMS 
intensities may reflect global excitability (combination of inhibitory and 
facilitatory outputs) measures such as short interval intracortical inhibition (SICI) 
can give specific information about the engagement of GABAergic mechanisms, 
in particular effects occurring at GABA-A receptor sites.  Interestingly, the one 
study which did explore the effects of SICI failed to replicate previous findings in 
which SICI is reduced following anodal stimulation (Batsikadze et al., 2013; 
Cengiz et al., 2013; Kidgell et al., 2013; Nitsche et al., 2005). Lopez-Alonso et al. 
(2015) found that 1mA anodal tDCS did not significantly alter SICI. However, the 
amount of change in this measure was found to have some consistency between 
two testing sessions when measured 6 minutes but not 46 minutes following 
anodal stimulation.  
As previously discussed, one of the parameters known to influence the 
effects of tDCS is the intensity at which it is applied. At present, the maximum 
used in humans is often 2mA, and although considered safe (Fregni et al., 2014), 
the effects at this intensity are less well explored than those resulting from 1mA 
applications. However, the use of 2mA intensities in both therapeutic and 
research contexts is not uncommon, and for many, the idea of using a ‘stronger 
dose’ of stimulation may be appealing. In fact, the assumption that a stronger 
intensity may yield stronger changes in cortical excitability is tentatively 
supported by the findings in Chapter 3, in which it was possible to see some 
change in excitability following 2mA but not 1mA anodal stimulation.  
  This study aimed to explore inter and intra-subject variability using a 
repeated measures design in which participants experienced multiple sessions of 
2mA tDCS applied to the motor cortex (M1)for 20 minutes. Changes in cortical 
excitability were assessed using the following single and paired pulse TMS 
measures: IO curves, resting motor thresholds (RMT), short interval intracortical 
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inhibition (SICI), intracortical facilitation (ICF) and long interval intracortical 
inhibition (LICI). The TMS parameters used in the study were informed by the 
previous work in Chapter 3 and also by a specially conducted pilot study.     
4.2 Pilot 
The aim of the pilot study was to identify the optimal paired pulse 
parameters which reliably showed inhibition/ facilitation without producing 
ceiling effects. As a result, the optimal parameters were not always the ones 
showing the largest change in MEP as this would have limited the ability to see 
the influence of tDCS on those measures.  
The three main factors influencing the effects of paired pulse protocols are 
the inter stimulus interval (ISI), the conditioning stimulus (CS) and the test 
stimulus (TS). Overall there is strong consensus that when a subthreshold CS is 
applied before a suprathreshold TS the result will be increased inhibition if the ISI 
was 1-5ms, and increased facilitation with ISIs of 8-30ms (O'Shea & Walsh, 2007). 
Choosing the optimal CS and TS parameters to elicit these effects is difficult due 
to the wide range of intensities which could be used and methodological factors 
such as the use of Resting (RMT) or Active Motor Thresholds (AMT).  
Much of the previous literature utilizing SICI and ICF protocols has used 
suprathreshold TS of SI 1mV or 120%RMT. Although the intensity of the TS is 
known to influence the magnitude of SICI effects (Garry & Thomson, 2009; Ilic et 
al., 2002), intensities that yield MEPs of 1mV (SI 1mV) or are delivered at 120% 
RMT are commonly used; and there is evidence to support that these intensities 
are optimal. For example, Garry and Thomson (2009) found that CS intensities of 
110-120%RMT yield the largest inhibitory effects when ISIs of 1-5ms were used. 
It was beyond the scope of this pilot study to explore both the effects of TS and 
CS on the different protocols, therefore, it was decided that the TS would remain 
fixed at SI 1mV and that the optimal CS intensity would be explored. SI 1mV was 
used rather than 120% RMT in line with previous key studies investigating the 
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effects of tDCS on paired pulse protocols (Batsikadze et al., 2013; Nitsche et al., 
2005). 
Previous research with SICI has revealed that when 3ms ISIs are used the 
relationship between CS intensity and the inhibitory effects appears to form a U-
shaped pattern (Kossev et al., 2003; Peurala et al., 2008), with CS intensities of 
60-75% RMT reportedly producing the largest inhibitory effects (Kossev et al., 
2003). CS intensities ranging from 70-80% RMT have been traditionally used (for 
example: (Kujirai et al., 1993; Roshan et al., 2003), however, it is not easy to find 
a general consensus as some researchers prefer to use a percentage of active 
rather than resting threshold (for example, Batsikadze et al. (2013)). With regard 
to SICI occurring using ISIs at and around 1ms, there is less information available. 
However, there is some evidence that the optimal CS intensities for this distinct 
measure are lower than those used in later SICI (Fisher et al., 2002; Vucic et al., 
2009). In this pilot study the effects of CS intensity on 1ms and 3ms SICI were 
explored. Percentages of RMT were used throughout.  
This pilot study also explored the effects of CS intensity on ICF 
measurements using ISIs of 10, 12 and 15ms. Previous research suggests that CS 
intensities of 70% AMT are effective when measuring ICF with ISIs of 10 and 
15ms (Batsikadze et al., 2013; Nitsche et al., 2005); but also that CS intensities of 
70, 80 and 85% RMT are effective when 13ms ISIs are used (Kossev et al., 2003).  
The final paired pulse measure explored in the pilot study was LICI. The 
effects of LICI are thought to be reliably produced by ISIs of 100ms (McDonnell et 
al., 2006; Sanger et al., 2001), and can be found using a range of suprathreshold 
CS intensities (Sanger et al., 2001). Unlike in SICI and ICF protocols the intensities 
used for both CS and TS in LICI can be identical as both are required to be 
suprathreshold. In this pilot the effects of various suprathreshold CS intensities 
were explored using an ISI of 100ms and a TS set at SI 1mV. Few studies have 
reported investigating the effects of tDCS using this measure, and when this has 
been done it has been with patient populations (Antal et al., 2010) which may 
differ to healthy controls. LICI effects can reach ceiling level rapidly, therefore, a 
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key aim of this pilot was to identify CS intensities which would avoid this 
problem. 
Pilot Method 
Participants 
Five healthy participants (2 male, 3 female) with a mean age of 26 years 
(range 25-27) took part in this study. Participants were right handed and free of 
any medications or counter indications to TMS.  
Design 
The pilot experiment was designed to select the optimal parameters for 
paired pulse measures. This was done by examining the effects of a range of TMS 
protocols on MEP amplitudes.  Participants completed all conditions with the 
measures for ICF 12 and 15 being completed in a secondary testing session.  
TMS delivery and recording of MEPs 
TMS was delivered using Magstim 200 stimulators connected via a Bistim 
module (Magstim, Whiteland, Dyfed, UK) through a figure of eight magnetic coil 
(diameter of one winding 70mm). The coil was held tangentially to the scalp and 
positioned 45° from the midline. The optimal location for stimulation (‘hot spot’) 
of the contralateral FDI muscle was defined as the location over the left motor 
cortex which when stimulated, consistently resulted in the largest MEP. To keep 
the location of the coil stable the neural navigation software Brainsight (Rogue 
Research Inc., Montreal Quebec, Canada) was used. Anatomical brain scans were 
not available for the participants, therefore, the location was mapped to a 
template head (constructed from a consenting individuals anatomical scan), 
which was registered to anatomical landmarks on each participant. This method 
allowed coil placement with reasonable accuracy although it was compromised 
slightly by the use of a template. Consequently, the coil location was also marked 
in pen onto a swimming cap which the participants wore throughout the study. 
During stimulation participants’ head positions were kept stable with the aid of a 
chin rest. The TMS coil was held in place using a Manfrotto mechanical arm 
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(Vitec Group, Italy). Participants were asked to remain as still as possible during 
testing, but were offered frequent breaks to stretch and adjust their position.     
MEPs were recorded using disposable, Ag-AgCl surface electrodes 
attached to the right FDI muscle in a belly tendon montage. The signals were 
amplified and bandpass filtered (10 Hz- 2kHz, sampling rate 5kHz) and digitized 
using Brainamp ExG (Brain Products GmbH, Gilching, Germany) controlled by 
Brain Vision Recorder (Brain Products GmbH, Gilching, Germany). Participants 
were encouraged to maintain their hand in a relaxed position throughout testing.   
All trials were triggered using an in-house software program (written 
using Matlab: Mathworks, MA, USA). Paired pulse and single pulse trials were 
intermixed to limit any effects of presentation order from occurring.   
TMS parameters 
Resting motor threshold (RMT) 
Resting motor threshold (RMT) was determined as the lowest intensity 
needed to yield an MEP with a peak-to-peak amplitude of >50µV in the relaxed 
FDI muscle, in a minimum of 5 of 10 trials. 
Stimulus intensity needed for 1mV MEP amplitude (SI 1mV) 
A 1mV (SI 1mv) threshold was also determined by calculating the lowest 
intensity needed to evoke an MEP of 1mV in 5 of 10 consecutive trials. 
Short Interval Intracortical Inhibition (SICI) 
Two ISIs were tested, 1ms and 3ms. The conditioning stimulus (CS) was 
delivered at one of nine intensities ranging from 40-80% RMT in 5% increments. 
The test stimulus (TS) was delivered at SI 1mV. Each condition was tested 10 
times, hence, 90 trials were used to test 1ms ISI and an additional 90 trials were 
used to test 3ms ISI.   
Intracortical Facilitation (ICF) 
ICF was tested using ISIs of 10, 12 and 15ms. Conditioning pulses were 
delivered at one of nine intensities between 40% and 80% of the individual’s 
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RMT in 5% increments. Each condition was tested 10 times and 90 trials were 
used in total to study each ISI.  
 
Long Interval Intracortical Inhibition (LICI) 
A single ISI of 100ms was investigated using one of seven conditioning 
pulses ranging from 100-130% RMT in 5% increments. The test pulse was SI 1mV. 
Each condition was repeated 10 times, hence a total of 90 trials were used to 
measure LICI.  
 
Unconditioned trials 
A total of 60 trials were measured at SI 1mV in the first experimental 
session. A further 30 unconditioned trials were measured in the second session 
in which ICF was measured with ISIs of 12 and 15ms.  
 
Procedure 
After gaining informed consent, participants were seated in a 
comfortable chair with their head positioned in a chin rest and their right hand 
placed in a relaxed position in front of them. The location of the participant’s 
head was then registered to a computation template using the Brainsight system 
(Rogue Research Inc., Montreal Quebec, Canada), and disposable electrodes 
were attached to the hand. The hotspot for FDI stimulation was then identified 
using TMS, which was then mapped onto the template brain to aid coil 
localization and marked lightly onto the swimming cap that participants wore 
throughout. RMT and SI 1mV were then determined.  The various paired pulse 
measures were then collected in a randomized order.  Exactly the same 
procedure was followed for the second session of testing in which ICF with 12 
and 15ms ISIs was collected in addition to 30 unconditioned trials.  
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Analysis and Statistics 
Peak-to-peak amplitude of MEPs evoked by the TS were measured using in-
house software (programed using Matlab, Mathworks, MA, USA). Any trials in 
which there was evidence of pre-contraction of the FDI muscle were excluded. 
Median MEP sizes were calculated for each CS at each respective ISI. The 
resulting values were then normalized to the respective median of 
unconditioned trials to create a ratio.  
Repeated measures ANOVAs were used to identify any significant effects of 
CS intensity on MEP amplitude for each TMS measure (1ms SICI, 3ms SICI, 10ms 
ICF, 12ms ICF, 15ms ICF and 100ms LICI). CS intensity served as a within subjects 
independent factor whereas ratio of change in MEP amplitude (CS/TS) served as 
the dependent factor. Any significant effects were explored further using one 
sample t-tests in which normalized values were compared to a value of no 
change (1). Data are not corrected for multiple comparisons and should 
therefore be interpreted with a degree of caution.  
 
Pilot Results 
 
Figure 4.1. Normalized values showing median change in MEP amplitude for 1ms 
SICI protocol. Black dotted line indicates no change in amplitude from 
unconditioned pulses. Each colour represents an individual participant. 
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A repeated measures ANOVA revealed that CS intensity significantly 
influenced MEP amplitude in the 1ms SICI condition F(8,32) =8.51, p=0.00. One 
sample T-tests revealed significant inhibitory effects at CS intensities of 45% RMT 
t(4)=-3.18, p=.03;  50%; 50% RMT t(4)=-3.20, p=.03;  55% RMT, t(4)=-12.48, 
p=.00;  60% RMT, t(4)=-14.47,p=.00;  65% RMT t(4)=-15.65,p=.00;  70%r RMT 
t(4)=--3.77,p=.02,  75% RMT t(4)=-6.2,p=.00 and 80%RMT t(4)=5.09,p=.01.  Data 
is shown in Figure 4.1.  
 
Figure 4.2. Normalized values showing median change in MEP amplitude for the 
3ms SICI protocol. Black dotted line indicates no change from unconditioned 
pulses. Each colour represents an individual participant. 
 
A separate repeated measures ANOVA revealed that CS has a significant 
impact on the data in the 3ms SICI condition F(8,32)=-3.74,p=.00. One sample t-
tests revealed that a CS intensity of 65% RMT yielded a significant reduction in 
MEP size t(4)=-3.56, p=.02, as did 70% RMT t(4)=-3.8, p=.02 and 80% RMT t(4) = -
8.31, p=.00. Relevant data are shown in Figure 4.2.  
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Figure 4.3 Normalized values showing median change in MEP for 100ms LICI 
protocol. Black dotted line indicates no change from unconditioned pulses. Each 
colour represents an individual participant. 
 CS intensity was found to have a significant effect on MEPs in the 100ms 
LICI condition F(6,24) =9.689, p=.000 (Figure 4.3). One sample t-tests revealed 
significant differences between unconditioned and conditioned MEP sizes at CS 
intensities of 110% RMT t(4)=-3.33,p=.029; 115% RMT t(4)=4.75, p=.009; 
120%RMT t(4)=3.31, p=.030; 125%RMT t(4)=12.18, p=.000; and 
130%RMT(4)=23.69, p=.000.  
Figure 4.4. Normalized values showing median change in MEP amplitude for 
10ms ICF protocol. Black dotted line indicates no change from unconditioned 
pulses. Each colour represents an individual participant. 
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No significant differences were found between MEP amplitudes evoked 
from different CS intensities in the 10ms ICF condition F(8,32) =.881, p=.4 (Figure 
4.4). Further explorative analysis using one sample t-tests revealed a significant 
facilitator effect of CS intensity of 60% RMT t(4)=2.895, p=.044. No other 
significant effects were identified.  
Figure 4.5. Normalized values showing median change in MEP amplitude for 
12ms ICF protocol. Black dotted line indicates no change from unconditioned 
pulses. Each colour represents an individual participant. 
12ms ICF was not found to be significantly influenced by CS intensity 
F(8,32)=1.504, p=0.195 (Figure 4.5).
 
Figure 4.6 Normalized values showing median change in MEP amplitude for 15ms 
ICF protocol. Black dotted line indicates no change from unconditioned pulses. 
Each colour represents an individual participant. 
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15ms ICF was also not found to be significantly influenced by CS 
F(8,32)=1.18, p=0.34 (Figure 4.6). 
 
Discussion of pilot data 
A wide range of CS intensities were found to lead to significant inhibition 
of MEPs for 1ms SICI and 100ms LICI. The range of CS intensities capable of 
leading to significant inhibition evoked from 3ms SICI was slightly narrower, and 
required higher CS intensities than the effects of 1ms SICI. The finding that 1ms 
SICI requires lower CS intensities to be effective is in agreement with previous 
findings (Fisher et al., 2002; Vucic et al., 2009). Although the sample size is very 
small this could be seen as further evidence to suggest that the mechanisms 
underlying 1ms and 3ms SICI effects differ.  
Unlike Kossev et al. (2003) 3ms SICI did not show a U-shaped pattern of 
response in the pilot study.  This is probably due to methodological differences 
between the experiments. In particular, the TS used in this experiment was 1mV 
whereas in the previous studies 120% RMT was used. In addition to this, Kossev 
et al. (2003) measured CS intensities of up to 85% RMT which is closer to 
threshold than the 80% used here. It seems likely that if a wider range of CS 
intensities were measured a U-shaped pattern would have emerged; this is 
almost apparent in the 1ms SICI condition.  
 
ICF measured using ISIs of 10, 12 and 15ms were not found to lead to 
significant facilitation. This was unexpected as these ISIs have previously been 
found to be effective (Kujirai et al., 1993; Ziemann, Rothwell, et al., 1996) and 
have been used within tDCS literature to demonstrate alterations in cortical 
excitability following stimulation (Batsikadze et al., 2013; Nitsche et al., 2005). 
Batsikadze et al. (2013) found that 2mA anodal and cathodal tDCS significantly 
increased facilitation using 10ms ICF whereas 15ms ICF was unaffected. As this 
pilot study revealed no clear differences between the ISIs tested, 10ms ICF was 
selected to be used in the main study based on this literature. Visual inspection 
of graphical data presented by Batsikadze et al. (2013) shows only a small effect 
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of ICF at baseline, yet clear changes following tDCS are visible therefore even if 
ICF does not reveal powerful effects at baseline it may still be possible to 
measure tDCS induced changes.  
 
The pilot study was designed to select the optimal parameters for use in 
subsequent research into the effects of tDCS. In order to avoid confounds of 
ceiling effects the optimal parameters for SICI and LICI cannot be those which 
show absolute inhibition of MEP responses. On this basis CS intensities of 40, 45, 
50 and 55% RMT were used to measure 1ms SICI; intensities of 60, 65, 70 and 
75% RMT were used to measure 3ms SICI and CS intensities of 65, 70 and 75% 
RMT were used to measure 10ms ICF. In order to reduce the amount of total 
pulses used in the experiment only one CS intensity of 115% was used to 
measure LICI.  
4.3 Method 
 
4.3.1 Participants 
Ten participants were enrolled in the study, of whom 7 were female. The 
mean age was 24 ± 4 years.  The anodal and cathodal stimulation conditions 
were completed by all ten participants. The sham stimulation condition was 
completed by all but one participants (F, 23.4years) who was unable to complete 
the sham condition due to relocating.  All participants were healthy, free from 
medication and counter indications to TMS. Participants were deemed right-
handed using an adapted, shortened, version of the Edinburgh Handedness 
Inventory (Oldfield, 1971).   
4.3.2 Design 
A within subjects design was utilized to explore the stability of tDCS 
effects across a number of sessions. All participants completed anodal and 
cathodal tDCS conditions; nine also completed the sham condition. The study 
was initially designed to investigate the stability of 2mA anodal tDCS but was 
extended to include cathodal and sham conditions. As a result participants 
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always completed the anodal session first followed by completion of sham and 
cathodal conditions, the order of which was counterbalanced between 
participants. On average the study took 6 months for participants to complete all 
10 testing sessions. Anodal and cathodal sessions were separated by a minimum 
of one month (mean separation period 5 months). The participants were blind to 
the experimental condition, however, for practical reasons the researcher was 
not. Change in MEP amplitude following tDCS or sham stimulation served as the 
dependent measure. 
4.3.3 tDCS of the motor cortex 
tDCS was delivered using a NeuroConn DC- stimulator (GmbH, Ilmenau, 
Germany) with a maximum stimulation output of 4.5mA. Stimulation was 
delivered using saline soaked surface sponge electrodes, each measuring 35 cm², 
to the area representing the first dorsal interosseous (FDI) muscle for the right 
hand (identified using TMS). The reference electrode was located over the 
contralateral right orbit. For anodal and cathodal stimulation, the current was 
ramped up to 2mA over 15 seconds, held constant for 20 minutes and then 
ramped down over a further 15 seconds. By contrast, in the sham condition the 
current was ramped up to 2mA over a period of 15 seconds, sustained at this 
intensity for 30 seconds and then ramped down over a further period of 15 
seconds. Electrodes were removed during TMS. 
4.3.4 TMS measurements and EMG recording 
TMS was delivered using a BiStim TMS system (Magstim, Whiteland, 
Dyfed, UK) with a figure of 8 coil (diameter of one winding 70mm). The coil was 
held tangentially to the scalp and positioned 45° from the midline resulting in a 
posterior to anterior current flow. Neural navigation software (Brainsight, Rogue 
Research Inc., Montreal Quebec, Canada) was used in conjunction with each 
participant’s anatomical brain scan to aid accurate coil placement over the left 
motor cortex. The coil was moved in small increments within the anatomical 
target to locate the optimal stimulation site (‘hot spot’), which was identified as 
the location which when stimulated produced the largest MEP amplitude. The 
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optimal location was tracked using the software and was also marked onto a 
swimming cap which the participant wore during stimulation. Participants were 
asked to remain as still as possible during testing with the aid of a chin rest, but 
were offered frequent breaks to stretch and adjust their position. The coil was 
held stable over the hot spot using a Manfrotto mechanical arm (Vitec Group, 
Italy) and adjusted as necessary.  
MEPs were recorded using disposable Ag-AgCl surface electrodes 
attached to the right FDI muscle in a belly tendon montage. The signals were 
amplified, bandpass filtered (10Hz- 2kHz, sampling rate 5kHz), and digitized using 
Brainamp ExG (Brain Products GmbH, Gilching, Germany) controlled by Brain 
Vision Recorder (Brain Products GmbH, Gilching, Germany). Participants were 
encouraged to maintain their hand in a relaxed position throughout testing.   
Threshold determination 
Resting motor threshold (RMT) was determined as the lowest intensity needed 
to yield an MEP with a peak-to-peak amplitude of >50µV in the relaxed FDI 
muscle in a minimum of 5 of 10 trials. A 1mV (SI 1mv) threshold was also 
determined by calculating the lowest intensity needed to evoke an MEP of 1mV 
in 5 of 10 consecutive trials.  
Input Output curves 
IO curves were measured using TMS intensities set at 100, 110, 120, 130, 140 
and 150% of RMT. Ten pulses at each of the 6 intensities were delivered in a 
randomized order with 5 seconds occurring between each pulse. 
Intracortical inhibition and facilitation  
1ms SICI 
Subthreshold conditioning stimuli (CS) were delivered at one of four intensities 
(45, 50, 55, 60% RMT) which were followed after a 1ms interval by a supra 
threshold test stimulus (TS) of S1 1mV delivered to the same location within M1. 
Ten trials were measures for each CS- TS pairing.  
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3ms SICI 
Subthreshold CS was delivered at 60, 65, 70 or 75% RMT prior to a 
suprathreshold TS at S1 1mV that was delivered after an interval of 3ms. Ten 
trials were measured for each CS- TS pairing.  
 
LICI 
A single ISI of 100ms was adopted between a suprathreshold CS of 115% RMT 
and a TS that was also delivered at 115% RMT. A total of 20 trials were 
measured.  
 
ICF 
One ISI of 10ms was tested. Conditioning pulses were delivered at one of three 
subthreshold intensities at 65, 70 or 75% RMT and followed by a suprathreshold 
TS of S1 1mV after 10ms. Each CS-TS pairing was measured 10 times.  
 
Unconditioned trials 
A total of 30 unconditioned trials were measured at SI 1mV. 
4.3.5 Experimental procedures 
During the first testing session the hot spot for FDI stimulation was 
identified with the aid of an anatomical target displayed using neuro-navigation 
software. This location was then used to guide coil placement for subsequent 
sessions, and was only subject to minor adjustments. Following hot spot 
identification, both RMT and S1 1mV were measured. IO curves and paired pulse 
measures were then taken, the order of which was counterbalanced within and 
between subjects. Following the TMS measures of baseline cortical excitability 
the tDCS electrodes were placed on the scalp and stimulation was applied for 20 
minutes. Immediately after tDCS stimulation the electrodes were removed, the 
TMS coil was replaced, and TMS coil location and thresholds (both RMT and SI 
1mv) were checked. If necessary small adjustments to thresholds were made 
prior to measuring IO curves and paired pulse measures the second time. The 
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same procedure was completed four times for cathodal and anodal conditions; 
and twice for the sham condition. Each testing session was separated by a 
minimum of 3 and a maximum of 4 days, and where possible the time of testing 
was kept constant within subjects. To maintain relatively constant levels of 
alertness and arousal throughout testing, subjects watched wildlife 
documentaries throughout the testing sessions.  
4.3.6 Data analysis  
Peak-to-peak MEP amplitudes were estimated using in-house Matlab 
software (Mathworks, MA, USA). All trials in the 500ms period prior to MEP were 
carefully visually inspected and any trials in which there was evidence of pre-
contraction of the FDI muscle were excluded. 
IO curve measurements were estimated by calculating the median intra-
individual MEP amplitudes for each TMS intensity value (i.e. 100-150% of RMT); 
linear fits were then applied to the resultant values (mean R² = 0.89). For 
alternative slope fitting please see Appendix.iv. Median values were calculated 
rather than the mean in order to limit the effect of non-standard distribution of 
individual data. For one participant 150% RMT could not be tested. Slopes were 
therefore fitted to the available values (i.e. 100-140% RMT). 
Paired pulse data was analysed by normalizing median MEP amplitudes 
evoked from conditioned trials to the respective median of unconditioned trials. 
Intra-subject median inhibition or facilitation across the various CS intensities 
was then calculated for each protocol. This method was chosen because average 
slope fits were poor and highly variable across participants (for example the 
mean R² value for baseline measures in the 3ms SICI anodal condition was 
R²=0.63, with a range of R²=0.12- 0.99).  
Repeated measures ANOVAS were calculated for each TMS measure (IO 
curve slope, 1ms SICI, 3ms SICI, LICI and ICF) with time of testing (pre/post) and 
experimental session (1-4) entered as within-subject independent factors.  
Mauchley’s test of sphericity was performed and corrections were made using 
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the Greenhouse-Geisser correction when necessary. A priori assessment of 
baseline threshold differences were carried out using Students t tests (paired 
samples, two tailed, p <0.05).  
In order to investigate intra-subject reliability of tDCS induced changes, 
ratios of IO curve slope change were calculated by dividing each individual’s 
post-tDCS IO slope by their baseline (pre tDCS) slope for each session. Ratios of 
change in the paired pulse measures were also calculated in the same manner. 
Intra-class correlation coefficient (ICC (2,1)) analysis was then used to explore 
the reliability of tDCS induced changes over the four sessions for anodal, 
cathodal and sham data. ICC results are reported based upon Lahey et al. (1983), 
whereby ICC values of <0.4 are considered to indicate poor intra-class reliability, 
values >0.4 and <0.59 are fair, values >0.6 and <0.74 are good, and values >0.74 
are excellent. Negative ICC values are taken to indicate a lack of reliability within 
the measure.  
4.4 Results 
Paired sample t-tests confirmed that baseline values for RMT did not 
significantly differ between sessions (p > 0.05) for anodal (all t(9) < 1.63, all p > 
0.14), cathodal (all t(9) < 1.13, all p > 0.29) or sham conditions (t(8)=.610, 
p=0.56). These details can be seen in Table 4.1.  
Paired samples t-tests also confirmed that RMT did not significantly alter 
from baseline for any session following anodal stimulation (all p>0.168), cathodal 
stimulation (all p>0.343) or sham (all p>0.347).   
 
Table 4.1. Mean ± standard deviation of RMT for each condition and testing 
session. 
 Anodal  
RMT  
Cathodal RMT  Sham RMT  
 
Session 1 45.8 ± 4.6 45.8 ± 4.3 45.6 ± 5.8 
Session 2 46 ± 4.4 45.9 ± 4.8 45.8 ±5.8  
Session 3 46.2 ± 4.7 46 ± 5.0 Na 
Session 4 46.3 ± 4.6 47.1 ± 5.0 Na 
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4.4.1 Analysis of group effects 
Input Output curve slope 
For the anodal condition a repeated-measures ANOVA revealed a 
significant main effect of time of stimulation (i.e., Pre vs. Post tDCS), 
F(1,9)=5.232, p = 0.048. There was no significant effect of testing session 
F(3,27)=2.5, p=0.08, and no significant interaction between these two factors 
F(3,27)=0.58, p=0.63. Figure 4.7 shows mean MEP amplitudes at each TMS 
intensity before and after anodal stimulation.  
 
For the cathodal condition a separate repeated-measures ANOVA was 
calculated. The ANOVA revealed no significant main effects of time of stimulation 
F(1,9)=3.491, p=0.095 or of testing session F(3,27)=0.03, p=0.99, and the 
interaction between these two factors was not significant F(3,27) 0.53, p=0.67.  
Figure 4.8 shows mean MEP amplitudes at each TMS intensity before and after 
cathodal stimulation.  
 
For the sham condition a repeated-measures ANOVA revealed no 
significant main effect of time of stimulation, F(1,8)=.218, p=.653. There was no 
significant effect of testing session F(1,8)=.424, p=0.533, and no significant 
interaction between these two factors F(1,8)=0.186, p=0.678. Figure 4.9 shows 
mean MEP amplitudes at each TMS intensity before and after sham stimulation 
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Figure 4.7. Mean & SEM MEP amplitude pre and post anodal tDCS. 
 
Figure 4.8. Mean & SEM MEP amplitude pre and post cathodal tDCS. 
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Figure 4.9. Mean & SEM MEP amplitude pre and post sham tDCS. 
 
Intracortical facilitation 
 
Anodal tDCS was not found to significantly 
alter the amount of ICF (Figure 4.10 A). 
Full results can be seen in Table 4.2. 
Repeated measures ANOVA revealed no 
significant main effect of cathodal tDCS on 
ICF, nor a significant main effect of time 
(pre/post). However, a significant 
interaction was revealed. Further 
exploration using paired samples t-tests 
revealed a significant difference between 
pre (M=104.1, SD=37.0) and post 
(M=133.8, SD=48.6) measures in session 4 
t(9)=-3.01, p=0.015. Relevant data can be 
seen in Figure 4.10 B and Table 4.3. 
ICF was not significantly altered in the sham 
condition on either of the two testing 
sessions (Figure 4.10C). See Table 4.4 for full 
results.  
Figure 4.10. Mean and SEM change in 
ICF pre/post anodal (A), cathodal (B) or 
sham (C) stimulation. 
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Short interval intracortical inhibition (1 and 3ms) 
 
1ms SICI was not significantly altered by anodal tDCS (Figure 4.11 A), no 
significant main effects or interactions were found.  Contrasting with the findings 
of 1ms SICI, the ANOVA run using the 3ms SICI data (Figure 4.11 B) revealed a 
significant main effect of measurement time (pre/post) F(1,9)=7.803, p=0.021. 
No main effect of session was revealed F(3,27)=.687,p=.568, however a 
significant interaction between the two factors was observed F(3,27)=3.727, 
p=0.023. Paired sample t-tests revealed a trend towards a reduction in inhibition 
after tDCS for sessions 1, 2 and 4, however, this difference was only found to be 
significant for session 4, t(9)=-4.425, p=.002. A significant difference between 
baseline and post anodal inhibition was also found for session 3, however, this 
showed the opposite pattern of results t(9)=3.590, p= .006. Further exploration 
of the data suggests that the results for session three should be interpreted with 
caution. This is because during this session the average MEP amplitude of the 
1mV test pulse differed significantly between baseline (M=0.84, SD=0.76) and 
post measures (M=1.33, SD=0.62) for this session (t(9)=-2.419, p=.039). TS 
intensity has been found to significantly influence inhibition caused by SICI (Garry 
& Thomson, 2009), with lower TS intensities found to yield less inhibition. 
Therefore, it should be considered that differences between TS intensities in 
session 3 could be masking any true effects of anodal tDCS.  
 
1ms SICI was not significantly altered by cathodal tDCS (Figure 4.11 C). 
The repeated measures ANOVA revealed no significant main effects nor a 
significant interaction. 3ms SICI was also not significantly altered (Figure 4.11 D). 
Full results are shown in Table 4.3 Similarly, the effects of sham stimulation also 
did not significantly alter 1ms or 3ms SICI (Figure 4.11 E, F). See Table 4.4 for full 
results.  
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Long interval intracortical inhibition 
LICI was found to reach ceiling level and totally abolish the MEP response 
in 7 of 10 participants during baseline anodal sessions (Figure 4.12). 
Consequently, the results of LICI were not further analysed as this would make it 
impossible to identify any significant decreases. As a result of the findings during 
the anodal testing session the measure was dropped from cathodal and sham 
conditions.  
 
 
Figure 4.11. Mean & SEM levels of inhibition for 1ms SICI pre/post anodal (A), 
cathodal (C) or sham (E) stimulation. Pre/post level of inhibition for 3ms SICI 
pre/post anodal (B), cathodal (D) or sham (F) stimulation. 
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Figure 4.12. Average inhibition caused by LICI for each participant over each 
session of pre anodal stimulation. Each colour represents an individual 
participant. Dashed line illustrates no change from unconditioned stimulus 
elicited by TS alone (uncondi all).  
 
 
 
 
 
  
Table 4.2. Summary of Repeated measures ANOVA results for anodal sessions. 
Measurement Factor d.f F P p² 
IO curve slope  Session 3 2.505 .08 .218 
 Time 1 5.232 .048* .368 
 Session*Time  3 .583 .631 .061 
1ms SICI Session 1.5 .190 .902 .021 
 Time 1 1.897 .202 .174 
 Session*Time  3 2.038 .132 .185 
3ms SICI Session 3 .687 .568 .071 
 Time 1 7.803 .021* .464 
 Session*Time  3 3.727 .023* .293 
ICF Session 3 .761 .526 .078 
 Time 1 .770 .403 .079 
 Session*Time  1.6 .2.321 .142 .205 
101 
 
Table 4.3. Summary of Repeated measures ANOVA results for cathodal sessions. 
Measurement Factor d.f F P p² 
IO curve slope  Session 3 .030 .993 .003 
 Time 1 3.491 .095 .279 
 Session*Time  3 .525 .669 .055 
1ms SICI Session 3 1.751 .180 .163 
 Time 1 .346 .571 .037 
 Session*Time  3 1.679 .195 .157 
3ms SICI Session 1.3 1.140 .326 .112 
 Time 1 .284 .607 .031 
 Session*Time  1.3 1.577 .218 .149 
ICF Session 3 1.274 .302 .124 
 Time 1 .011 .919 .001 
 Session*Time  3 3.295 .036* .268 
 
 
Table 4.4. Summary of Repeated measures ANOVA results for sham sessions. 
Measurement Factor d.f F P p² 
IO curve slope  Session 1 .424 .533 .050 
 Time 1 .218 .653 .027 
 Session*Time  1 .186 .678 .023 
1ms SICI Session 1 1.643 .236 .170 
 Time 1 2.366 .163 .228 
 Session*Time  1 .058 .815 .007 
3ms SICI Session 1 .254 .628 .031 
 Time 1 .990 .349 .110 
 Session*Time  1 .045 .837 .006 
ICF Session 1 .043 .841 .005 
 Time 1 .079 .786 .010 
 Session*Time  1 1.33 .282 .143 
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4.4.2 Analysis of inter-subject reliability 
To investigate the intra-subject reliability of the effect of anodal, cathodal 
and sham tDCS on the slope of each participant’s IO curve, an intra-class 
correlation coefficient (ICC) analysis was conducted, based upon the ratio of 
post-tDCS and pre-tDCS slopes, separately for each stimulation. For anodal 
stimulation, the change in IO curve slope was found to be poorly related across 
the four separate testing sessions, ICC(2,1) = 0.28 . Relevant data are presented 
in Figure 4.13A. When the same analyses were conducted for cathodal tDCS the 
ICC analysis revealed poor interclass reliability, ICC(2,1) = 0.04, Relevant data are 
presented in Figure 4.13B .  ICC analysis of the sham condition revealed fair 
interclass reliability across the two testing sessions ICC(2,1)=.44. Relevant data 
are shown in Figure 4.13C.  
 
 To allow for more accurate comparisons to the sham condition ICC was 
also calculated using the first two sessions for the 9 participants who completed 
all conditions. For anodal stimulation this revealed a poor reliability ICC(2,1)=0.1, 
poor reliability was also found for the cathodal condition ICC(2,1)=0.35.  
 
Change in 1ms SICI was not reliable across the different anodal testing 
sessions ICC(2,1)=.02. Nor was it reliable across cathodal sessions ICC(2,1)=-0.15; 
or sham sessions ICC(2,1)=-0.21.  Change in 3ms SICI was also found to be 
unreliable across the different anodal testing sessions ICC(2,1)=0.33; cathodal 
sessions ICC(2,1)=0.23 and sham sessions ICC(2,1)=0.06. ICC analysis of the ICF 
data revealed no reliable changes across sessions following anodal stimulation 
ICC(2,1)=0.37; cathodal stimulation ICC(2,1)=0.10; or sham ICC(2,1)=0.01. 
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Figure 4.13. Amount of change in IO curve slope (pre/post) for each participant 
following (A) anodal, (B) cathodal and (C) sham stimulations. Each coloured data 
point represents a single session, black diamonds indicate mean change. 
Horizontal line indicated no change from baseline. 
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4.5 Discussion 
 
This study investigated the reliability and consistency of the effects of 2mA 
tDCS by assessing changes induced in a number of single and paired pulse TMS 
measures over repeated testing sessions. The effects of anodal, cathodal and 
sham stimulations were assessed at group level and also individually across the 
multiple testing sessions.  For clarity, the results of the single pulse (IO curve) 
and paired pulse measures (SICI, ICF, LICI) will be discussed separately.  
tDCS effects on single pulse (IO curve) measures of cortical excitability 
The results demonstrate a group level increase in IO curve slope following 
anodal tDCS, but no significant change in this measure following cathodal or 
sham stimulation. IO curves are thought to reflect the strength of cortico-spinal 
projections (Chen, 2000) and the balance of inhibitory and facilitatory processes. 
Therefore, the finding of increased IO curve slopes following anodal tDCS is a 
good indication of increased cortical excitability overall, and a finding which has 
also been reported by others (Nitsche & Paulus, 2000; Nitsche et al., 2005). 
Interestingly, although this effect was signficant at a group level, individual 
analysis of the data for each testing session revealed variability both within and 
between subjects in response to the stimulation, with ICC anlysis suggesting the 
effect to be of poor reliability within individuals. The effects of cathodal tDCS 
were also found to show poor reliability across sessions, whereas the sham 
condition revealed moderate stability.   
It should be noted that the above findings and conclusions are restricted 
to the effects occurring within a 30 minute period after 2mA tDCS stimulation 
was applied to the motor cortex for 20 minutes. It is possible that the lack of 
effects in the cathodal condition are resultant of the time the measurements 
were taken. This is because previous research (Batsikadze et al., 2013) has 
reported a significant change in excitability which only became apparent after 90 
minutes. Batsikadze et al. (2013) inferred change in cortical excitability by a 
change in MEP amplitude from a single intensity rather than in an IO curve 
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measurement, therefore, timing is not the only difference between their study 
and this one. However, the differences between the measures used are not 
necessarily problematic. This is because IO curves measure the change in MEP 
amplitude over a range of TMS intensities and would, therefore, encompass 
those measured using a single intensity such as that used by Batsikadze et al. 
(2013).   
The results reported by Batsikadze et al. (2013) are counter to previous 
studies reporting the effects of cathodal tDCS on motor excitability insofar as 
they reported that cortical excitability, as indexed by MEP amplitude, was 
increased following 2mA cathodal tDCS whereas previous studies of cathodal 
tDCS at lower stimulation intensities had reported that cathodal tDCS decreases 
cortical excitability (Nitsche, Nitsche, et al., 2003; Nitsche & Paulus, 2001). 
Although non-significant, inspection of Figure 4.8 suggests that the findings are 
broadly consistent with the findings of Batsikadze et al. (2013), in that many 
participants showed an increase rather than a decrease in motor excitability and 
this effect was close (p=0.08) to conventional statistical significance thresholds. 
However, this effect was variable across participants and more importantly it 
was variable within participants, as indicated by ICC analysis. It is possible that a 
longer follow-up period using TMS would have revealed significant effects and 
furthermore that these effects may have become more stable and consistent 
following a sizeable delay such as 90-120 minutes. However, for practical reasons 
this was not tested and, therefore, this can only be speculation.  
The finding that the effects of 2mA anodal stimulation were not reliable 
within individuals despite significant group level effects is particularly interesting 
as it suggests that group level analysis may hide substantial variability which 
occurs both between and within subjects. Previous evidence regarding stability 
of anodal effects has been mixed. The results of this study are more in line with 
the recent findings of Horvath et al. (2016) than those of Lopez-Alonso et al. 
(2015). However, as previously noted there are methodological differences 
between the studies which may in part contribute to the findings. In particular, 
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the study by Lopez-Alonso et al. (2015) was conducted with sessions separated 
by 6-12 months and only two sessions were compared, although it should be 
noted that this work was conducted with a larger sample. Our finding of 
moderate stability following sham stimulation is also in agreement with previous 
work (Horvath et al., 2016). 
Throughout the study efforts were made to maintain stability across 
testing sessions (e.g. by the use of neuro-navigation software). However, one 
factor which may have varied across the sessions was the exact timing of when 
the TMS measurements were taken. This was due to three factors: 1) Delays due 
to set-up issues such as removing tDCS electrodes and re-registering the 
participants head using neuro-navigation software. 2) TMS delays such as 
identifying the optimal stimulation location and if necessary re-calculate RMT 
and SI1mV. 3) Counterbalancing of TMS measures (pp/ IO) which was done to 
allow for better detection of group level effects. It is difficult to say how much of 
the variability seen in the data reflects these timing issues. However, it should be 
noted that when a large amount of TMS measures are collected (as in this study) 
it takes time, therefore even if data collection starts exactly as tDCS finished this 
may be acquired over a period of 10-20 minutes. When fewer TMS 
measurements are taken it becomes possible to measure more discrete time 
points, this was done by both Horvath et al. (2016) and Lopez-Alonso et al. 
(2015) who measured every 10 minutes following tDCS. Using this method and 
examining change in a single MEP amplitude Horvath et al. (2016) found the 
effects of 1mA anodal tDCS to be unreliable over a 30 minute follow up period. 
Contrarily Lopez-Alonso et al. (2015) found the effects to be of fair reliability in 
the 0-30 minute period following stimulation, but not after 30-60 minutes. These 
findings are based on ICC analysis with binned data, yet it is worth noting that 
when individual time points are studied (such as 10, 15 and 20 minutes) the ICC 
values drop in the study by Lopez-Alonso et al. (2015) to revealed poorer 
reliability in most instances. Based on these findings the variability found in the 
present results seems unlikely to be due to timing issues alone.  
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tDCS effects on paired pulse (SICI, ICF) measures of cortical excitability 
2mA anodal tDCS was not found to significantly alter 3ms SICI. Although 
Lopez-Alonso et al. (2015) also failed to show a significant change in SICI (using a 
2ms ISI), this is counter to previous work which has reported reductions during 
anodal stimulation (Cengiz et al., 2013), and also following stimulation applied at 
0.8mA (Kidgell et al., 2013); 1mA (Batsikadze et al., 2013; Kidgell et al., 2013; 
Nitsche et al., 2005) and 2mA (Batsikadze et al., 2013).  
SICI is considered to be primarily dependent on GABA-A synaptic activity 
(Ziemann et al., 2015), and therefore many have argued that a reduction in SICI 
indicates that the effects of anodal tDCS are at least in part resultant of synaptic 
changes and alterations in levels of GABA. Our results do not provide clear 
support for this; however, neither do they strongly refute them, as in three of 
the four sessions there was a trend for SICI to be reduced.  
ICC analysis of 3ms SICI effects showed that the influence of anodal 
stimulation on this measure was unreliable across sessions. This conflicts with 
the findings of Lopez-Alonso et al. (2015) whose ICC analysis revealed ‘fair’ 
reliability. As previously discussed there are a number of differences between 
the two studies which may have contributed to the different findings, including 
differences in the intensity and duration of tDCS used, differences in sample sizes 
and differences between SICI measurements.  
Less is currently known about 1ms SICI with regards to its origin. 
However, it has been found that the effects of anodal tDCS (both 1 and 2mA) on 
1ms SICI appear to be the reverse of those occurring when SICI is measured using 
ISIs of 3ms  (Cengiz et al., 2013). The study by Cengiz et al., (2013) was conducted 
during stimulation, and therefore is not directly comparable to the offline results 
seen here. However, it is worth noting that in this offline study there is no clear 
evidence that 1ms and 3ms SICI were influenced differently by anodal tDCS.  
Cathodal tDCS also failed to influence either of the SICI measurements. 
The effects of 2mA cathodal stimulation are far less explored than those of 1mA; 
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and although there is evidence that 1mA cathodal stimulation increases 3ms SICI 
(Nitsche et al., 2005); the effects of cathodal stimulation are known to be more 
difficult to produce and have been found to show a more variable pattern of 
responses (Wiethoff et al; Horvath et al 2016). The study by Batsikadze et al. 
(2013), revealed a significant reduction in SICI following cathodal stimulation 
which became apparent only 60 and 90 minutes after tDCS. Interestingly the 
significant change in SICI was only found for ISIs of 5ms but not in the 2 or 3ms 
conditions. This highlights further complexities in the study of tDCS effects using 
TMS. Particularly as there is no clear reason to believe that the underlying 
mechanisms of 3 and 5ms SICI to be different (although 2ms may be closer to the 
seeming distinct processes underlying 1ms SICI effects).   
Neither anodal nor sham stimulation significantly altered ICF measures. 
This is counter to previous research which has reported increases in ICF following 
anodal stimulation (Batsikadze et al., 2013; Nitsche et al., 2005).  The finding that 
2mA cathodal stimulation significantly increased ICF on a single session is similar 
to the increase reported by Batsikadze et al. (2013); however it’s unclear why 
this difference was only apparent on the fourth session.  
Limitations: 
The counterbalancing of the conditions tested in this experiment was not 
optimal, and ideally the experimenter would be blind to the stimulation used. 
Unfortunately, for practical reasons this was not feasible. However, experimental 
controls were in place (such as the use of neuro-navigation systems to guide TMS 
coil placement) to offset these limitations.   
A further potential limitation of the study is the sample size. Although 
small sample sizes are common within tDCS research and this sample size was 
large enough to reveal a significant group effect following anodal stimulation, a 
larger sample may have provided more robust results. Recent work has revealed 
surprisingly low rates of responses to tDCS even for anodal stimulation which is 
thought to be more reliable than cathodal. For example, in a study of 45 
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participants Lopez-Alonso et al. (2015) estimated 60-64% of participants 
responded to anodal stimulation with an overall increase in cortical excitability.  
Another study by Wiethoff et al. (2014) estimated that approximately 50% of the 
53 participants they tested had minor or no response to tDCS.  
Conclusions:  
In summary, we investigated the reliability and consistency of the effects 
of 2mA anodal and cathodal tDCS on motor excitability by examining how a 
number of TMS measures were influenced by tDCS. We found that anodal 
stimulation significantly increased the slope of TMS IO curves and that this effect 
was consistent at a group level across repeated testing sessions. Using ICC 
analysis these effects were not found to be reliably consistent within individuals. 
Sham stimulation failed to significantly influence IO curve slope, however the 
effects of this intervention were found to be moderately reliable within subjects. 
The results of the paired pulse stimulations revealed no clear tDCS induced 
changes for any measures, with the exception of an increase in ICF following 
cathodal stimulation in a single session.   
As previously discussed, variability with non-invasive brain stimulation 
techniques is not uncommon. However, in order to develop techniques such as 
tDCS into more powerful methods in both research and therapeutic contexts, 
understanding the sources of this are likely to be critical. In particular furthering 
our understanding regarding the reliability and consistency of these effects may 
allow us to better identify responders and non-responders to particular 
paradigms. The present research suggests that at least some of the variability 
comes from non-fixed factors (opposed to more stable factors such as anatomy), 
as variability was apparent within participants. This makes the task of identifying 
features causing variability more complex, and it is unlikely that all will be 
identified. Nevertheless, research identifying key sources could be particularly 
useful in furthering the development of tDCS as an effective treatment 
alternative to conventional approaches.   
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 Can cathodal tDCS reduce tics in Tourette’s 
syndrome?  
 
Key words: Gilles de la Tourette’s syndrome (GTS), transcranial direct current 
stimulation (tDCS), transcranial magnetic stimulation (TMS), resting motor 
threshold (RMT), input output curve (IO curve), Yale global tic severity score 
(YGTSS).  
 
5.1 Introduction 
As previously discussed in Chapter 1, Gilles de la Tourette’s syndrome 
(GTS) is a childhood onset disorder, characterized by the presence of motor and 
phonic tics which are present for a minimum of 1 year (Leckman, 2002). Tics can 
vary in their complexity, intensity and frequency. They can also vary over time 
and from person to person, for example, one individual with GTS may experience 
only ‘simple’ tics such as eye blinking and sniffing, whereas another may 
experience more ‘complex’ tics such as imitating actions or repeating words. Tics 
are thought to wax and wane over both long and short periods of time. Tics are 
often at their worst in children aged 10-12 years and follow a time course in 
which approximately three-quarters of children will see their tics largely diminish 
by the time they are adults (Bloch & Leckman, 2009). Over a shorter time period 
stress and fatigue may exacerbate tics (Hoekstra et al., 2004; Lin et al., 2007), 
whereas engaging in enjoyable activities have been reported to reduce them. 
Although tics and reactions to them can vary from person to person, the 
quality of life in adults with GTS has been found to be strongly related to GTS 
symptomology (Jalenques et al., 2012). In both adults and children, tics have 
been found to influence various aspects of life including social, 
occupational/academic and psychological well-being (Conelea et al., 2011; 
Conelea et al., 2013). Tics may also put a physical strain on the body, for example 
sudden tics may be painful, tissue damage may occur from repetitive tics and 
injury secondary to a tic may occur (-such as by striking an object). Tics may even 
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result in stress fractures and musculoskeletal damage (Fusco et al., 2006; Moon 
et al., 1998). Sadly, painful tics are not uncommon. A recent large scale study 
found that 60% of adults with GTS reported having at least one tic which caused 
pain or physical damage (Conelea et al., 2013); for children a similar large scale 
study found rates to be 64% (Conelea et al., 2011). Consequently, developing 
treatments which reduce tics are critical in improving quality of life for 
individuals with GTS. 
At present, two of the most common treatments for GTS are medication 
and behavioural interventions. The most popular behavioural intervention is 
‘habit reversal training’ which is a form of cognitive behavioural therapy 
involving two stages. The first stage is ‘awareness training’, during which the 
individual learns to focus on any sensory phenomena they experience prior to a 
tic. These sensations as often referred to as premonitory urges and can involve 
unpleasant sensations such as feelings of pressure which are temporarily relived 
or reduced following a tic (Woods et al, 2005). The second stage is known as 
‘competing response training’, and involves learning to perform a voluntary 
action that is incompatible with the tic whenever an urge to tic occurs. This 
voluntary action is intended to help manage the urge to perform a tic in a way 
that differs from tic suppression (Piacentini et al., 2010).  There is evidence that 
habit reversal training can work well to reduce tics (Piacentini et al., 2010; Yates 
et al., 2016), however, access to this type of treatment is limited by the amount 
of trained professionals able to deliver it.  The treatment is also time consuming 
and may be too large a commitment for families, particularly if a long commute 
is necessary to visit specialists.  
At present the main alternative to behavioural therapy is medication and  
although few medications have received formal FDA approval for the treatment 
of GTS, a number of different drugs can be prescribed by clinicians, often based 
on their personal experience (Kurlan, 2014). Some of the main drugs prescribed 
for treatment of GTS are antipsychotics such as Haloperidol; dopamine depletors 
such as Tetrabenazine, and alpha-agonists such as Clonidine (Kurlan, 2014).  
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Although these treatments will work for some, others may not respond, or find 
that the side effects outweigh the benefits. For example, antipsychotics are often 
prescribed but have been associated with sedation, depression, increased 
appetite and Parkinsonism (Kurlan, 2014). Tardive dyskinesia has also been 
reported as a side effect of the antipsychotic Aripiprazole (Pena et al., 2011). Due 
to the known side effects of this class of drug, clinicians may prescribe other 
medications first, including alpha-2 adrenergic drugs such as clonidine, and drugs 
which deplete dopamine such as Tetrabenazine (Kurlan, 2014). Although 
Clondine has been found to outperform placebo in the treatment of tics 
(Leckman et al., 1991) and Tetrabenazine has also been found to be helpful 
(Porta et al., 2008), neither are without side effects. Clondine has been 
associated with sedation, headaches, dizziness and irritability (Kurlan, 2014); and 
sedation, depression, insomnia and restlessness are reported side effects of 
Tetrabenazine  (Jimenez-Shahed & Jankovic, 2013). 
Although there are clear merits to behavioural therapies and 
pharmacological interventions, the disadvantages of these treatments cannot be 
ignored. There is a clear need to develop alternatives which are both convenient 
and free of side effect. These alternatives may come in the form of non-invasive 
brain stimulation (NIBS) techniques.  
The approach of using NIBS to treat symptoms of GTS is rather different 
from the approaches used in behavioural therapies and pharmacology.  One key 
difference is that NIBS techniques allow a specific brain region to be targeted, 
unlike behavioural interventions which are less direct or pharmacological 
interventions which may involve influencing the level of a neurotransmitter 
throughout the whole brain. 
As discussed in Chapter 1, the neurological underpinnings of GTS are not 
yet fully understood. Although advances in neuroimaging techniques have 
implicated an array of different brain regions, many of which support the idea of 
dysfunction in cortico-striato-thalamo-cortical networks (Greene et al., 2015; 
Mink, 2006), the results are not always consistent and can be contradictory. One 
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area of the brain in which the evidence for alterations is somewhat more 
consistent is the supplementary motor area (SMA). This area of the brain has 
extensive connections to areas relating to motor control and cognitive 
processing (Picard & Strick, 2001) and has been linked to the genesis of tics in a 
number of multi-modal studies. fMRI blood oxygen level dependent (BOLD) 
signal in the SMA has been found to increase proceeding the occurrence of a tic 
(Bohlhalter et al., 2006). In addition to this, evidence from a positron emission 
tomography (PET) study found increased SMA activity in individuals with GTS 
(Eidelberg et al., 1997). Magnetic encephalography (MEG) has also been used 
and implicated the SMA as an important area in GTS. Based on the findings of a 
MEG study involving simple motor movements, Franzkowiak et al. (2012) 
suggested that the hyper-activity within M1 in GTS is caused by increases in the 
functional interaction between SMA and this area.  
In addition to findings from fMRI, PET and MEG, stimulation studies in 
individuals with GTS and neurologically typical participants provide further 
support for the involvement of the SMA in GTS. A recent study by Finis et al. 
(2013) demonstrated that it was possible to induce tic like behaviours (similar to 
echolalia) in neurologically typical individuals by stimulating the SMA with 5Hz 
rTMS. As 5Hz rTMS protocols are known to lead to temporary increases in 
excitability (Pascual-Leone et al., 1994), this provides support for the theory that 
elevated SMA excitability can contribute to the genesis of tics.  
As outlined in Chapter 1, using NIBS to reduce excitability within the SMA 
could be an effective method of reducing tics in individuals with GTS. Following 
promising results of an open label study in GTS and OCD (Mantovani et al., 2006); 
Mantovani et al. (2007) conducted a further study in which it was found that 
inhibitory 1Hz rTMS applied to the SMA for 10 days reduced tic symptoms in two 
individuals for up to 4 months after treatment. Kwon et al. (2011) also found that 
10 sessions of 1Hz rTMS reduced tic symptoms in 10 children/adolescents (ages 
11-14) over the course of a 12 week follow-up. A similar finding was reported by 
Le et al. (2013) who found that 20 sessions of 1Hz rTMS to the SMA reduced tic 
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symptoms, and that these effects lasted up to 6 months in some of the 25 
participants tested.  
Studies with tDCS have also shown promise in reducing tics. Carvalho et al. 
(2015) identified significant changes in tics which were still present at 6 months 
following 10 sessions of cathodal tDCS applied to the SMA. Finally, Mrakic-Sposta 
et al. (2008) found tics significantly reduced following 5 days of tDCS applied to the 
left motor cortex. These effects were found to be greater than in a sham condition. 
Although the previous work has shown promise, with the exception of the work by 
Mrakic-Sposta et al. (2008) the studies have not been sham controlled and the 
majority have been conducted using rTMS. One of the key advantages of tDCS 
stimulation is that it has potential for home use due to its portability and 
comparably cheap price. It is also associated with a much lower risk of major side 
effects than rTMS. Therefore, there is a need for more studies investigating its 
potential in addition to a need for further sham controlled studies using rTMS.  
In this study, the effects of a single session of cathodal/sham tDCS on tic 
symptoms was investigated. Many previous studies, including most discussed above, 
have assessed changes in tic severity using self-report based measures and semi-
structure interviews such as the Yale Global Tic Severity Scale (YTSSG). In this study 
tics were assessed using short video recordings of participants. This method has a 
number of advantages, including the ability for trained individuals to objectively 
assess tics whilst being blind to the condition. It is also relatively quick and is not 
restricted by the participant’s ability to describe their experiences of tics. 
Furthermore, it is less likely to be subject to self-reporting biases as a result of 
experiencing an intervention.  
In addition to video recordings, TMS was also used in an effort to explore how 
tDCS may be influencing cortical excitability. This was done by recording changes in 
MEP amplitudes at M1. Unlike the previous studies reported in Chapters 3 and 4, 
tDCS was not applied at the same location, therefore, any effects observed may 
suggest an indirect change resulting from the influence the SMA may exert over M1.   
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5.2 Method  
 
5.2.1 Participants 
A total of ten participants with a diagnosis of Tourette’s syndrome (N=9) 
or Chronic tic disorder (N=1) were recruited. The mean age of participants was 
22.8 years (range 16-33 years); five were male and five were female. Participants 
were recruited through a UK charity, Tourettes Action, and through a local NHS 
clinic. Some participants had diagnoses of additional co-occurring disorders and 
some were taking medications (see Table 5.1 for details).  
 
Table 5.1. Participant demographics 
ID Sex 
(M/F) 
Age Tic 
diagnosis 
Co-occurring 
 diagnoses 
Medication 
1 M 23.3 GTS N/A Clonidine 
2 M 16.1 GTS Anxiety Clonidine, Aripiprazole, Sertraline 
3 M 20.5 GTS ADHD Pentasa (not CNS active) 
4 F 20.5 GTS N/A N/A 
5 F 18.4 GTS OCD, dyscalculia, depression Citalopram (20mg) 
6 F 32.2 GTS N/A N/A 
7 F 33.3 GTS ADHD Concerta, Fluoxetine 
8 M 20.3 GTS N/A Clonidine (175mg) 
9 M 20.5 GTS ADHD Methylphenidate hydrochloride 
10 F 23.1 CTD N/A N/A 
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5.2.2 Design 
A within subjects design was used to explore the effects of sham and 
cathodal tDCS on tic expression and motor cortical excitability. The independent 
variable was tDCS which had two levels (sham/ cathodal), the dependent 
variables were the amount of change in TMS measures (IO curve and SI 1mv) and 
also the change in tic expression measured via short video clips.  Each 
experimental session was separated by a minimum of one week to avoid any 
potential carry over effects. The order in which participant’s experienced 
stimulation (sham or cathodal) was counterbalanced across participants.  
5.2.3 tDCS of the supplementary motor area (SMA) 
tDCS was delivered via a NeuroConn DC- stimulator (GmbH, Ilmenau, 
Germany) with a maximum stimulation output of 4.5mA. Stimulation was applied 
using surface sponge electrodes measuring 35 cm². The ‘active’ electrode was 
placed on the area of the scalp thought to be directly above SMA in a way which 
afforded bilateral stimulation. This location was identified in accordance with 
previous studies (Enticott et al., 2012; Finis et al., 2013; Mantovani et al., 2007)   
in which the 10-20 EEG system was used to identify the site which is 15% of the 
distance between nasion and inion anterior of the CZ location. The reference 
electrode was placed on the right hand side of the participant’s forehead. In the 
cathodal condition a 1mA current was run between the two electrodes for 20 
minutes, this was ramped up for 15 seconds at the start of the stimulation and 
ramped down over 15 seconds at the end. In the sham condition the current was 
also ramped up and down over a 15 second period, although it was only held 
constant at 1mA for 30 seconds. This resulted in a maximum current density of 
0.028 mA cm² (1mA/35cm²) in both conditions. Participants were blind to the 
experimental condition, however for practical reasons the researcher was not.  
5.2.4 TMS measurement and EMG recording 
TMS was delivered using a Magstim 200 (Magstim, Whiteland, Dyfed, UK) 
with a figure-of-8 magnetic coil (diameter of one winding 70mm). The coil was 
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held tangentially to the scalp and positioned 45° from the midline. The optimal 
location for stimulation (‘hot spot’) of the contralateral FDI was defined as the 
location over the left motor cortex which when stimulated consistently resulted 
in the largest MEP.   
MEPs were recorded using disposable, Ag-AgCl surface electrodes 
attached to the right FDI muscle in a belly tendon montage. Alcohol wipes were 
used to prepare the skin prior to application of the electrodes. The signals were 
amplified and bandpass filtered (10Hz- 2kHz, sampling rate 5kHz) then digitalized 
using Brainamp ExG (Brain Products GmbH, Gilching, Germany) controlled by 
Brain Vision Recorder (Brain Products GmbH, Gilching, Germany). Participants 
were encouraged to maintain their hand in a relaxed position on a table directly 
in front of them. Resting motor threshold (RMT) was determined as the lowest 
intensity needed to yield an MEP response of 50-100µV in the relaxed FDI 
muscle, in a minimum of 5 of 10 trials.  
A neural navigation system (Brainsight, Rogue Research Inc., Montreal 
Quebec, Canada) was used to track coil position in relation to the participant’s 
head and the location of the identified hotspot. This was done using a template 
as individual anatomical scans were not available. A chin rest was used during 
stimulation to maintain the position of the participant’s head. Participants were 
informed that they could take breaks if necessary and move if uncomfortable.  
IO curve measurement 
IO curves were measured using TMS intensities of 100, 110, 120, 130, 140 
and 150% RMT. The order of the stimuli was randomized, controlled and 
triggered via a software program (Matlab, The Mathworks, MA, USA). Each 
intensity was tested a total of 10 times and each TMS pulse was separated by an 
inter-stimulus interval (ISI) of 5 seconds (S). There was a pause every 10 pulses in 
which the coil position was checked carefully and participant comfort was also 
assessed.  
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SI 1mV measurement 
A 1mV threshold was identified as the intensity needed to yield an MEP 
of approximately 1mV when the coil was located over the hot spot. A total of 20 
pulses were delivered to this area with an ISI of 5s separating each individual 
pulse.  
TMS thresholds (RMT, SI 1mV) were not adjusted following tDCS, thereby 
allowing for identification of any changes in threshold through change in MEP 
amplitudes following stimulation.  
5.2.5 Video recording 
Video recordings lasting 8 minutes were collected both before and after 
tDCS. During this time participants were instructed to not supress their tics, to sit 
and relax and to try to stay awake. The researcher waited outside the room 
throughout recording.  
5.2.6 Yale Global tic severity scale  
The Yale global tic severity scale (YGTSS; (Leckman et al., 1989)) was used 
to rate the number, frequency, intensity, complexity and interference of motor 
and phonic tics at baseline. The scale was also used to provide an overall 
estimate of impairment (by summing motor + phonic + impairments scores). The 
YGTSS is a common measurement instrument within GTS research and has been 
found to have good psychometric properties, including internal consistency, 
convergent validity and association with clinician rating of impairment (Leckman 
et al., 1989; Storch et al., 2005). 
The YGTSS was administered by one of two experienced researchers; this 
was held constant for both sessions (sham/ cathodal).  For baseline YGTSS score 
in each condition see Table 5.3 and Table 5.4.  
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5.2.7 Procedure 
 
 
Figure 5.1. Schematic of experimental procedure. 
After gaining informed consent the YGTSS was administered by the 
primary investigator (KD) or an experienced research nurse (JF). This took the 
form of a semi-structured interview in which participants were asked about the 
tics they had experienced within the last week. Tics noticed by the researcher 
but not reported by the participant were included in the total score. On average 
this took 15-30 minutes to complete.  
  Following completion of YGTSS the participant was moved to sit directly 
in front of a camera and an 8-minute video recording was taken with the 
researcher and any other individuals (such as parents) outside of the room.   
After the video recordings the participant was seated in a comfortable 
chair with their head positioned on a chin rest and their right hand and forearm 
placed in a relaxed position on a table directly in front of them. The location of 
the participant’s head was then registered to a template (constructed from a 
consenting individuals anatomical brain scan) using the Brain sight system 
(Rogue Research Inc., Montreal Quebec, Canada), and disposable electrodes 
were attached to the hand. Following this, the hotspot for FDI stimulation was 
identified using TMS, which was then mapped onto the template brain to aid coil 
localization.  RMT was then defined before the measurement of IO curves. 
Following this SI 1mV threshold was measured and data was collected from 20 
pulses delivered at this intensity.   
After the first session of TMS the head tracker was removed and the 
researcher measured the approximate location of the SMA on the scalp using the 
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method previously described. This was marked in pen to aid placement of the 
tDCS electrode. The saline soaked sponge covered tDCS electrodes were then 
placed over this mark and over the right side of the forehead. These were 
attached using a rubber band and elasticated bandage. Participants then 
remained seated during 20 minutes of sham or active stimulation. After tDCS 
stimulation the electrodes were removed, the headband tracker was replaced 
and re-registration was performed using the neural navigation software. The 
hotspot was then checked using the previously sampled location; at times this 
required minor adjustments due to registration issues. IO curves and SI 1mV 
measures were then taken using the same intensities as in the pre tDCS 
condition. Throughout the TMS and tDCS protocols participants were able to 
watch wildlife documentaries. This was done in an attempt to maintain levels of 
arousal and attention during stimulation.   
After the second session of TMS, another 8-minute video recording was 
made with the participant alone in the room. Following this the participants 
were thanked and received financial compensation for their time. The whole 
procedure was completed twice for each participant in a counter-balanced 
fashion with at least one week separating each session.  
5.2.8 Data analysis 
 
Tic coding procedure 
Prior to tic coding the videos were anonymised, therefore, coders scored 
all videos while blind to the experimental condition. A list of potential tics was 
generated to aid tic identification using the tic type subscale of the YGTSS. Videos 
were played using VLC media player. The advanced tools options were used to 
allow videos to be slowed down and played frame by frame. Whenever possible 
a continuous 5-minute segment was sampled from the 8 minute videos. This 
sample was taken from the 2-minute point onwards to allow participants to relax 
and become familiar with the situation. For two data sets it was only possible to 
score 3 minutes of data due to camera failure and the participant falling asleep. 
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In addition to this it was not possible to analyse a continuous 5-minute segment 
for a further three data sets. For each video segment in each condition, motor 
and phonic tics were counted and averaged per minute resulting in a score of tics 
per minute (TPM). These TPM scores were then averaged to give the mean tic 
rate for each video clip in accordance with previous protocols (Himle et al., 2006; 
Nixon et al., 2014).  
Each video recording was also scored using the Modified Rush Video 
Scale (Goetz et al., 1999). The scale has five components which are as follows: 
number of body areas, motor/phonic tic frequency (scored as TPM) and 
motor/phonic tic severity, each of which have been found to correlate well with 
comparable items on the YGTSS (Goetz et al., 1999). The total impairment score, 
calculated from the Rush by summing the five measured components, has also 
been found to correlate with the ‘overall impairment rating’ on YGTSS (Goetz et 
al., 1999). Each component on the Rush is typically scored on a scale of 0-4, 
however, for the purposes of this study it was only possible to score 0-3 on the 
body areas component. This is because tics were only counted from the upper 
body and face, meaning the maximal amount of body areas was 5, which 
corresponds with a rating of 3 on the scale. As a result, the maximal score 
possible on the Rush in this study was 29 rather than 30. The scores from each 
minute segment were combined to calculate the mean Rush score for each video 
clip.  
By using the Rush scale it is possible to get an overall impression of an 
individual’s tics over a short period of time, including the severity of them. This is 
not recognised in TPM analysis, therefore, there is merit in studying the two side-
by-side.  
Assessment of inter-rater reliability 
The 5-minute video segments were first analysed by the primary 
investigator (KD) who then trained two secondary coders (ER and KF). Training 
was conducted using 1-minute video segments taken from the start of recordings 
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(these were not included in the later analysis). Once the coders were familiar 
with the distinct tics of each participant they were given 2 minute segments to 
rate. Each coder (KF and ER) scored half of the participants resulting in 40% of 
the total data being reviewed twice. As previous studies have used a sample of 
24% (Himle et al., 2006; Nixon et al., 2014) this was considered more than 
adequate.  
Inter-rater agreement for total tic counts was assessed using the 
frequency-within-interval method (Sharenow et al., 1989). In accordance with 
previously established protocols (Himle et al., 2006), each of the 2-minute video 
clips were divided into 12 consecutive 10 second intervals. The amount of tics 
counted in each of these intervals was compared with the corresponding amount 
of tics counted by the primary coder (KD) by dividing the lower number of tics 
observed by the higher number and then multiplying these values by 100. The 
scores were then averaged across all 12 segments to calculate the percentage 
agreement for each video. Using this method, the median agreement between 
the primary (KD) and secondary (ER) coders was found to be 74% (range: 50-
94%) for motor tics and 96% for phonic tics (range: 55-100%). Agreement 
between the primary coder (KD) and the other secondary coder (KF) was 73% 
(range: 50-100%) for motor and 96% for phonic tics (range: 67-100%).  
Inter-rater agreement was also checked for the Rush scores. The Rush 
protocol was designed to be used in longer time segments, therefore, the scores 
for each of the two minutes were compared by dividing the lower score by the 
higher score and then calculating average agreement across the two as opposed 
to calculating agreement in 10 second intervals. This revealed 85% agreement 
between coders KD and KF (range: 71-96%), and 86% agreement between coders 
KD and EF (range: 67-100%).  
Intra-class correlation co-efficient (ICC) analysis was also calculated to 
assess agreement (for full details see Appendix.v). This showed varying degrees 
of agreement for the different measures/subscales, however, overall reliability of 
measurement for total impairment on the Rush was deemed excellent between 
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primary and secondary coders (KD-KF reliability: ICC(2,1)=.92; KD-ER reliability: 
ICC(2,1)=.81). ICC also revealed excellent reliability for total tic score using the 
average TPM method between the primary coder (KD) and the secondary coder 
(KF), ICC(2,1)=.97 and fair reliability between primary coder (KD) and secondary 
coder (ER), ICC(2,1)=.59.  
Based on the inter-rater agreements established, analysis of the full data 
set was conducted using the scores of the primary coder.   
Input-Output curves and SI 1mV 
Peak-to-peak MEP amplitudes were estimated using in-house Matlab 
software (Mathworks, MA, USA). All trials in the 500ms period prior to MEP were 
carefully visually inspected and any trials in which there was evidence of pre-
contraction of the FDI muscle were excluded. 
 
IO curve measurements were estimated by calculating the median intra-
individual MEP amplitudes for each TMS intensity value (i.e., 100-150% of RMT). 
Linear fits were then applied to the resultant values (mean R² = 0.87). For 
alternative slope fitting details and analysis please see Appendix.vi. Median 
values were calculated rather than the mean in order to limit the effect of 
outliers.  
  
5.3 Results 
 
Video monitoring of tics: tics per minute 
A repeated measures ANOVA was calculated to explore any significant 
differences in total tic score (average TPM) following cathodal or sham 
stimulation. This revealed no significant main effect of tDCS type F(1,9)=2.25, 
p=.17; no significant main effects of time F(1,9)=2.28, p= .65 and no significant 
interaction F(1,9)=.21, p=.65. Change in average TPM scores pre/post sham 
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stimulation can be seen in Figure 5.2, whereas Figure 5.3 shows change pre/post 
cathodal stimulation.    
Additional repeated measures ANOVAs were calculated to assess any 
significant differences in motor tics following stimulation. This revealed no 
significant main effects of tDCS on motor tics F(1,9)=1.51, p=.25; no significant 
main effects of time of testing (pre/post) F(1,9)=.97, p=.35, and no significant 
interaction between the two F(1,9)=1.44, p=.26. tDCS also failed to have a 
significant main effect on phonic tics F(1,9)=3.33, p=.10; there were no 
significant effects of time F(1,9)=.77, p=.08, and no significant 
interactionbetween the two F(1,9)=.75, p=.41.   
 
Figure 5.2. Mean ± SD total tics per minute (TPM) for videos taken before and 
after sham stimulation. 
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Figure 5.3. Mean SD total tics per minute (TPM) from videos taken before and 
after cathodal stimulation. 
 
Video monitoring of tics: Rush 
A repeated measures ANOVA calculated using the total impairment score 
(body areas + tic frequency + tic severity) from the Rush revealed a significant 
main effect for tDCS type (cathodal/sham) F(1,9)=6.7 p=.03. However, the main 
effect of time (pre/post) was not found to be significant F(1,9)=1.25, p=.29; and 
there was no significant interaction between the two factors F(1,9)=.01, p=.93. 
Paired samples t-tests (two tailed) revealed no significant baseline differences 
between the sham and cathodal conditions t(9)= 1.65, p=.134. However, when 
comparing post tDCS tic severity scores, there was a significant difference 
between post sham (M=9.66, SD=3.29) and post cathodal (M=8.8, SD=3) 
conditions t(9)=2.35, p=.04. It should be noted that on average there was a small 
reduction in scores in both sham and cathodal conditions, however in both cases 
this difference was small.  Average change in total impairment scores can be 
seen for each individual in Figure 5.4 and Figure 5.5. Analysis of all sub-
components of the Rush can be seen in Appendix.vii.  
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Figure 5.4.Mean ± SD tic severity score using Rush scale before and after sham 
stimulation.  
 
Figure 5.5. Mean ± SD tic severity score using Rush scale before and after 
cathodal stimulation. 
 
Transcranial magnetic stimulation: IO curve 
Paired samples t-tests revealed no significant differences between IO 
curve slopes measured in the pre sham (M=65.53, SD=30.71) and pre cathodal 
(M=67.65, SD=46.14) conditions t(9)=-.17, p= .87. A repeated measures ANOVA 
was calculated in which time (pre/ post) and tDCS type (sham/ cathodal) served 
as independent factors. IO curve slope was entered as the dependent variable. 
The analysis revealed no significant main effects of tDCS type F(1,9)=.11, p=0.75 
or time F(1,9)=1.16, p= .31 and no significant interaction between these two 
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factors F(1,9)=.03,p=.87. Data showing average IO curve plots for each condition 
seen in Figure 5.6.  
 
Figure 5.6. Mean ± SEM IO curve slots. A: before and after cathodal tDCS, B: 
before and after sham tDCS. 
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Transcranial magnetic stimulation: SI 1mV data 
Paired samples t-tests revealed no 
significant difference between 
baseline MEP amplitude evoked in 
the SI 1mV condition in the 
cathodal (M=1302.1, SD=278.4) 
and sham conditions (M=1467.53, 
SD=514.7), t(9)=-.89, p=.397. 
Repeated measures ANOVA 
revealed no significant effects of 
tDCS type F(1,9)=.67, p=0.43; no 
significant effect of time 
F(1,9)=2.60, p= .14 and no 
significant interaction between the 
two factors F(1,9)=.11, p=.75. See 
Figure 5.7 for average change in SI 
1mV measures. 
 
 
5.4 Discussion 
 
Effects of cathodal tDCS on tics 
The effects of applying 1mA cathodal or sham stimulation to the SMA for 
20 minutes were explored. Average scores of TPM were compared before and 
after cathodal and sham stimulation. The analysis revealed no significant effect 
of tDCS type, no effect of time (pre/post) and no interaction between the two 
factors.  Analysis of the video data using the Rush total impairment score (in 
which both tic frequency and severity are taken into account) revealed no 
significant main effects of time and no significant interaction. However, there 
was a significant main effect of tDCS type. Further exploration with paired 
Figure 5.7. Mean SEM MEP amplitude 
evoked from SI 1mV pulse A: Pre/ post 
cathodal stimulation and B: pre/post 
sham stimulation. 
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sample t-tests revealed that although there were no significant differences at 
baseline between sham and cathodal conditions, there was a significant 
difference between them in the post stimulation measure. However, this effect 
and the differences between the two measures was small, and without a 
significant interaction must be treated with caution. Further analysis with the 
sub-component of the Rush scale failed to reveal any further significant 
differences.  
Although there was no strong evidence of change in tic frequency or 
severity here, it should be noted that there are a number of important 
differences between this study and those which have previously reported 
cathodal stimulation to be effective (Carvalho et al., 2015; Mrakic-Sposta et al., 
2008). In particular, the effects of cathodal stimulation were only explored 
immediately following a single application. To my knowledge there are no other 
papers investigating the immediate effects of cathodal tDCS on tics, however, 
there is evidence suggesting that more prolonged stimulations may lead to 
stronger effects. In their single case study,  Carvalho et al. (2015) reported a 
significant 21% reduction in the YGTSS (tic severity + deficit) following 5 sessions 
of stimulation; this increased to 41% following 10 sessions.  Mrakic-Sposta et al. 
(2008) also reported an increase in effect as time went on, with the effects of 5 
days of cathodal stimulation applied to the motor cortex being significantly 
stronger than those occurring on the 4 previous days.  
In some ways the lack of an effect immediately after stimulation is 
surprising, as numerous behavioural and physiological studies have suggested 
that tDCS can exert an influence both during, and for a number of hours after 
stimulation. However, it is possible that influencing a phenomenon such as tics in 
GTS is far more complex than simply changing excitability within M1 or 
increasing performance on simple motor based tasks. The mechanisms 
underlying the effects of tDCS within M1 are still not fully understood, and the 
underlying effects of longer courses of stimulation and at different locations 
remain even more enigmatic. However, it has been speculated that the more 
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long-term effects caused by tDCS may depend on modulations of the strength of 
underlying synaptic connections (Stagg & Nitsche, 2011). This may explain why 
findings of accumulative effects of tDCS stimulation in neurologically typical 
individuals revealed sustained increases in cortical excitability with increased 
testing session, rather than showing increased sensitivity to stimulation at each 
session (Galvez et al., 2013).  
It is theoretically possible that if repeated testing sessions were used to 
build up accumulative effects then changes in tics would have been revealed 
even with this small sample size. However, at present, this study serves as the 
first of its kind to investigate the immediate effects of cathodal tDCS applied to 
the SMA. 
Effects of cathodal tDCS applied to the SMA on cortical excitability at M1 
Although the main focus of this study was exploration of cathodal tDCS 
on tics, changes in MEPs measured from M1 were also explored in an attempt to 
provide physiological evidence of change in cortical excitability induced by 
cathodal stimulation. It may seem counter-intuitive to measure MEPs from the 
hand area of M1 when cathodal stimulation was applied to the SMA, however, 
these areas are known to be highly connected and, therefore, influencing 
excitability of the SMA may impact on M1. Evidence to support this comes from 
dual site TMS experiments in which applying a conditioning pulse to the SMA has 
been found to influence MEP amplitudes measured from the M1 just 
milliseconds afterwards (Arai et al., 2012; Civardi et al., 2001; Oliveri et al., 2003). 
These studies clearly demonstrate connectivity between the regions and how 
causing a brief interference within the SMA can impact on the output of M1. 
Although no studies appear to have investigated changes in MEP 
amplitude after tDCS stimulation of the SMA, this has been explored using rTMS. 
Matsunaga et al. (2005) found that 750 pulses of 5Hz rTMS to the SMA increased 
MEP amplitudes for up to 10 minutes, which strongly suggest that changes of 
excitability induced by NIBS within the SMA can be measured by recording MEPs 
133 
 
at M1. Therefore, it is not clear why significant differences were not found in this 
present study between the sham and cathodal conditions for either IO curves of 
SI 1mV.  
Timing of measurements seems unlikely to be an issue, as all TMS 
measurements were repeated within 5-15 minutes of tDCS ending which should 
still be well within the period of expected after-effects. It is possible that the 
stimulation parameters used (1mA cathodal tDCS for 20 minutes) may have been 
inadequate to induce significant changes in excitability in this participant sample. 
Although a number of studies have demonstrated significant decreases in 
cortical excitability following similar applications of cathodal stimulation (see 
Table 2.1), the effects produced appear to be weaker on average when 
compared to those of anodal stimulation (Horvath et al., 2015) and physiological 
changes following cathodal stimulation are not always found (for example 
Horvath et al. (2016), Kim et al. (2014)). In addition to this, the majority of 
evidence of physiological change induced by tDCS has all been measured from 
M1 and it is possible that the effects at the SMA may differ. It is also possible 
that the electrode montage used in this study was not optimal for stimulating 
SMA.  
Summary and limitations 
The effects of 20-minute stimulation of the SMA using 1mA 
cathodal/sham tDCS were explored. The average number of tics per minute was 
not significantly altered by either stimulation. However, a significant difference 
was observed between the post sham and post cathodal scores for the Rush 
measure of total tic impairment, despite no significant differences at baseline. 
Although this finding is somewhat promising, it should be treated with extreme 
caution as the difference was small. Measures of cortical excitability (IO curve, SI 
1mV) failed to be influenced by either stimulation.  
The findings suggest that a single session of cathodal tDCS has no clear, 
immediate effects on tics. As discussed, it may be that a single session is not 
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enough to induce any measurable behavioural changes in such a complex 
phenomenon, and that repeated stimulations may be necessary. In order to fully 
test the effectiveness of cathodal tDCS in reducing tics, a sham controlled study 
over a number of days is necessary. Arguably, this should involve a range of 
measures such as video recording, self-report and physiological measures in 
order to identify objective, subjective and physiological markers of change.  
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 Case study report - Can repeated 
applications of cathodal tDCS help to reduce tics in 
Tourette’s syndrome? 
 
Key words: Gilles de la Tourette’s syndrome (GTS), transcranial direct current 
stimulation (tDCS), supplementary motor area (SMA), Yale global tic severity 
score (YGTSS), premonitory urge to tic scale (PUTS), false discovery rate (FDR), field 
of view (FOV), repetition time (TR), echo time (ET) tics per minute (TMS).  
 
6.1 Introduction 
 
As discussed in Chapter 5, there is promising evidence that NIBS 
techniques could be effective in reducing tics in individuals with GTS. However, 
despite some positive findings, the quantity of research is sparse, particularly 
with regard to tDCS. With the exception of two small scale studies (Carvalho et 
al., 2015; Mrakic-Sposta et al., 2008) there is little published work and, therefore, 
little consensus regarding what works and how these effects manifest. In my own 
work (presented in Chapter 5), I failed to find any clear evidence that a single 
session of cathodal tDCS was any different to sham stimulation. It is possible that 
a single session of stimulation is too weak an intervention to have any 
measureable impact, whereas repeated sessions may be more effective. In 
support of this, substantially larger reductions in tics have been reported after 10 
days of stimulation when compared with four (Carvalho et al., 2015), and the 
effects of five days of stimulation have been found to be larger than those 
measured on any of the previous four days  (Mrakic-Sposta et al., 2008).   
Although the two studies by Mrakic-Sposta et al. (2008) and Carvalho et al. 
(2015) both suggest that tDCS could be a useful tool in the reduction of tics, 
there are important methodological differences between the two. Mrakic-Sposta 
et al. (2008) conducted a sham controlled study to compare the effects of 
cathodal/sham tDCS in two individuals with GTS. Effects on tics were measured 
using video recordings and the Yale global tic severity scale (YGTSS), a visual 
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analogue scale (VAS) for wellness was also used. A significant reduction in tic 
frequency (measured from video data) was found in the cathodal but not the 
sham condition, this was also apparent in scores on the YGTSS and ratings of 
‘quietness’ on the VAS. These findings provide support for the effectiveness of 
cathodal tDCS in reducing tics, however, the measures tell us nothing about the 
biological underpinnings of these changes. This could be particularly important in 
understanding any long term effects, and was explored in more depth by 
Carvalho et al. (2015). In a single case study Carvalho et al. (2015) found that ten 
sessions of consecutive cathodal stimulation applied to the SMA reduced scores 
on the YGTSS, hence suggesting a reduction in perceived tics. Importantly, a 
change in resting state fMRI was also seen between scans taken before and after 
the ten days of stimulation. In particular, activity within the left precentral region 
and left cerebellum of the sensorimotor resting state network was reduced.  The 
sensorimotor region has repeatedly been found to show increased activity in 
individuals with GTS (Rickards, 2009) as has the cerebellum (Bohlhalter et al., 
2006; Pourfar et al., 2011) and animal work has suggested that spiking activity 
occurs in these regions immediately before the production of tic like behaviours 
(McCairn et al., 2013). Given these findings, it may be that cathodal tDCS can 
reduce tics by downregulating these areas. 
In the following case-study I aimed to build upon the previous work by 
Carvalho et al. (2015) and Mrakic-Sposta et al. (2008) by using a sham controlled, 
multi modal design to explore the effects of cathodal tDCS on tics.  Video 
recordings were used to obtain an objective measure of tics and their severity, 
questionnaires recorded the participants’ own views and MRI scanning was used 
to identify any substantial neuroanatomical changes.   
Unlike previous studies, stimulation was applied in the participants own 
home with remote supervision. The reasons for doing this were two fold. Firstly, 
for tDCS to fulfil its potential as a viable alternative to pharmacology or other 
forms of stimulation, it is necessary that it works in day-to-day life. Secondly, this 
method caused the least disturbance to the normal routine of the participant 
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and their family.  Although two well cited advantages of tDCS are its portability 
and relative ease of use, very few studies have been conducted outside of highly 
controlled laboratory settings. In one notable exception, Kasschau et al. (2016) 
found that patients with muscular sclerosis were able to cope well with remote 
supervision of tDCS application and that both tolerability of stimulation and 
protocol adherence were good.  If tDCS is to be developed and marketed as a 
useful therapeutic technique, it is critical that it can be flexible. Therefore, what 
is relinquished in experimental control in home use studies is gained in valuable 
experience and knowledge of the techniques potential for treatment in day-to-
day life.  
6.2 Method 
6.2.1 Participant details 
The participant was a 16-year-old male who had received a formal 
diagnosis of Tourette’s syndrome at the age of 8 years. The participant had no 
additional diagnoses, however, elevated levels of anxiety had previously been an 
issue, for which the participant took the SSRI Sertraline (100mg). Some obsessive 
compulsive behaviours were also reported, although there was no formal 
diagnosis of OCD. In addition to Sertraline the participant was also on a stable 
medication regime using both Clondine (200mg) and Aripiprazole (10mg).  
6.2.2 Design 
Phase 1 
A schematic of all experimental procedures is summarised in Figure 6.1. 
During the first part of this case study, the participant and one of their parental 
guardians visited the University of Nottingham where baseline MRI scans and 
questionnaire measures (described below in 6.2.5) were collected. During this 
visit, the participant and their guardian were trained by the primary researcher 
(KD) to safely and effectively use the pre-programed tDCS machine. They then 
returned home with detailed instructions and the equipment needed to start the 
first phase of this home use study.  
138 
 
Over 10 consecutive days, the participant received sham stimulation 
within the comfort of his own home. Application of the stimulation was 
monitored remotely by the primary researcher (KD). With the exception of a few 
issues on the first day, application and use of tDCS went well. During the 
stimulation period, ten-minute video segments of the participant passively 
watching the television were recorded every other day. The first video clip was 
assessed to give guidance regarding camera positioning and lighting to ensure 
that tics could clearly be seen. After this, the videos were not seen by the 
primary researcher (KD) so that they could later be coded with the researcher 
blind to the condition.  
Four days after the final sham stimulation the participant returned to the 
University of Nottingham to repeat the questionnaire measures and to be 
scanned. The participant then returned home to complete a further 10 days of 
consecutive 1mA cathodal stimulation and video recordings every other day. Five 
days after the last application of tDCS the participant returned to the University 
of Nottingham for follow up questionnaires and scanning. An additional follow 
up was completed approximately one month later.   
Phase 2 
After reviewing the findings of the first study, it was decided that a 
second phase of the experiment would be run in which a stronger intensity of 
tDCS would be used (Figure 6.1B). Two months elapsed between the final 1mA 
cathodal stimulation and the new data collection. As sham stimulation appeared 
to have a limited effect on tics, the effects of a sham protocol were not 
measured again in phase 2. Instead a more extensive baseline was measured in 
which home video recordings were included in addition to scans and 
questionnaire measures. Following the 10-day baseline, a further 10 days of 
consecutive stimulation were completed, this time using 1.5mA cathodal 
stimulation. During this time, videos were also recorded every other day.  A final 
follow up including scanning and questionnaire measures was taken five days 
after the last stimulation.  The participant was always blind to the experimental 
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condition, and all data were analysed with details of experimental condition 
removed.   
 
Figure 6.1. Schematic showing the study design. A. shows the initial baseline, 
sham, 1mA cathodal and 1 month follow up conditions which were tested. B. 
shows the second phase of the study in which 1.5mA cathodal stimulation was 
tested against a new baseline. Two months elapsed between the final 1mA 
cathodal stimulation and the measurement of the second baseline. 
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6.2.3 tDCS of the supplementary motor area (SMA) 
tDCS was delivered via a NeuroConn DC 
stimulator mobile (GmbH, Ilmenau, Germany). This 
was programed in advance by the researcher (KD) 
to deliver one of three options (sham, 1mA, 
1.5mA). The stimulator was set so that it could only 
be used once within a 22 hour period and the 
settings could not be changed by anyone other 
than the researcher. In the first session, the stimulator 
was set to deliver a 20-minute sham protocol, in 
which the current was ramped up for 15s, held 
constant at 1mA for 30s and then ramped down over 
a further 15s period. For the second part of the initial 
study the machine was programed to deliver 1mA stimulation for 20 minutes 
with a ramp up and ramp down time of 15s at the start and end. In phase 2 of 
the study the stimulator intensity was increased to 1.5mA and kept constant for 
20 minutes; the ramp up and down time were also set to 15s.  The current was 
run between two saline soaked sponge covered electrodes, the smallest of which 
measured (25cm2) and was placed approximately over the SMA. This location 
was identified in accordance with previous studies (Enticott et al., 2012; Finis et 
al., 2013; Mantovani et al., 2007), in which the 10-20 EEG system was used to 
identify the site which is 15% of the distance between the nasion and inion, 
anterior of the CZ location.  The ‘reference’ electrode measured 100cm2 and was 
placed on the upper deltoid muscle on the participant’s right arm (Figure 6.2). 
The participant and their guardian were trained to apply the stimulation during 
the baseline session. Over the first few sessions the electrode placement was 
monitored remotely via photographs showing electrode montage. 
Communication and support were provided throughout the studies duration.  
Figure 6.2. Schematic of 
electrode placement with the 
smaller electrode placed over 
the SMA, and the larger one 
placed over the upper deltoid 
muscle of the arm. 
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6.2.4 Video recordings 
10-minute video clips were recorded on alternative days during 
stimulation periods. The video clips were taken by the participant’s guardian 
while the participant passively watched television in their family home. These 
video clips were collected with the aim of generating naturalistic data in which 
day-to day tic levels could be recorded. Unfortunately, this resulted in some 
variation in the timings for both videos and stimulation, and a miscommunication 
resulted in the videos being recorded before stimulation in phase 1 (sham and 
1mA cathodal conditions) of the study. In the sham condition the videos were 
taken on average 39 minutes prior to stimulation (SD= 50 minutes) at 17.28pm 
(earliest 15:51pm, latest 19:41pm). In the 1mA cathodal condition the average 
duration between video and stimulation was 32minutes (SD=26 minutes) and the 
videos were taken on average at 17:46pm (earliest 16:08 pm, latest 19:33pm) 
which is similar to those recorded during sham. 
During the second phase of the study (no stimulation baseline and 1.5mA 
cathodal) the videos were consistently recorded after stimulation. However, the 
average timing of video recordings was far later in the 1.5mA condition.  At 
baseline videos were taken on average at 18:22pm (earliest 16:45pm, latest 
22:27pm) whereas this was 21.30pm in the 1.5mA cathodal condition (earliest: 
19:14pm, latest 22:43pm). In the 1.5mA condition the duration between video 
and stimulation was 147 minutes on average (SD=125 minutes). These timing 
differences should be kept in mind when considering the results and 
interpretations of this measure.  
6.2.5 Questionnaire measures  
All questionnaire measures were administered by an experienced 
professional (JF) who was blind to the experimental condition. The measures 
used were as follows:  
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Yale Global tic severity scale (YGTSS) 
The Yale global tic severity scale (YGTSS; (Leckman et al., 1989)) was used 
to rate the number, frequency, intensity, complexity and interference of motor 
and phonic tics at the various time points. The YGTSS was selected as it has good 
psychometric properties including internal consistency, convergent validity and 
association with clinician rating of impairment (Leckman et al., 1989; Storch et 
al., 2005).  
Premonitory urge to tic scale (PUTS) 
The Premonitory Urge for Tics Scale (PUTS; Woods et al. (2005)) was used 
to measure the experience of sensation prior to the onset of a tic. PUTS is a self-
report measure which contains 10 items designed to assess different sensory 
properties of urges and their relationships to tics. The measure has been found 
to have good internal consistency, test-retest reliability and construct validity 
among 11-16 year olds (Woods et al., 2005). 
6.2.6 Scanning protocol (anatomical, resting state FMRI) 
All scanning procedures took place at the Sir Peter Mansfield Imaging 
Centre (SPMIC), University of Nottingham using a 3T Philips Achieva system 
(Philips Healthcare, Best, Netherlands) and a 32-channel SENSE radio frequency 
head coil. Following thorough explanation of the scanning procedure, the 
participant was placed supine and head-first into the scanner. Head motion was 
minimized by inserting foam pads between the participant’s head and the coil.  
The participant wore ear plugs and also large headphones for hearing protection; 
the headphones also provided additional padding around the head, thereby 
helping to reduce potential head motion.  
T1- weighted anatomical scans were acquired using the magnetization-
prepared rapid gradient echo (MPRAGE) sequence (180 continuous axial slices 
with 1mm³ isotropic resolution, field of view (FOV)= 256x256 mm, matrix size = 
256x224, repetition time (TR)= 8.6ms, echo time (TE)= 4.0ms). Following this T2* 
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weighted resting-state functional MRI (rs-fMRI) images were acquired using 
gradient-echo echo-planar imaging (GE-EPI) sequence (TR=2000ms, TE=35ms, 
FOV= 208x208 mm, matrix size 64x64 with 34 slices, 320 dynamics with voxel 
size = 3.25mm²). 
6.2.7 TMS data collection 
In the original design of this study it was planned that TMS measures of 
global cortical excitability (IO curve), intracortical inhibition (SICI) and facilitation 
(ICF) would be recorded during each visit to the University of Nottingham. TMS 
was included in the design to supplement the other techniques, and to give 
insight into any potential changes in GABAergic activity. However, although this 
was achieved in the first baseline session, it was not possible to obtain full data 
sets in two subsequent time points due to participant discomfort (headache and 
desire to tic). As a result, the measure was dropped from the experiment and not 
analysed further due to a lack of data.    
6.2.8 Tic coding procedure (analysis of video data) 
Prior to tic coding the videos were anonymised, thereby allowing coders 
to score the videos while blind to the experimental condition. A list of potential 
tics was generated to aid tic identification using the tic type subscale of the 
YGTSS. Videos were played using VLC media player and the advanced tools 
options were used to allow videos to be slowed down and played frame by 
frame. For phase one of the experiment (sham vs. 1mA cathodal) the first video 
from each condition was dropped from the analysis due to poor quality in the 
first sham session. The 10-minute video clips were analysed in whole by the 
primary coder (KD) in the first phase of the experiment. However, statistical 
analysis revealed no differences between scores calculated from 10 vs. 5 minute 
segments, therefore only 5 minutes of video were scored for the second phase 
(baseline vs. 1.5mA). For each video segment, motor and phonic tics were 
counted and averaged per minute resulting in a score of tics per minute (TPM). In 
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accordance with previous protocols (Himle et al., 2006; Nixon et al., 2014) these 
TPM scores were then averaged to give the mean tic rate for each video clip. 
 Each video recording was also scored using the modified Rush video scale 
(Goetz et al., 1999), resulting in scores for motor/phonic tic severity, 
motor/phonic tic frequency, number of body areas and a total impairment score 
calculated from the sum of the others. Each component on the Rush is typically 
scored on a scale of 0-4, however, for the purposes of this study it was only 
possible to score 0-3 on the body areas component. This was because tics were 
only counted from the upper body and face meaning the maximal amount of 
body areas was 5, which corresponds with a rating of 3 on the scale. As a result, 
the maximum score possible on the Rush in this study was 29 rather than 30. The 
scores from each minute segment were combined to calculate the mean Rush 
score for each video clip.  
Assessment of inter-rater reliability 
In the first phase (sham vs 1mA cathodal) of the study, continuous 2 
minute segments from each video were selected at random and scored by a 
trained secondary coder (KF), resulting in 25% of the total video duration being 
scored twice. As previous studies have used a sample of 24% (Himle et al., 2006; 
Nixon et al., 2014) this was considered more than adequate.  For the second 
phase of the experiment (baseline vs 1.5mA cathodal) 1.5 minutes of data were 
cross-checked (30% duration of the 5 minute videos analysed).  Using this 
method, the median agreement between the two coders for phase one of the 
experiment was 69%; this was 77% for the second phase.  
6.2.9 rs-fMRI data pre-processing 
The rs-fMRI data was pre-processed using the Statistical Parametric 
Mapping toolbox (SPM v8; www.fil.ion.ac.uk/spm) for Matlab (Mathworks, MA, 
USA). The structural and functional images were manually reoriented so that the 
origin was set to the anterior-commissure posterior-commissure (AC-PC) plane. 
The functional scans were then corrected for head motion using the six rigid 
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body motion parameters and by realigning to the first volume in the scanning 
sequence. In order to account for potential head movements between the 
anatomical and resting state scans the mean functional image was then co-
registered to the respective structural scan. Following these processing steps, 
both the structural image and functional images were normalized to the 
Montreal Neurological Institute (MNI) template. Finally, the normalized 
functional images were smoothed using an 8mm full-width half-maximum 
(FWHM) Gaussian kernel. Throughout the pre-processing steps, data was visually 
inspected to ensure quality.  The data were further pre-processed using ART- 
based scrubbing for functional outlier detection using the functional connectivity 
SPM toolbox Conn v.15d (Whitfield-Gabrieli & Nieto-Castanon, 2012). Scrubbing 
is a censoring technique proposed by Power et al. (2012) which makes it possible 
to identify and address subtle movement artefacts the data imaging data. This 
method identified a total of 7 time points during the sham scan, 9 during the 
active scan, 2 during the phase2 baseline scan and 5 during the final scan which 
was measured after the 1.5mA cathodal condition. No time points were 
identified as outliers in the phase 1 baseline condition, nor in the follow up 
condition.  
Analysis of resting state connectivity 
Following the initial pre-processing steps the SPM toolbox Conn v.15d 
(Whitfield-Gabrieli & Nieto-Castanon, 2012) was used to assess connectivity 
between different areas at rest. This was achieved by entering each individual 
scan into the first level analysis as a separate condition, with the respective 
motion parameters (identified previously using the six rigid body motion 
parameters) and outliers (detected using ART-based scrubbing) entered as 
covariates in order to guard against spurious correlations which have been 
known to arise due to subject motion (Power et al., 2012). The steps applied 
during this analysis included linear de-trending and de-meaning followed by 
regression of nuisance parameter signals (entered as co-variates) from white 
matter, CSF and their first temporal derivatives. Functional rs-fMRI images were 
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then band-pass filtered (0.009 < ƒ < 0.001) in order to remove physiological 
fluctuations occurring due to respiratory and cardiac noise. Following these 
steps, a general linear model (GLM) for connectivity was estimated for each scan 
and these correlations were transformed using r-z-transformation. A total of 132 
regions of interest (ROI) were identified based on the default atlas available in 
CONN which combines the cortical and subcortical regions of the FSL Harvard-
Oxford atlas with cerebral areas from the automated anatomical labelling (AAL) 
atlas. It was not always possible to generate z-scores for all ROIs; in particular, in 
4 of the 6 scans connectivity to some areas of the cerebellum was not calculated 
(3-4 regions per scan of a possible 18 identified as cerebellum by the atlas). This 
was due to issues during the planning of the scan which resulted in this area 
being cropped from the FOV. These data points were therefore removed from 
further analysis. In addition to this, if the sum of the z-scores for a particular ROI 
was smaller than 0.01 and larger than -0.01 these ROIs were removed from 
further analysis. This only effected the values obtained in the second baseline 
scan and resulted in the removal of additional ROIs within the cerebellum.   
Statistical analysis of rs-fMRI: average connectivity 
 Paired sample t-tests were used to compare average differences in 
functional connectivity between the different scans. This was done separately for 
negative and positive correlations based on regions identified from the active 
condition. Only half of the correlation matrix was used in order to avoid 
duplicates. The following steps were applied: 
1. Any ROIs showing positive connectivity values (z-score >0) in the active 
condition were identified.  
2. The z-scores identified for these ROIs were then compared between the 
different scans. For example, to assess differences in the averaged 
functional connectivity between sham and baseline scans the z-scores in 
the predefined ROIs (from the Active scan) were compared using paired 
samples t-tests.  
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3. The same procedure was completed to test for changes in ROIs which 
showed negative connectivity in the active condition (z-score <0).   
The same steps were used for the second phase of the experiment, however, the 
scan acquired after 1.5mA cathodal (active2) was used in steps 1 and 2 rather 
than the scan acquired after 1mA stimulation (active).  
Statistical analysis of rs-fMRI: Identifying differences in functional connectivity 
across ROIs 
The data were analysed further to identify statistically significant differences in 
functional connectivity between ROIs across the different scans. Paired sample t-
tests were used to compare the connectivity of each ROI in the sham condition 
to baseline. The same procedure was also carried out to compare the 
connectivity of ROIs in the Active condition to those in the baseline condition 
and between the active and sham conditions. Paired samples t-tests were also 
used to assess differences between ROIs in the baseline2 and active2 conditions. 
The resulting p values from these t-tests were corrected using the false discovery 
rate (FDR). 
 Statistical analysis of rs-fMRI: identifying ROI pairs which predict change 
Using the data acquired from phase 1 of the experiment it is possible to 
explore how any changes from baseline in the active condition may predict the 
change from baseline seen in the Post condition. This was explored using two 
different methods. The first method involved using a customised script in Matlab 
(Mathworks, MA, USA) to calculate a series of linear regression analyses for the 
purpose of identifying any significant ROI pairs in the active - baseline condition 
which significantly predicted change in connectivity in the post - baseline 
condition. The false discovery rate was used to correct for multiple comparisons. 
To determine if the levels of variance explained by these ROI pairs was 
significantly different to that which would be expected from non-intervention 
(sham-baseline) a paired samples t-test was used to compare differences 
between the obtained R² values.    
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 Using the second analysis method the correlation coefficients between 
sham and post, and between active and post were measured. Corrections for 
multiple comparisons were addressed using false discovery rate. A z-test was 
then used to test whether the correlations obtained for the active-baseline 
condition were significantly different from those obtained in the sham- baseline 
condition.  
6.3 Results 
 
6.3.1  Tic counts measure from video data 
 
Phase 1 
 
Figure 6.3. Mean and SD of tic per minute counted from ten-minute video 
segments recorded on alternate days during sham and 1mA cathodal (active) 
conditions. 
 
There were no clear differences in total tics per minute between the 
sham and cathodal conditions. There was also no clear pattern of results when 
the video data was analysed using the Rush scale. Average tics per minute are 
shown in Figure 6.3.  
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Phase 2
 
Figure 6.4. Mean and sd of tic per minute counted from video segments collected 
during baseline2 which was taken after 2 months with no stimulation, and after 
10 days of 1.5mA cathodal stimulation (active2). 
There was no clear difference between the number of tics counted per 
minute in the sham and 1.5mA cathodal tDCS. Rush scores were also not clearly 
influenced by the stimulation. Average scores from each video are shown in 
Figure 6.4. 
6.3.2 Scores on questionnaire measures 
Phase 1 
 
Figure 6.5. YGTSS score on the various subcomponents measured at baseline, 
after 10 days of sham stimulation, after 10 days of 1mA cathodal stimulation 
(active) and in a 1 month follow up (post) condition. 
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There was a gradual decrease in global severity score on the YGTSS in 
which the final follow-up measure was 24% smaller than the value given at 
baseline (Figure 6.5). Examination of the subscales for total motor and total vocal 
(sum of the number, frequency, intensity, complexity and interference 
components) revealed no clear pattern of tic reduction following 1mA cathodal 
stimulation. The effects on the global severity score appear to be primarily driven 
by changes in impairment ratings.  
Scores on the PUTS also gradually declined over the course of the study. 
Scores in the sham condition showed a 21.7% decrease from baseline, which 
enlarged to a 34.8% decrease after cathodal and a 39.1% decrease in the follow-
up measure.  
Phase 2 
 
Figure 6.6. YGTSS score on the various subcomponents measured during a second 
baseline (baseline2) taken over 2 month after any active stimulation took place 
and after 10 days of 1.5mA cathodal stimulation (active2). 
 
Scores on the YGTSS global severity score decreased 35% from baseline 
after 1.5mA cathodal stimulation. Scores on the total motor tic component 
reduced by 45.8%, and impairment rating decreased by 33.3% (Figure 6.6). There 
was no change in the total vocal tic score. Scores on the PUTS reduced by 14.3% 
after 1.5mA cathodal tDCS.  
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6.3.3 Resting state fMRI 
Phase 1: average connectivity 
  
 
Figure 6.7. Plots showing changes in functional connectivity from baseline for 
sham stimulation (top left), active stimulation (top right) and post stimulation 
(bottom left). Bottom right shows differences in functional connectivity following 
active stimulation compared to sham).  
A total of 128 ROI pairs remained in the analysis after the removal of 
regions for which there was insufficient data (defined as ROIs in which the sum 
across all possible pairings was <0.01 and >-0.01). This data was then analysed 
using the methods described above in 6.2.9. Paired sample t-tests revealed that 
the average amount of positive connectivity between ROIs was significantly 
larger in the scan taken after 1mA cathodal stimulation (active) compared to the 
baseline t(4849)=31.04, p= <.0001. There was also significantly stronger positive 
connectivity overall in the 1 month follow up condition (post) in comparison to 
baseline t(4849)=7.68, p=<.0001. Positive connectivity was actually lower in the 
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sham condition than at baseline, however, this effect was notably smaller than 
the other comparisons t(4849)=-3.01, p=.0027. Finally and most importantly, 
there was a clear difference between the scans taken following sham and active 
stimulation t(4849)=35.91, p= <.001, with the active scan revealing significantly 
more positive connectivity.  
Separate paired sample t-tests were calculated to explore differences 
between areas of negative connectivity. These revealed that the active scan had 
significantly stronger levels of negative connectivity than the baseline scan 
t(3277)=31.93, p= <.0001. The scan taken following sham stimulation also had 
significantly stronger negative functional connectivity than the baseline 
condition t(3277)=5.71, p= <.0001. No significant differences were found 
between the baseline and follow up (post) scan t(3277)=1.28, p= .20. The 
strength of the negatively connected ROIs was stronger after 1mA cathodal 
stimulation (active) compared to connectivity following sham stimulation 
t(3277)=27.01, p= <.0001. The contrasts between the different scans can be seen 
in Figure 6.7. 
Phase 1: Identifying statistical differences in functional connectivity across ROIs 
 In order to further investigate differences between ROIs, paired sample t-
tests were used to compare the connectivity of each ROI to all other ROIs 
between baseline and sham scans, baseline and active scans, and between 
sham and active scans. The resulting p values were corrected for multiple 
comparisons using FDR.  
The analysis revealed a total of 41 ROIs which showed significant 
differences (p <0.05, FDR corrected) in connectivity between the baseline and 
sham scans, including one region of the cerebellum and both the left and right 
accumbens. When a more conservative alpha level was used (p<0.01, FDR 
corrected), a total of 23 ROIs were identified including areas within the 
precentral gyrus, inferior frontal gyrus (IFG), superior temporal gyrus (STG) and 
inferior temporal gyrus (ITG). Differences in the left accumbens also remained 
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statistically significant. A full list of ROIs can be found in Appendix.Viii. 
Comparison of ROIs in the active scan compared to the baseline scan 
revealed 42 ROIs which showed statistically significant differences in connectivity 
(p<0.05, FDR corrected), including 5 regions within the cerebellum and the right 
accumbens. A total of 16 differences between ROIs were identified when a more 
stringent criteria was applied (p<0.01, FDR corrected), including two regions of 
the cerebellum, regions in the IFG, ITG and supramarginal gyrus (SMG). A full list 
of ROIs can be found in Appendix.ix. 
A number of the ROIs identified as statistically different from baseline in 
the sham condition, were also found to be statistically different from baseline in 
the active condition (12 in total). However, when the scans from the active and 
sham conditions were compared directly, a large number of differences were 
also found. Using a conservative threshold of p=<0.01 (FDR corrected) a total of 
51 ROIs were found to be statistically different (A full list of ROIs can be found in 
Appendix.x. Of these differences, some of the largest (p<0.001) were seen 
between the right post central gyrus, the left posterior division of the superior 
temporal gyrus (STG), the left posterior division of the IFG, the right postcentral 
gyrus, 3 regions of the lateral occipital cortex, left/right central and parietal 
operculum cortex and the right planum temporale. There was also a strong 
statistical difference (p<0.001) between both left and right regions of the 
supplementary motor area (SMA).  
Phase 1: Identifying ROI pairs which predict change 
First it was necessary to identify if any of the ROI pairs which were 
different in the active condition compared to baseline (active – baseline) were 
significantly different to the relative amount of change between the two scans 
(active – baseline). In order to assess this the following steps were followed:  
1: Mean and standard deviation of change in the active – baseline condition 
were calculated.  
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2: Scores from the active condition were standardized relative to those derived 
from step 1. 
3: ROI pairs with change scores greater or less than 1.96 STD from the mean 
were identified.  
This analysis revealed a large number of ROI- pairs that can be seen in Figure 6.8. 
These ROIs were used in the subsequent analysis described below.   
 
Figure 6.8. Left image: shows the change in connectivity strength (active-
baseline) expressed as standard scores. Right image: shows a binarised image 
identifying those ROI pairs with standard scores greater than 1.96 or less than -
1.96. 
Two methods were used to identify ROIs which predict change following 
active stimulation in the follow up condition (post). The first involved a series of 
linear regression analyses which were conducted to identify any significant ROI 
pairs in the active-baseline condition (identified above) which predict change in 
connectivity in the post-baseline condition (corrected for multiple comparisons 
using false discovery rate (FDR)). This analysis identified a number of ROIs. In 
order to test that the variance explained by this condition significantly differed to 
that which would be expected in a non-intervention case the results obtained 
were tested against those found when the same analysis was conducted for the 
sham-baseline condition. This was done using a paired sample t-test comparing 
the R² values obtained from the active-baseline condition (M=0.52, SD= 0.12) to 
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those obtained using Sham-Baseline condition as predictors (M=0.47, SD= 0.19). 
The t-test revealed that the two are statistically different t(125)=-4.23, p=<.001. 
This suggests that changes in connectivity found in the post condition are more 
reliably predicted by changes from baseline in the active than sham conditions.  
Using the second analysis method, the correlation coefficients between 
ROI pairs in the sham and post conditions and between active and post 
conditions were measured. Corrections for multiple comparisons were addressed 
using false discovery rate.  A z-test was then used to determine whether the 
correlations obtained for the active/baseline condition were significantly 
different from those obtained in the sham/ baseline condition. A number of ROI 
pairs were identified by this analysis.  
 A total of 25 ROIs were identified by both analyses out of a possible 128. 
Of these 8 are of particular interest (right caudate, right accumbens and 6 
regions within the cerebellum). All regions identified by both analyses can be 
seen in Appendix.xii.  
Phase 2: average connectivity  
 
Figure 6.9. Plot showing changes in functional connectivity for baseline2 for 
active2. Whereby active2 is the scan taken shortly after the completion of 10 
sessions of 1.5mA stimulation.  
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 A total of 112 ROI pairs remained in the analysis after the removal of 
regions for which there was insufficient data (defined as ROIs in which the sum 
of z scores across all possible pairings was <0.01 and >-0.01). Paired sample t-
tests revealed that the average amount of positive connectivity between ROIs 
was significantly larger in the scan taken after 1.5mA cathodal stimulation 
(active2) compared to the second baseline scan (baseline2) t(3619)=77.75, p= 
<.0001. Interestingly the active2 condition also showed significantly stronger 
negative connectivity than baseline2 t(2595)=-64.13, p=<.0001. The data can be 
seen in Figure 6.9.  
Phase 2: Identifying statistical differences in functional connectivity across ROIs 
 Paired sample t-tests were used to compare the connectivity of each ROI 
to all other ROIs in the baseline2 and active2 scans. The resulting p values were 
corrected for multiple comparisons using FDR. This analysis revealed a total of 47 
ROIs in which connectivity to other ROIs was significantly different between the 
two conditions (Appendix.xi).  
6.4 Discussion 
Previous research (Carvalho et al., 2015; Mrakic-Sposta et al., 2008) has 
found that multiple sessions of cathodal tDCS can have a strong and significant 
impact on the number of tics experienced by individuals with GTS. This study 
aimed to extend and build upon the previous work. The main findings of the 
experiment are summarized below.  
Findings from the questionnaire data 
Questionnaire data provide a unique insight into the participants own 
feelings towards premonitory urges and tics and are, therefore, a valuable tool 
for assessing tDCS as an intervention. In phase 1 (baseline, sham, active, post 
conditions) scores on the global tic severity component of the YGTSS decreased 
over the course of the study (Figure 6.5). The global tic severity component 
reduced from baseline to active measures and remained reduced in the 1 month 
follow up. Scores on the PUTS also decreased from baseline as the study 
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progressed. These results could suggest that both tics and the urge to tic reduced 
following tDCS intervention, and that this persisted even one month afterwards. 
However, it should be noted that these reductions in scores from baseline were 
present in both the sham and 1mA active conditions. Furthermore, the 
reductions in YGTSS scores were primarily influenced by changes in the ratings 
given for the impairment subsection of the scale. While this is an important 
component of the YGTSS, the findings of previous studies (Carvalho et al., 2015; 
Mrakic-Sposta et al., 2008) suggest that a change in the motor or vocal 
component would have also been expected. As a result, although the findings in 
phase 1 hint at an effect of tDCS, it is not possible to rule out a placebo effect or 
a natural reduction in tics over time.  
In phase two of the experiment there was a substantial drop in values 
from the baseline condition to those collected after 10 sessions of 1.5mA 
cathodal stimulation (Figure 6.6) Unlike in phase 1, the scores on the YGTSS 
decreased in the motor, impairment and global severity aspects of the 
questionnaire. These reductions were also far larger than those seen in phase 1 
of the experiment. In particular, global severity score was reduced by 35% after 
stimulation, whereas in phase 1 of the experiment this reduction was 24%. 
Scores on the PUTS also decreased, although in this measure the reduction was 
smaller than in phase 1. It is likely that this reflects the differences between the 
baseline scores as in phase 1 these were far larger (PUTS score: 23 of a maximum 
score of 36) than the baseline2 (PUTS score: 14).  
Although it could be argued that the reductions in the YGTSS scores seen 
in this study reflect a natural, gradual decline in tic severity due to the 
participants age, this is not supported by the data. This is because there are no 
clear differences between the YGTSS scores in the Post and Baseline2 conditions. 
If a natural decline were occurring independent of any intervention, then it 
would be expected that the scores in Baseline2 would be lower, as these were 
measured 2 months after the Post condition. The scores on the PUTS were also 
identical between Post and Baseline2 measures which suggests that intervention 
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(or at least perception of an intervention) influenced the results opposed to a 
natural decline.    
Taken together, the results of the questionnaire measures suggest that 
the participant perceived a reduction in tic related symptoms over the course of 
the study. There is tentative evidence to suggest that the 1.5mA cathodal tDCS 
intervention had an impact on tics and urge to tic that went far beyond the 
effects of the 1mA intervention.   
Findings from video data 
There were no apparent differences in the amount of tics executed 
during videos taken in the sham condition compared to those recorded in the 
1mA cathodal condition (Figure 6.3). Somewhat surprisingly, there were also no 
clear differences between the amount of tics counted during the 1.5mA cathodal 
condition and the second baseline measure (Figure 6.4). These findings are at 
odds with the results from the questionnaire data, particularly for phase 2 of the 
experiment. They also conflict with previous research conducted by Mrakic-
Sposta et al. (2008). 
 Mrakic-Sposta et al. (2008) found that the amount of motor and vocal 
tics exhibited by their two participants reduced substantially by the end of 5 days 
of cathodal stimulation; critically this was not found after sham stimulation. 
Furthermore, unlike the findings of this study, the drop in tics counted during the 
videos also corresponded with a drop in tic symptoms reported on the YGTSS.  
There are a number of differences between the studies regarding the application 
of tDCS, however, it seems unlikely that these would fully account for the 
differences. For example, although Mrakic-Sposta et al. (2008) applied 2mA 
cathodal stimulation above the left M1 and  the current study stimulated the 
SMA at 1 or 1.5mA, the optimal stimulation parameters are likely to differ from 
individual to individual. Furthermore, stimulating the SMA has previously been 
found to be effective in reducing tics  (Carvalho et al., 2015; Kwon et al., 2011; Le 
et al., 2013; Mantovani et al., 2007; Mantovani et al., 2006) and weaker 
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intensities such as 1mA have been found to influence cortical excitability 
(Batsikadze et al., 2013; Furubayashi et al., 2008; Nitsche & Paulus, 2000). It 
seems more likely that the discrepancy in findings (particularly with the results of 
the 1.5mA intervention) relate to methodological issues regarding data collection 
which may have undermined the quality of the data, hence making it difficult to 
see any real effects.  
Due to the prolonged nature of this study, compromises were made in 
order to limit the impact on day-to-day living for the participant and his family.  It 
was decided that videos should only be taken every other day and that the 
timings of these could be slightly flexible to fit in with their normal schedule. 
Unfortunately, this led to more variability than initially expected. It is possible 
that differences between the timings of when the videos were taken could have 
impacted on the findings, especially in phase 2 of the experiment. This is because 
on average the videos were taken much earlier (approx. 18.30pm) during the 
baseline2 condition than during the active2 condition (approx. 21.30 pm).  The 
participant and his parents reported that his tics typically became worse later 
into the evening, as a result any differences between the conditions may have 
been masked. This may explain the discrepancy between the video and the 
questionnaire data, particularly in phase 2.   
Findings from the imaging data 
  Analysis of the overall patterns of connectivity between the 
different scans revealed statistically significant changes from baseline in the 
active and sham conditions and also partial differences (only for positive 
connectivity) between baseline and the follow up (post) scans. Although the 
sham condition was found to be statistically different to baseline in both 
analyses (exploring negative and positive connectivity), this was always smaller 
than the difference between baseline and active. Furthermore, when sham and 
active conditions were directly compared they were found to be significantly 
different. Analysis of phase 2 of the experiment also revealed statistically 
significant differences between baseline2 and active2 scans. These results are 
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encouraging, however, additional analysis was required in order to study these 
findings in more depth.  
 The data was further analysed to identify differences between the 
connectivity of specific ROIs. In phase 1 of the experiment statistically significant 
differences between a variety of ROIs were found when baseline and sham 
conditions were compared. A large number of ROIs were also found to have 
significantly altered connectivity between the baseline and active scans. 
Although some of the same regions were identified in the sham/baseline and 
active/baseline comparisons, there were also a large number of differences 
which were further highlighted when these conditions were directly compared. 
Interestingly, the total number of ROIs found to be different between the 
baseline/sham conditions was similar to the number found for baseline/active 
conditions. This was somewhat surprising, as it was initially expected that more 
change from baseline would be observed in the active condition. Furthermore, 
the results are particularly difficult to interpret as the lack of clear effects on the 
motor/vocal component of the YGTSS and from the video data make it 
impossible to interpret what the consequences of these changes in connectivity 
may be.  
Although in their current form it is not possible to rule out that the 
findings in phase 1 of the experiment were in part due to extraneous factors (see 
conclusions/ limitations) it is worth noting that there were changes in a number 
of ROIs in the cerebellum in the baseline/active comparison which were not 
found in the baseline/sham comparison. Furthermore, there were statistically 
significant differences between these areas when the two scans were directly 
compared. A total of 5 regions within the cerebellum were found to have 
statistically significant differences in connectivity (p<.05), of which 3 (cerebellum 
3 left, 3 right and 4 5 right in the atlas) had significantly lower connectivity in the 
active than in the sham scan when tested at p<.01.  
Differences within the cerebellum are notable because in a previous case 
study Carvalho et al. (2015) found that activity within left regions decreased after 
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10 sessions of cathodal tDCS. Furthermore, the cerebellum has been implicated 
in a number of GTS studies using a variety of experimental methods. For 
example, in an event related fMRI study the cerebellum was found to be more 
active during the beginning of a tic action (Bohlhalter et al., 2006) and in an 
animal model of GTS increased neuronal spiking in the region has also been 
associated with tic onset (McCairn et al., 2013). Studies using PET have found 
increased metabolic activity within the region at rest (Pourfar et al., 2011) and 
altered GABA-A receptor binding bilaterally (Lerner et al., 2012). Structural 
differences have also been noted, with individuals with GTS having bilateral 
reductions in cerebral hemispheres when compared to controls (Tobe et al., 
2010).  
Unfortunately, in this experiment a large proportion of the cerebellum 
was not captured by the scans in baseline2 and active2 conditions, therefore 
changes in these regions could not be assessed for phase 2 of the study. A 
number of ROIs were identified as having significantly altered levels of 
connectivity between these two scans. However, although a clear reduction in 
tics was seen on the YGTSS between baseline2 and active2, the finding of 
widespread change in connectivity in the sham-baseline condition makes it 
difficult to draw any strong conclusions regarding how change in specific ROIs 
may relate to changes in tics following stimulation. Consequently, this is not 
speculated here, although a full list of identified ROIS can be found in 
Appendix.xi.    
In phase 1 of the experiment it was possible to assess how change in the 
active condition may predict the change from baseline seen in the post 
condition. Both the analyses used implicated the cerebellum, with a total of 6 
regions being identified as significant predictors. Scores on the global 
impairment scale of YGTSS remained stable between the active and post scans, 
and the PUTS score actually dropped slightly over this time. Taken together it 
may be that changes within the cerebellum had a sustained effect on some 
aspects relating to the participant’s perception of their own tics and feelings of 
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premonitory urge. However, as there were also changes in the questionnaire 
measures between baseline and sham conditions and little effect on the 
motor/vocal component of the YGTSS, it is not possible to conclude that these 
changes were necessarily the result of 1mA cathodal tDCS or even linked to 
changes in tics.  
 In addition to the cerebellum, a number of regions were implicated as 
significant predictors. Of particular interest were changes in the right Caudate 
nucleus and the right accumbens. Findings within the caudate are particularly 
notable for a number of reasons. Firstly, the caudate is known to receive inputs 
from the SMA (Vergani et al., 2014), secondly, the caudate has repeatedly been 
implicated as both structurally and functionally different in individuals with GTS 
when compared to control subjects. In particular, the caudate has been reported 
to be smaller in children and adolescents with GTS (Makki et al., 2008; Peterson 
et al., 2003), and the volume of the caudate in childhood has been found to be 
predictive of symptom severity in adults with GTS (Bloch et al., 2005), with 
smaller caudate volumes in childhood (<14 years old) correlating with higher 
scores on the YGTSS years later in life (>16 years old). Furthermore, in a study of 
13 adults with GTS, Wang et al. (2011) found that activity within the caudate was 
reduced in GTS individuals during spontaneous tics in comparison with self-paced 
tic-like- movements in 22 healthy controls, hence implicating the region in tic 
production. The caudate is thought to be important in exerting top-down control 
over motor pathways, therefore when taken together with research in GTS it 
seems logical that changes in this region may contribute to changes in 
symptomology. However, although the caudate was implicated in this analysis, it 
is important to note that the connectivity of this region was not found to be 
significantly altered when the active or sham conditions were compared to 
baseline. Thus while the findings suggest that the caudate is an interesting ROI to 
examine in future work, strong conclusions about this area cannot be drawn 
from this data.   
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A final notable finding from the imaging data was that changes in the 
connectivity of the right accumbens following sessions of 1mA tDCS predicted 
change from baseline in the follow-up condition (post). Changes in this region are 
interesting as the area has previously been found to have altered structural 
connectivity in adults with GTS (Neuner et al., 2011). Furthermore, there is 
evidence that deep brain stimulation of the accumbens may help with symptoms 
of obsessive compulsive disorder (OCD)  (Denys et al., 2010), a disorder which 
commonly co-occurs with GTS (Bitsko et al., 2014).However, in the present study 
it is not possible to draw strong conclusions about changes in the accumbens and 
changes in tics as a result of 1mA cathodal stimulation. This is due to the finding 
that resting state connectivity in the accumbens was significantly different 
between the baseline and sham scans, in addition to being different when active 
and baseline scans were compared (see Appendix ix and x). Nevertheless, the 
finding that change in the active – baseline condition was predictive of post- 
baseline condition and that during this time the scores on the global severity 
rating of the YGTSS remained stable while scores on PUTS dropped could 
implicate this region as linked with the participants own experiences of their tics.  
  Although no strong conclusions can be drawn from the imaging data, the 
findings may play an important role in identifying the physiological basis of 
change in tics for future studies in which larger sample sizes and full 
counterbalancing of conditions could be used.  
Evaluation of home use stimulation 
 To my knowledge this study is the first to trial home use stimulation for 
the treatment of GTS and one of a very small number of studies to use tDCS 
outside of the laboratory. Despite a few teething issues with electrode 
placement at the start, overall application of tDCS went well. Compliance was 
very high, and all of the 30 advised stimulations were attempted (10 for sham, 
1mA cathodal and 1.5mA cathodal respectively). Of these, only one was not fully 
completed due to an electrode moving after a head tic which caused the 
machine to abort stimulation for that day.  Rates of compliance in larger studies 
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have also shown that tDCS application at home is feasible. Kasschau et al. (2016) 
found that compliance was high in a group of 20 participants with muscular 
sclerosis (MS) with 98% completing at least 8 of the 10 advised sessions. 
Kasschau et al. (2016) also found that of 192 supervised treatment sessions none 
required discontinuations and no adverse events were reported. In this study the 
participant did report some feelings of mild nausea and headache following 
stimulation. However, these were reported in both the sham and cathodal 
conditions and were reported by the participant and their family to be tolerable.  
 The main challenge of the home use approach in this study was not the 
application of tDCS, but the accurate data collection of video clips. Although 
video recordings in naturalistic settings provide a rich data set which can give 
insight into the frequency, intensity and type of tics experienced, this type of 
data comes with some inherit variability, and it proved difficult to obtain good 
quality video recordings using this method.  
Conclusions and limitations 
Overall the study provides some support that tDCS may be a useful tool in 
reducing tics in individuals with GTS, however, there are some important 
limitations which must be considered. Firstly, the study consisted of a single 
participant, and while efforts were made to include a sham condition it remains 
a possibility that the order in which the different sessions were tested may have 
had an impact. Furthermore, the participant was a 16 year old and it is known 
that tics may wax and wane with age and that many adolescents will experience 
a remission in symptom severity as they approach adulthood (Bloch & Leckman, 
2009). Despite this, a natural decline in tics over the course of the study seems an 
unlikely explanation for the effects seen after 1.5mA cathodal stimulation, due to 
the finding that scores on the PUTS and YGTSS did not decrease during the two 
month interval between Post and Baseline2 data collection. Nevertheless, without 
additional participants and counter balancing it is not possible to rule out the 
possibility that random fluctuation in tic symptoms unrelated to tDCS may have 
contributed to the data.  
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Although the application of tDCS within the participant’s home was relatively 
unproblematic, this was not true of the video recordings. A number of issues were 
present which may have compromised the quality of the data and could account for 
the discrepancy between scores on the YGTSS and tic count; in particular, in phase 2 
of the experiment in which a decrease in motor tics was reported yet not evidenced 
in the video data.     
The findings of the resting state fMRI analysis are somewhat difficult to 
interpret, particularly as significant differences were identified in the sham condition 
in addition to after the 1mA cathodal and 1.5mA cathodal sessions. Furthermore, a 
surprisingly large number of ROIs were found to show significant alterations in 
connectivity between the different scans. Although some of this may be 
resultant of the intervention/perceived intervention in the sham condition, it is 
also possible that a number of additional uncontrolled variables contributed to 
these findings. In particular, although the participant was instructed to keep his 
eyes shut it was not possible to check this. Furthermore, it was apparent that 
during some scans the participant may have fallen asleep. Previous work has 
demonstrated that having the eyes open or closed can have an impact on resting 
state data (McAvoy et al., 2008; Yan et al., 2009) as can being asleep or awake 
(Tagliazucchi & Laufs, 2014). In larger scale studies this may be less problematic, 
however, in a single case design such as in this study the impact is likely be more 
apparent.  
It is also possible that some of the differences found between the scans 
may reflect differences in the participant’s level of tic suppression/ tic enactment 
during the scan. Previous work using fMRI has identified distinct patterns of 
activity occurring shortly before tic onset and during tic execution (Bohlhalter et 
al., 2006), and differences have also been found between patterns of activity 
during tics compared with voluntary motor actions (Bohlhalter et al., 2006; 
Hampson et al., 2009; Wang et al., 2011). These studies have implicated a 
number of regions particularly within the motor pathway including the 
sensorimotor cortex, putamen, palladium, substantial nigra (Wang et al., 2011), 
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the SMA (Bohlhalter et al., 2006; Hampson et al., 2009) and cerebellum 
(Bohlhalter et al., 2006). In this study some of these regions were found to be 
significantly different across the scans, however, as no information about tic 
occurrence or suppression was collected during the scan it is not possible to 
decipher if these differences were related to tic occurrence or if they were more 
stable. This is a consideration for future research in order to determine if the 
effects seen using techniques such as resting state fMRI reflect stable changes or 
the consequences of differences in the level of tics an individual experiences 
while in the scanner. It may also be beneficial to use other methods to assess 
change, including any change in white matter connectivity.  
 To conclude, this study provides some support that the home application 
of tDCS may be useful in reducing tics in Tourette’s syndrome. The evidence from 
the YGTSS suggests that 1.5mA cathodal stimulation was more effective than 
1mA, this was also reflected by the participants’ own sentiments after receiving 
this intervention. This research adds to that of Carvalho et al. (2015) and Mrakic-
Sposta et al. (2008) and highlights the need for larger, counterbalanced, sham 
controlled studies to fully evaluate the techniques’ potential.  
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 What are we measuring with magnetic 
resonance spectroscopy and why is this important?  
 
Some of this work has previously been presented in: Dyke, K., Pépés, S, E., 
Chen, C., Kim, S., Sigurdsson, H. P., Draper, A., Husain, M., Nachev, P., Gowland, 
P, A., Morris, P. G., & Jackson, S. R. (2017). Comparing GABA-dependent 
physiological measures of inhibition with proton magnetic resonance 
spectroscopy measurement of GABA using ultra-high-field MRI. Neuroimage, 
152, 360-370. 
Key words: transcranial magnetic stimulation (TMS), resting motor threshold 
(RMT), input output curve (IO curve), short interval intracortical inhibition (SICI), 
long intracortical inhibition (LICI), intracortical facilitation (ICF), magnetic 
resonance spectroscopy (MRS), gamma-aminobutyric acid (GABA), glutamate 
(Glu) glutamine (Gln). 
MRS data collection was completed by Sophia Pépés with whom co-authorship of 
this study is shared.  
7.1 Introduction 
 
Although the exact mechanisms underlying Tourette’s Syndrome (GTS) 
remain partially unclear, there is a large amount of convergent evidence to 
suggest that GTS is characterised by altered GABA function.  GABA is the primary 
inhibitory neurotransmitter in the human brain, and has been estimated to be 
present at 20-50% of all synapses. GABA plays a critical role in the regulation of 
cortical excitability, and is of great importance during brain maturation (Ben-Ari 
et al., 2012). Dysregulation of GABA has been reported in a number of 
neurodevelopmental disorders including autism spectrum disorder (Hussman, 
2001; Pizzarelli & Cherubini, 2011) , epilepsy (Treiman, 2001), Tourette’s 
syndrome  (Draper et al., 2014) and schizophrenia (Gonzalez-Burgos et al., 2010). 
As a result, GABA is a major target for drug development and interventions using 
NIBS.  
The evidence for dysregulation of GABAergic systems in GTS is convergent 
across multiple methods, and consistent with the view that GTS is specifically 
linked to alterations in GABA signalling and the operation of inhibitory brain 
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circuits. It is generally acknowledged that cortical-striatal-thalamic-cortical 
circuits (CSTC) are dysfunctional in GTS. As a result of this dysfunction, subsets of 
striatal neurons are thought to become active in inappropriate contexts. This is 
thought to result in disinhibition of thalamo-cortical projections (Albin & Mink, 
2006) and hyper-excitability of limbic and motor regions of the brain, both of 
which are thought to result in the occurrence of tics (Bohlhalter et al., 2006; 
Orth, 2009; Tinaz et al., 2015). Consistent with these findings, post-mortem 
studies have found significant reductions in the amount of GABAergic 
interneurons within the striatum in individuals with GTS (Kalanithi et al., 2005; 
Kataoka et al., 2010). In addition to this, positron emission tomography (PET) has 
revealed a reduction in GABA-A receptor binding sites in the striatum, thalamus 
and insular cortex (Lerner et al., 2012). Evidence from paired pulse TMS studies 
also suggests abnormalities in GABA levels. Individuals with GTS have been found 
to have lower levels of SICI responses (Gilbert et al., 2005; Orth et al., 2005; 
Ziemann et al., 1997) which suggests a reduction of GABA-A receptor mediated 
inhibition within the motor cortex. Furthermore, studies using animal models 
have suggested a direct link between GABA and tic generation. For example, 
injecting different parts of the striatum with a GABA antagonist has been found 
to induce motor and phonic tic like behaviours in monkey and rat models 
(Bronfeld et al., 2013). 
A recent study using ultra-high-field strength (7 Tesla) magnetic resonance 
spectroscopy (MRS) found significantly elevated levels of GABA within the 
supplementary motor area (SMA) in individuals with GTS when compared with 
closely matched control subjects (Draper et al., 2014). Although this finding may 
seem counter intuitive at first, Draper et al. (2014) argued that this seemingly 
paradoxical increase may be a compensatory, adaptive mechanism, through 
which individuals with GTS develop increased control over motor outputs. 
Draper et al. (2014) also found that levels of MRS-GABA within the SMA were 
correlated with tic severity, which suggest that this compensatory mechanism 
may arise due to the gain of motor outputs being altered as a result of increased 
GABA levels within the SMA. Interestingly, Draper et al. (2014) failed to find any 
169 
 
significant alterations in GABA levels within the motor cortex. This is somewhat 
surprising, as a number of previous studies using SICI have suggested a reduction 
of GABAergic activity within this brain region (Gilbert et al., 2005; Orth et al., 
2005; Ziemann et al., 1997). However, it is possible that the discrepancy between 
these results at M1 and the seemingly paradoxical elevation of GABA at the SMA, 
relate to differences between the two techniques.  
It has been speculated that what is measured in MRS may reflect 
extracellular levels of GABA which are linked to ‘tonic’ GABA-ergic inhibition 
(Rae, 2014). Whereas, TMS measures of SICI are thought to primarily reflect the 
operation of low threshold, transiently activated, cortical GABA interneurons 
(Ziemann, Lonnecker, et al., 1996; Ziemann, Rothwell, et al., 1996). If the two 
techniques are measuring from distinct pools of GABA, it would be unsurprising 
to find a decrease in one and increase in another, particularly in the context of 
syndromes such as GTS whereby an adaptive compensatory response may be 
apparent.  
Enhancing our understanding into what we are measuring with MRS is 
important to better comprehend the causes and consequences of disorders such 
as Tourette’s syndrome. In addition to this, enhancing knowledge about MRS 
measures could also help to develop our understanding of the effects of NIBS 
techniques.   
Past research with TMS (Batsikadze et al., 2013; Cengiz et al., 2013; Kidgell 
et al., 2013; Nitsche et al., 2005) and MRS (Stagg et al., 2009) has suggested that 
tDCS can influence levels of GABA. This could be particularly important with 
respect to using these techniques therapeutically, as long-term potentiation 
(LTP) type plasticity within the neocortex is thought to be critically dependent on 
the modulation of this neurotransmitter (Trepel & Racine, 2000).  However, the 
effects of tDCS on GABA levels may not be direct, particularly for cathodal 
stimulation. This is supported by the finding that administration of the GABA-A 
receptor agonist Lorazepam did not significantly alter the after-effects of 
cathodal stimulation (as measures by TMS), although it did significantly reduce 
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anodal tDCS after-effects (Nitsche et al., 2004). This finding has led to speculation 
that the observed after-effects of cathodal stimulation may be due to the tight 
coupling between GABA and Glutamate (Stagg & Nitsche, 2011). As GABA is 
synthesised from glutamate, and glutamate level has been shown to change 
following cathodal stimulation (Nitsche et al., 2005; Stagg et al., 2009) this seems 
plausible. Testing this further using a multi-modal approach is likely to answer 
this question, but in order for this to be truly effective it is important that 
questions such as exactly where is the MRS-GABA signal coming from are 
answered.  
  Two recent studies have sought to address the relationship between TMS 
and MRS measures of GABA and glutamate/glutamine within the sensorimotor 
cortex (Stagg et al., 2011; Tremblay et al., 2013). Both studies acquired TMS and 
MRS measures using conventional field strengths (3 Tesla) within the same 
individuals. Tremblay et al. (2013) failed to find any significant correlations 
between any TMS measures (including 3ms SICI) and MRS measured GABA 
levels. However, Stagg et al. (2011) reported that although MRS-GABA 
concentrations within motor cortex (M1) were uncorrelated with 2.5ms SICI, 
there was a significant correlation with the slope of the 1ms SICI curve. As 
discussed in chapter 2, the physiological mechanisms underlying 1ms SICI effects 
are thought to be distinct from those occurring at later ISIs, and although these 
mechanisms are not yet fully understood, it has been speculated that the effects 
may reflect axonal refractory periods (Fisher et al., 2002). In line with this, Stagg 
et al. (2011) discuss the possibility that the relationship suggests that MRS 
measures extra synaptic, tonic GABA which may relate to the duration of the 
refractory periods of neuronal axons. Although a plausible explanation, the 
refractory periods theory of 1ms SICI is not held by all, and some argue that 
synaptic involvement in the effect is also likely (Vucic et al., 2009). In addition to 
this,  although Tremblay et al. (2013) also failed to identify correlations between 
MRS measured GABA and later SICI (3ms SICI), they did not measure 1ms SICI, 
hence the results of Stagg et al. (2011), have yet to be replicated.  
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The Stagg and Tremblay studies also differ in the associations that they 
reported for other TMS/MRS metabolite pairings, partially due to the use of 
different TMS measurements. Thus, while Stagg et al. (2011) reported that a 
general measure of cortical excitability - the slope of the TMS recruitment (IO) 
curve - was significantly associated with MRS glutamate concentrations within 
M1, Tremblay et al. (2013) reported a significant positive correlation between 
Glx (a composite measure of glutamate and glutamine) and the duration of the 
cortical silent period (CSP). Furthermore, in addition to differing on which 
particular TMS measures to relate to MRS measures of motor cortical excitability 
and physiological inhibition, the above studies also differed in that one study 
used a GABA-edited MRS sequence (Tremblay et al., 2013) while the other (Stagg 
et al., 2011) did not. This may have had important implications for the 
measurements obtained, particularly as both studies were conducted at 
conventional MR field strengths.  
The advantages of ultra-high field (7 Tesla) are the increased signal-to-
noise ratio (SNR) obtained and greater chemical shift dispersion (Tkác et al., 
2009). The increased SNR improves the detection sensitivity and efficiency of 
metabolites, especially those with low concentration such as GABA. Greater 
chemical shift dispersion increases the separation of signals with similar 
resonance frequencies, allowing a more accurate identification and 
quantification of each metabolite. For instance, due to spectral overlapping the 
differentiation of GABA, Glu and Gln signals are difficult in 1H spectra at field 
strengths of 3 T or less (Puts & Edden, 2012), and Glx (a composite measure of 
Glu + Gln) is reported instead. By contrast, GABA, Glu and Gln become separable 
at field strengths of 7 T or above. Also, GABA-edited (J-difference editing) 
sequences (Mescher et al., 1998; Near et al., 2013) rely on subtraction to remove 
overlapping signals from the spectrum. This technique is therefore particularly 
susceptible to motion-related errors that are less of an issue for non-edited MRS 
sequences (e.g., STEAM) that can be utilised at 7 T (Bhattacharyya et al., 2007; 
Bogner et al., 2014). 
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In this study, we investigated how TMS and MRS measures relate by 
directly comparing a wide range of TMS measurements of motor cortical 
excitability (including TMS recruitment curves and paired-pulse measures of 
intracortical facilitation [ICF]) and physiological inhibition (including both 1ms  
and 3ms SICI) with MRS measures of GABA, Glu and Gln acquired at ultra-high-
field (7 Tesla) using a non-edited STEAM sequence. 
In addition to investigating correlations of TMS and MRS measured at 
baseline, the effects of a pharmacological manipulation of GABA using the drug 
gabapentin (GBP) were explored. Gabapentin (1-
(aminomethyl)cyclohexaneacetic acid (Neurontin®)) is a safe and widely 
prescribed drug typically used to treat conditions such as epilepsy and neuralgia. 
It was originally synthesised as a GABA analogue, however, animal experiments 
revealed that the drug failed to show direct GABAergic receptor action (Ziemann 
et al., 2015). The exact mechanisms of action for GBP are yet to be fully 
understood, however, there is evidence that GBP may increase GABA synthesis 
and turnover, decrease glutamate release and block α2 voltage gated calcium 
channel sub-units (VGCC) (Ziemann et al., 2015).  
Although GBP does not appear to interact directly with GABA-A or GABA-
B receptors (Goa & Sorkin, 1993; Sills, 2006; Taylor et al., 1998), and does not 
appear to be a GABA-A (Kondo et al., 1991) or GABA-B agonist (Lanneau et al., 
2001), it has been found to influence both TMS and MRS measures associated 
with GABA.  Of particular interest are the findings of two TMS studies in which 
800mg and 1200mg doses of GBP were found to increase SICI and decrease ICF, 
while not influencing motor thresholds (Rizzo et al., 2001; Ziemann, Lonnecker, 
et al., 1996). As MT is known to be effected by voltage-gated sodium channel 
blockers such as carbamazepine (Menzler et al., 2014; Ziemann, Lonnecker, et 
al., 1996) but is not influenced by GBP, this suggests that calcium channel 
inactivation is unlikely to fully explain the effects.  It has been proposed that 
GBP’s effect on SICI could be a result of increased GABA synthesis (Ziemann et 
al., 2015). Unfortunately, neither TMS study was placebo controlled, and there 
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appears to have been no subsequent attempts to establish the effects of GBP 
using TMS.  
Evidence from MRS studies supports the hypothesis that GBP influences 
GABA synthesis, and the drug has repeatedly been found to cause elevated levels 
of GABA in vivo in the human brain. Three notable studies have been 
documented, the first of which was conducted by Petroff et al. (1996). They 
found elevated levels of GABA in patients with epilepsy who were medicated 
with GBP compared with individuals who were taking medications such as 
carbamazepine. Interestingly the effects appeared to be dose specific, with those 
taking higher doses showing higher levels of GABA. In a more recent 7T MRS 
study with healthy participants, Cai et al. (2012) found that a single 900mg dose 
of GBP significantly elevated levels of GABA within the visual cortex. This 
elevation was far greater than that seen in the control condition and therefore, 
the effects cannot be accounted for by natural GABA fluctuations over time. 
Finally, Kuzniecky et al. (2002) studied the effects of acute and chronic doses of 
GBP in healthy participants using MRS at a field strength of 4.2 Tesla. A single 
acute dose of the drug (adjusted to participant’s weight (17mg/kg)), caused 
significant increases in GABA measures 6 but not 3 hours after ingestion. 
Significantly elevated levels of GABA were also measurable after a 4 week course 
of the drug, although not after 2 weeks.  
It appears that no placebo controlled trials have been conducted in which 
the effects of a single dose of GBP are studied using both TMS and MRS from the 
same individuals. Therefore, the aims of this study were two fold.  Firstly, to 
investigate the relationship between MRS and TMS measures of GABA, Glu and 
Gln, and secondly, to explore the effects a single dose of GBP may have on both 
of these measures.  
7.2 Method 
7.2.1 Participants 
29 healthy right-handed adults (age range 19-27) participated in the 
study. All participants were free from neurological or psychiatric illness and any 
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contra-indications for MR scanning or TMS.  Of the 29 participants recruited, two 
were subsequently excluded from the analysis of baseline MRS/TMS measures: 
one due to poor quality TMS data (insufficient test pulse intensity) and one due 
to poor quality MRS data.  Details of the 27 participants included in the data 
analyses for baseline correlations are contained in Table 7.1. 
Table 7.1. Participant demographics for baseline analysis. Data are presented as mean 
value ± sd. RMT = mean resting motor threshold. SI 1mV = mean stimulator output 
required to produce a MEP with an amplitude of 1mV. † Percentage of maximal 
stimulator intensity. 
N Sex (M/F) Age RMT † S1 1MV † 
27 13/14 23.1 ± 2.4 45.7 ±6  55.3±6.8  
 
Of the 29 participants tested 14 were assigned to the placebo condition 
and 15 were assigned to the GBP condition. Due to the exclusion of one data set 
for poor quality TMS in the placebo group, and one data set from the GBP group 
due to poor quality MRS data, there were slight variations between sample sizes. 
Participant demographics for the different conditions can be seen in Table 7.2. 
Table 7.2. Participant demographics for analysis of drug manipulation data. Data are 
presented as mean value ± sd.  
 N Sex (m/f) Age BMI 
MRS placebo  14 8F, 6M 22.3 ± 2.4 21.8±3.6 
MRS gabapentin 14 7F, 7M 23.6 ± 2.4 21.9 ± 2.6 
TMS placebo 13 7F, 6M 23 ± 2.5 22.1 ± 3.7 
TMS gabapentin 15 7F, 8M 23.6 ± 2.4 21.9 ± 2.6 
 
7.2.2 MR acquisition 
All MR data were acquired using an ultra-high field 7T Philips Achieva 
system (Philips Healthcare, Best, Netherlands) with a 32-channel radio frequency 
head coil at the Sir Peter Mansfield Imaging Centre (SPMIC), University of 
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Nottingham. Participants were placed supine and head-first into the scanner. 
Foam pads were inserted between the participant’s head and the coil to 
minimise and control head movement; a pair of prism glasses was provided to 
allow participants to view a screen outside the magnet bore.  
At the start of each imaging session 1H image localiser and B0 maps were 
acquired, followed by BOLD-fMRI T2*-weighted images, which were acquired to 
guide placement of the left motor cortex (M1) spectroscopy voxel in the 
following MRS scans. The BOLD-fMRI used a single shot EPI sequence 
(TR/TE=1999/25ms, FOV=208×192 mm3, matrix=112×112, 30 slices, slice 
thickness=4mm, no slice gap, 160 dynamics). During the fMRI scan, eight blocks 
of bimanual finger-to-thumb opposition tapping were performed in a blocked-
trial paradigm as follows. The words ‘TAP’ and ‘REST’ were alternately displayed 
for 8s and 32s, respectively. Participants were asked to tap their thumbs to each 
finger with both hands simultaneously and continuously during the ‘TAP’ phase 
and to rest (withhold movement) during the ‘REST’ phase. Maximum activation 
of the left M1 was found by analysing the BOLD response on-line using the 
Philips IViewBOLD software. 
T1-weighted anatomical images were then acquired with a MPRAGE 
sequence (TR/TE/TI=7.3/3.4/998ms, FA=8o, FOV=224×224×120 mm3, isotropic 
resolution=1mm3) for tissue segmentation. Anatomical landmarks from these 
images were also used to assist in the placement of the left M1 voxel for MRS. 
In vivo 1H MRS data were acquired from a voxel of interest 
(VOI=20×20×20mm3) placed over the hand area in the left M1 (Figure 7.1A) using 
a STEAM sequence (TE/TM/TR=17/17/2000ms, sample size=4096, spectral 
bandwidth=4000Hz, phase cycling=8, 288 averages, 9.6mins). Water suppression 
was performed using multiply optimised insensitive suppression train (MOIST) 
(Murdoch, 1993).  Prior to this, a non-suppressed water reference spectrum (16 
averages) from the same VOI was acquired for eddy current correction and 
quantification. B0 shimming of the VOI was performed automatically by the 
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Philips pencil beam (PB) algorithm (Gruetter, 1993) in order to increase B0 field 
homogeneity.  
 
Figure 7.1 [A] Position of the voxel of interest (VOI=20×20×20mm3) located over 
the left-hand area of M1 shown in (i) sagittal, (ii) axial (iii) and coronal views. [B] 
Standard deviations (shaded area) overlying the group mean in vivo spectrum 
acquired from the VOI obtained with STEAM sequence (TS/M=17/17ms) at 7T are 
shown (N=27). [C] A representative in vivo spectrum obtained from the M1 VOI is 
shown, together with its LCModel fot. Residual and fitted signals for metabolites 
of interest and macromolecules (MM) and baseline (BL) are shown. 
 
7.2.3 TMS measurements and EMG recording 
 
MR scanning sessions were performed before TMS measurements were 
obtained. On average the time in between the final MR scan and the 
commencement of the collection of TMS measurements was 30 minutes.   
TMS was delivered using a Magstim Bistim system (Magstim, Whiteland, 
Dyfed, UK) with a figure-of-eight magnetic coil (70mm diameter of each 
winding). The coil was held tangentially to the scalp and positioned 45° from the 
midline, resulting in a posterior to anterior current flow. Neuro-navigation 
software (Brainsight, Rogue Research Inc., Montreal Quebec, Canada) was used 
in conjunction with individual T1-weighted anatomical images (acquired using the 
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MPRAGE sequence outlined above) to aid coil placement over the hand area of 
the left motor cortex. All TMS measures were obtained from the motor hot spot 
identified for the First Dorsal Interosseous (FDI) muscle. This was defined as the 
location that consistently yielded the largest MEP amplitudes for the FDI. 
Participants were required to remain still during testing, and head movements 
were minimised with the aid of a chin rest. Participants were offered frequent 
breaks to stretch and adjust their position and neuro-navigation was used to 
accurately reposition the coil over the motor hot spot on each occasion. The coil 
was held stable over the hot-spot using a Manfrotto mechanical arm (Vitec 
Group, Italy) and adjusted when necessary.  
Motor evoked potentials (MEPs) were recorded using disposable Ag-AgCl 
surface electrodes attached to the right FDI muscle in a belly-tendon montage. 
The signals were amplified and bandpass filtered (10 Hz- 2kHz, sampling rate 
5kHz) then digitalized using Brainamp ExG (Brain Products GmbH, Gilching, 
Germany) controlled by Brain Vision Recorder (Brain Products GmbH, Gilching, 
Germany). Participants were encouraged to maintain their hand in a relaxed 
position throughout testing.   
All trials were controlled using an in-house program (written using 
Matlab: Mathworks, MA, USA), with an inter-trial interval of 5s occurring 
between each trial for all measures. Intracortical inhibition and facilitation were 
investigated using a range of TMS paired pulse protocols, with a range of inter-
stimulus intervals (ISIs) including 1, 3, 10 and 12ms (Kujirai et al., 1993). A 100ms 
ISI inhibitory protocol was also measured (Claus et al., 1992; Valls-Sole et al., 
1992). All paired pulse measures and unconditioned trials were randomized and 
presented within the same session. Input output curves were always calculated 
prior to paired pulse measures.  
Threshold determination 
Resting motor threshold (RMT) was determined as the lowest intensity 
needed to yield an MEP with a peak-to-peak amplitude of >50µV in the relaxed 
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FDI muscle in a minimum of 5 of 10 trials. A 1mV (SI 1mV) threshold was also 
determined by calculating the lowest intensity needed to evoke an MEP of 1mV 
in 5 of 10 consecutive trials.  
Input output curves  
TMS intensities at 100, 110, 120, 130, 140 and 150% of RMT were used. 
10 pulses at each of the 6 intensities were delivered in a randomized order.  
Unconditioned trials 
A total of 30 unconditioned trials were measured at SI 1mV. 
Short interval intracortical inhibition (SICI) 
SICI was measured using 1 and 3ms ISIs. The selection of conditioning 
stimuli (CS) intensities was informed by a pilot study (data not shown) which 
revealed 1ms SICI to have a lower threshold than that of 3ms SICI. This finding 
confirms previous research (Fisher et al., 2002) and, therefore CS intensities of 
45,50,55 and 60% RMT were used to measure 1ms SICI, whereas 60, 65, 70 and 
75% RMT were used to measure 3ms SICI. Each CS was followed by a supra-
threshold test stimulus (TS) of SI 1mV delivered to the same location.  Ten trials 
were measured for each CS-TS pairing for both 1 and 3ms ISIs.  
Long interval intracortical inhibition (LICI) 
A single ISI of 100ms was tested using a supra-threshold CS of 110% RMT 
and a TS delivered at SI 1mV. A total of 20 trials were measured.  
Intracortical facilitation (ICF) 
10 and 12ms ISIs were measured using a CS at 75% RMT followed by a SI 1mV TS. 
20 trials were measured for each ISI.  
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7.2.4 Experimental procedure 
 
 
Figure 7.2. Schematic showing study timeline. 
The testing sessions commenced at the same time each morning for all 
participants and lasted approximately 6 hours in total (see Figure 7.2). A 7T Philips 
Achieva system (Philips Healthcare, Best, Netherlands) scanner was used to 
collect anatomical and MRS data (using MPRAGE and STEAM sequences 
respectively). Approximately 30 minutes after this, TMS measures (IO curve, 1ms 
SICI, 3ms SICI, 10ms ICF, 12ms ICF and LICI) were collected. After completing the 
first set of TMS measures, participants were asked to fill out a simple bespoke 
questionnaire to indicate their perceived level of fatigue and tiredness on a scale 
of 1(absent) to 10 (severe).  
Participants were then given a drink containing 900mg of GBP or with 
nothing added. A strong sugar free blackcurrant flavoured drink was used to 
mask the taste of the drug. Assignment of participants to the drug or control 
condition was done by a researcher (HS) who was not involved in data analysis 
but was present during scanning. The primary investigators (KD and SP) were 
kept blind to the condition until data analysis was complete. After receiving the 
drug or control drink, participants ate a light lunch which typically involved a 
sandwich, a low sugar snack such as crisps and a low sugar drink (typically 
water). During the break participants were closely monitored and engaged in 
restful activities such as watching films or reading. Participants were re-scanned 
on average 1.59 hours after consuming the control/ GBP containing drink. The 
second set of TMS measurements were then performed. On average these took 
MRS TMS 
Questionnaire 
MRS Gabapentin/ 
placebo 
TMS 
Questionnaire 
Break 
Baseline 
measures 
Post measures  
180 
 
place 2.52 hours following drug/placebo intake. If necessary thresholds (RMT/ SI 
1mV) were adjusted during the second measurement. Finally, participants were 
asked to rate their level of fatigue and tiredness again on the questionnaire. 
Participant comfort was closely monitored throughout the experiment.  
7.2.5 Analyses of MRS data 
In vivo 1H spectra were fitted and quantified with the LCModel software 
package (Provencher, 1993). The basis set used for quantification included an 
experimentally acquired macromolecule spectrum and model spectra of 20 
metabolites. The LCModel analysis was performed within the chemical shift 
range 0.5 to 4.2 ppm. Water scaling was applied using the non-suppressed water 
reference. The LCmodel control parameters were based on previously published 
parameters (Tkác et al., 2009). The absolute concentration for each cerebral 
metabolite are reported in institutional units. Metabolites with Cramer-Rao 
lower bound (CRLB) >20% were rejected from further analysis. The linewidth of 
in vivo spectra were 10.35±1.99 Hz. Total Cr (tCr, i.e., PCr+Cr) was used as the 
internal reference for quantification due to its relatively high and stable 
concentration in the human brain (Danielsen & Ross, 1999; Stagg & Rothman, 
2014).The group mean in vivo spectrum acquired from the VOI is presented in 
Figure 7.1B. Any significant outliers were identified and removed using Grubbs 
test.  
7.2.6 Analyses of TMS data  
 
All trials were carefully visually inspected and trials in which there was 
evidence of pre-contraction of the FDI muscle in the period 500ms prior to an 
MEP were excluded. For the remaining data peak-to-peak MEP amplitudes were 
measured using in-house software (programmed using Matlab, The Mathworks, 
MA, USA). When analysing individual participant data median values were 
calculated to indicate average MEP amplitude in response to a particular 
stimulator output.  Significant outliers were identified and removed from further 
analysis using Grubbs test. 
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Resting motor thresholds (RMT)  
The group mean RMT was 45.7 (±6) of maximum stimulator output.  The 
group mean for the 1mV (SI mV) threshold (i.e., the lowest intensity needed to 
evoke an MEP of 1mV in 5 of 10 consecutive trials) was 55.3(±6.8) %. The group 
mean MEP amplitude for a TMS pulse delivered at SI 1mV was 1365.3 
(±556.9)mV.  
TMS recruitment (IO) curves 
Single pulse TMS IO curves were measured by calculating for each 
individual the median MEP amplitude for each given TMS intensity (100 -150% 
RMT). Four-parameter sigmoidal fits were then applied to the resultant values 
and the maximal slope and the plateau of the curve were calculated. The 
sigmoidal function used to fit curves to the individual datasets was: 
MEP𝑆 = 𝑦0 +  
MEPMAX
1 + 10(𝑆50−𝑆)𝑘
 
MEPMAX is the maximum MEP amplitude measured, S50 is the TMS intensity 
needed to produce 50% of the maximum MEP, k is the gradient of the maximum 
steepness of the curve and y0 is the minimal MEP response, which was set to 0. 
Two measures of interest were taken from the sigmoid curve: the maximum 
slope of the sigmoid (IO curve slope) and plateau of the sigmoid (IO plateau). 
Paired pulse data 
Paired pulse trials were analysed by calculating for each individual the 
median MEP amplitude for each CS intensity at each ISI. These values were then 
divided by the median MEP amplitude for unconditioned trials to create a ratio 
measure. Linear slopes were fitted to 1ms and 3ms SICI measures (Figure 7.3) 
and a median value was calculated across the different CS intensities to reveal 
the average level of inhibition. Individual median MEP values were also 
calculated for ICF trials; the resultant group data are presented in Figure 7.3. 
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Inspection of this figure clearly illustrates that while the SICI paired pulse trials 
(ISIs 1ms and 3ms) led to a large reduction of the MEP produced by the test 
stimulus, the ICF trials (ISIs 10ms and 12ms) led to a large increase in the MEP to 
the test stimulus. These data are consistent with the inhibitory and excitatory 
effects of SICI and ICF paired pulse TMS stimulation. Statistical analysis using a 
one-way ANOVA confirmed that there was a significant effect of stimulator 
intensity on MEP amplitudes for both the 1ms SICI curve (F(3,104) = 32.58, p < 
0.0001) and the 3ms SICI curve (F(3,107) = 19.23, p < 0.0001). Paired sample t-
tests confirmed that the values for both 10ms ICF trials (t(26)=10.8, p=.00) and 
12ms ICF (t(26)=10.63, p=.00) differed significantly to unconditioned trials.  
 
Figure 7.3. Group mean of individual median MEP values for paired pulse SICI (1ms and 
3ms ISI) and ICF (10ms and 12ms ISI) trials. Error bars represent the standard error of the 
mean. 
 
Following initial analyses, it was determined that data from LICI trials 
would not be analysed further. This was based upon the large percentage of 
participants who reached floor levels for this measure (i.e., there was a complete 
inhibition of the MEP in 8/27 participants). While this illustrates that the LICI 
paired pulse TMS procedure was highly effective, it reduces individual variability 
in LICI values and, therefore, makes correlation analyses less effective. 
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7.2.7 Correlations between MRS and TMS measures 
 
One of the key aims of this study was to directly examine the association 
between TMS measures of physiological inhibition - assessed by TMS stimulation 
of the hand area of the motor cortex (M1) of the left hemisphere - with MRS 
measurement of GABA concentration – acquired from a voxel centred over the 
hand area of left hemisphere M1. To examine these association Pearson 
correlation coefficients were calculated for the entire set of TMS measures 
against a measure of M1 GABA concentration. For completeness correlations are 
reported without adjustment for multiple comparisons. Where correlation 
coefficients are statistically significant the adjusted statistical threshold (alpha) 
calculated for multiple comparisons using the Holm-Bonferroni correction 
method is reported separately for each neurotransmitter.  
The TMS measures used in the analyses consisted of the following ten 
measurements for each individual: the resting motor threshold (50-100μV); the 
median MEP for a single, unconditioned, TMS stimulus delivered at that 
individual’s RMT (med MEP); the stimulator output (%) required to produce an 
MEP of approximately 1mV (SI 1mV); the linear slope of the TMS IO curve (IO 
curve); the median inhibition value (%) observed for 1ms SICI trials (1ms SICI); 
the linear slope value for 1ms SICI trials (1ms SICI slope); the median inhibition 
value (%) observed for 3ms SICI trials (3ms SICI); the linear slope value for 3ms 
SICI trials (3ms SICI slope); the median value (%) observed for 10ms ICF trials 
(10ms ICF); and the median value (%) observed for 12ms ICF trials (12ms ICF). 
While the primary focus of this study was to examine the association 
between TMS measures of physiological inhibition (e.g., SICI) and MRS measures 
of GABA (hereafter referred to as MRS-GABA), and also the effects of GBP on 
GABA. For completeness, the relationship of TMS measures with MRS measures 
of glutamate (Glu), glutamine (Gln), and the ratio of glutamine to glutamate were 
also explored.  
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7.2.8 Analysis of acute effects of gabapentin/placebo administration 
 
Grubbs test was used to identify and remove outliers in the post GBP and 
post sham conditions. Once outliers were removed from each data set, 
percentage change from baseline was calculated. Independent samples t-tests 
were then used to test for significant differences occurring between the placebo 
and GBP groups for each TMS/MRS measure.  Pearson’s correlation analysis was 
also used to examine any relationships between change in MRS/TMS measures 
and baseline measures for each group. 
7.3 Results 
 
7.3.1 Correlations between baseline TMS and MRS measures 
Association of TMS measures with GABA (GABA/tCR) 
 
Figure 7.4 Spider’s web plot illustrating Pearson correlation coefficients for TMS 
measures with GABA/tCR ratios. Plot shows correlation coefficients running from 1.0 
(outer ring) to -1.0 (inner ring) with the broken black line representing a correlation 
coefficient of 0. Open blue circles are not statistically significant (p>0.05), whereas filled 
blue circles represent statistically significant correlations (p<0.05).  
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Figure 7.4 displays a spider plot of the Pearson correlation coefficients of 
the TMS measures with GABA/tCr ratio. These analyses revealed that all effects 
failed to reach conventional levels of statistical significance (all p > 0.29). In 
particular, the correlation coefficients for 1ms and 3ms SICI did not approach 
statistical significance for either median inhibition (1ms SICI: r = -0.19, p=0.34; 
3ms SICI: r = -0.08, p=0.68), or slope (1ms SICI: r = -0.17, p = 0.39; 3ms SICI: r = 
0.06, p = 0.77).  
Association of TMS measures with glutamate (Glu/tCR) 
 
Figure 7.5. Spider web plot illustrating Pearson correlation coefficients between 
individual values for each TMS measurement and glutamate concentrations (Glu/tCr 
ratios). Filled circled indicate significant relationships for 10ms ICF and IO plateau with 
Glu/Cr. 
Figure 7.5 displays a spider’s web plot of the Pearson correlation 
coefficients of the TMS measures with Glu/tCr ratio. Similar relationships were 
found as expected. A significant negative relationship was found between IO 
plateau and Glu/tCr (r=-0.74, p<0.0001 [corrected using Holm-Bonferroni 
method]) but not IO maximal slope (r=-0.2, p=0.34) or RMT (r=-0.09, p=0.67). A 
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significant positive relationship was found between Glu/tCR and 10ms ICF (ICF 
10ms: r=0.52, p<0.01), however, this did not survive Holm-Bonferroni correction 
(r=0.52, p=0.08).  12ms ICF was not found to have any relationship to Glu/tCR  
(ICF 12ms: r=0.06, p=0.78).  
 
Association of TMS measures with glutamine (Gln/tCR)  
 
Figure 7.6. Spider web plot illustrating Pearson correlation coefficients between 
individual values for each TMS measurement and glutamine concentrations (Gln/tCr 
ratios). Filled circled indicate significant relationships for Median MEP amplitude at RMT 
(Med MEP) and Gln/Cr. 
Figure 7.6 displays a spider’s web plot of the Pearson correlation 
coefficients of the TMS measures with Gln/tCr ratio. The analysis revealed a 
significant correlation between the Gln/tCr ratio and the median amplitude of 
MEPs in response to stimulation at RMT (r=-0.40, p=0.05), although this did not 
survive the Holm-Bonferroni correction (r=-0.4, p=0.5). Neither RMT (r=0.11, 
p=0.61) nor IO maximal slope (r=-0.01, p=0.97) were significantly associated with 
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Gln/tCR concentration and all other correlations failed to reach statistical 
significance. 
Multiple regression analyses 
To address any potential multivariate effects, the following six MRS 
measures were entered as separate predictors into a multiple regression model: 
GABA/tCR; Glu/tCR; Gln/tCR; GABA/Glu; GABA/Gln and Gln/Glu. These 
predictors were then used to predict each of the TMS measurements in turn.  
These analyses confirmed that the magnitude of the median MEP 
obtained at RMT was predicted by a combination of the Gln/Glu ratio (t=-3.43, 
p=0.03) and GABA/Glu ratio (t=-2.85, p=.01)(t = -3.09, p = 0.01); R2 = 0.4, F = 7.1, 
p = 0.00.  
The model also revealed that 10ms ICF was predicted by Glu/tCR ratio 
(t=-2.92, p=.01), R2= .27, F=8.5, p=.01. In addition to this Glu/tCR was found to 
significantly predict IO plateau (t=-2.92, p=.01), R2= .27, F=8.45, p=.01.  
Bayesian Statistics 
A Bayesian Hypothesis test was employed primarily to evaluate whether 
there was evidence in favour of the null hypothesis (H0), i.e. that a metabolite 
bore no relationship with neurotransmitter function as tested by TMS. It further 
allowed us to quantify the strength of the relationship of any correlations found 
(evidence in support of the alternative hypothesis, H1). Bayes Factors (BF10) were 
calculated using JASP (JASP-Team, 2016); JASP uses the Bayesian correlation test 
proposed by Jeffreys (1961). Bayes Factors above 1 show support for H1 whilst 
below 1 show support for the H0, the magnitude of the BF10 shows the strength 
of the evidence in support of either the H1 or H0. For cut-off values for the 
different strengths of evidence please see Table 7.3. 
In support of previous analyses, the Bayesian Hypothesis test showed 
there was decisive evidence that Glu/tCr is related to IO plateau (BF10=1119.59) 
and substantial evidence that ICF 10ms is related to Glu/tCr (BF10=7.05). Further, 
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there is substantial evidence that the majority of TMS measures do not relate to 
MRS measures of Glu/tCr, Gln/tCr or GABA/tCr. Most notably there is substantial 
evidence for no relationship between SICI 3ms, and SICI 3ms slope and GABA/tCr 
(BF01=3.86 and 4.02 respectively). For full results of the Bayesian Hypothesis Test 
please refer to Table 7.4. 
Table 7.3. Category values for BF10, adapted from Wetzels and Wagenmakers (2012) 
 
 
Table 7.4. Bayesian hypothesis test for correlations. Data presented are each BF10 
 
*substantial evidence for H1, **strong evidence for H1, ***decisive evidence for H1, †
substantial evidence for H0 BF10 > 1 supports H1, BF10<1 supports H0, BF10=1 suggests no 
evidence. 
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7.3.2 Acute effects of gabapentin/placebo on MRS measures 
 
 
Figure 7.7.  % change from baseline for GABA, Glu and Gln measures shown as mean and 
SEM for placebo and GBP groups. 
 
GABA/tCr 
Independent samples t-tests revealed no significant differences between 
the two groups for percentage change in GABA level, (t(26)=-1.42, p=.17). 
Bayesian statistics revealed anecdotal support in favour of no real differences 
existing between the two groups (BF10=0.74). Relevant data can be seen in Figure 
7.7.    
Glu/tCr 
There were no significant differences between the amount of change in 
Glu levels between the two groups (t(25)=.45, p=.66). Bayesian statistics provide 
anecdotal support in favour of there being no difference between the two 
(BF10=0.39).   Relevant data can be seen in Figure 7.7.    
Gln/tCr 
There were no statistically significant differences between the amount of 
change in Gln levels between the two groups (t(26)=.08, p=.93). Bayesian 
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statistics provide anecdotal evidence that the effects were not different 
(BF10=0.35).   Relevant data can be seen in Figure 7.7.    
7.3.3 Effects of baseline MRS measure and subsequent change  
 
Gabapentin condition 
 
 
Figure 7.8. Change in GABA level following gabapentin plotted against baseline GABA 
level. 
 
A significant relationship was found between baseline GABA and 
subsequent change in GABA level (r=-.78, p=.00). The results of the Bayesian 
hypothesis testing suggest very strong support that baseline GABA predicted the 
% change in GABA following GBP administration (BF10=41.82). This relationship 
can be seen in Figure 7.8. 
Baseline levels of glutamate were not found to significantly relate to 
subsequent levels of change in glutamate (r=-.53, p=.06). Bayesian hypothesis 
testing revealed only anecdotal support in favour of the relationship (BF10=1.63). 
Baseline levels of glutamine were not significantly related to subsequent 
change in glutamine measures (r=-.18, p=.55). Bayesian hypothesis testing 
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revealed anecdotal evidence in favour of no relationship between the two 
(BF10=0.39). 
 
Placebo condition 
 
Figure 7.9. Change in GABA level following placebo plotted against baseline GABA level. 
 
Levels of GABA at baseline were not significantly related to levels of GABA 
following placebo (r=-.34, p=.24). The results of the Bayesian hypothesis test 
showed anecdotal evidence in favour of there being no relationships (BF10=.63). 
This data can be seen in Figure 7.9.  
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No statistically significant relationship was found between baseline 
glutamate levels and subsequent change (r=-.421, p=.128). Bayesian hypothesis 
testing also failed to provide support for a relationship (BF10= 0.948). 
 
Baseline measures of glutamine were found to significantly correlate with 
the amount of change in this measure after placebo (r=-.71, p=.004). Bayesian 
hypothesis testing suggests strong evidence in favour of the existence of this 
relationship (BF10= 12.86). Relevant results can be seen in Figure 7.10.  
7.3.4 Acute effects of gabapentin/placebo on TMS measures 
There were no significant differences between the two participant groups 
for any of the TMS variables, including those thought to reflect GABAergic 
inhibition. In particular 3ms SICI median inhibition (t(26)=1.0, p=.33) and 3ms SICI 
slope (t(26)=-.17, p=.87) were not significantly different between groups. Change 
from baseline in measures of 1ms SICI median inhibition (t(26)=-1.59, p=.12) and 
1ms SICI slope (t(25)=-.32, p=.76) were also not significantly different.   
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7.3.5 Effects of baseline TMS measure and subsequent change  
 
 
Gabapentin 
Baseline values were not found to significantly relate to subsequent 
change in 3ms SICI median (r=-.42, p=.12) nor 3ms SICI slope (r=-.021, p=.94). 
Bayesian hypothesis testing revealed anecdotal evidence that there was no 
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Figure 7.11. Results of Pearson’s correlational analysis between A: baseline 1ms SICI slope and % slope 
change following gabapentin; B: baseline 1ms SICI slope and % change following placebo; C: baseline 10ms 
ICF and % change following gabapentin; D: 10ms ICF baseline and % change following placebo. Anything 
left of the blue line in C and D indicates a lack of true ICF effect in that conditioned MEPs were not larger 
than those from un-conditions trial.  
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relationship between baseline and change for either measure (BF10=0.99 and 
BF10=.32). 
Change in 1ms SICI median inhibition (r=-.76, p=.00) and 1ms SICI slope 
(r=-.85, p=.00) were found to negatively correlate with their respective baseline 
values. For the 1ms SICI median condition the model shows that as baseline 
median MEP amplitudes increase, the percentage change from baseline in the 
second measurement decreases or becomes negative. Larger median MEP 
amplitudes suggest lower levels of inhibition, therefore, this implies that those 
with initially low levels of inhibition at baseline show less change/a tendency 
towards increased inhibition (lower MEP amplitudes). Whereas, those who 
showed higher levels of inhibition at baseline (indexed by low med MEP 
amplitude) were more likely to show a larger percentage increase in MEP 
amplitude, hence indicating a shift towards lower levels of inhibition than 
previously measured.  A similar pattern of results is true for 1ms SICI slope 
measures (Figure 7.11 A) in which, as baseline slope increases (larger negative 
values suggest steeper slope), the percentage change from baseline decreases or 
becomes negative. Those with low slope values at baseline (indicating less 
inhibition) were more likely to show increased slope values in the second testing 
session (indicating an increase in inhibition) whereas the opposite is true for 
individuals whose baseline slopes were initially high.  Bayesian hypothesis testing 
revealed very strong evidence of the relationship between baseline and 
subsequent change in 1ms median inhibition (BF10=40.19) and decisive support 
for the relationship between baseline and change for 1ms SICI slope 
(BF10=407.5).  
Baseline values from 10ms but not 12m ICF significantly correlated with 
subsequent change (r=-.69, p=.00). The results can be seen in Figure 7.11 C, in 
which it can be observed that as baseline ICF values increased the percentage 
change decreased or became negative. This suggests that those who showed the 
largest ICF effects at baseline were then more likely to show a decrease in 
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subsequent measures and vice versa was true for those with lower values at 
baseline.   
 Bayesian hypothesis testing revealed strong support for the existence of 
a negative correlation between baseline 10ms SICI and subsequent change after 
GBP (BF10=13.38).  
Placebo 
The correlations between baseline TMS measures and their subsequent 
change are similar to those found for the GBP condition. Specifically, correlations 
between baseline and subsequent change were found for 1ms SICI slope and 
10ms ICF but no other measures.   
Change in 1ms SICI slope (r=-.81, p=.00) was significantly negatively 
correlated with its baseline values (Figure 7.11 B). Bayesian statistics suggest 
there is strong evidence in favour of the relationship (BF10=30.39).  
As was the case with the GBP participants, baseline 12ms ICF was not 
related to subsequent change in this measure, however, baseline 10ms ICF was 
(r=-.72, p=.00). Bayesian statistics revealed strong support for the negative 
correaltion (BF10=11.52). Relevant data can be seen in Figure 7.11 D. 
 
7.3.6 Questionnaire measures 
 
Independent samples t-tests revealed no significant differences between 
baseline ratings of fatigue t(24)=1.13, p=2.71. Ratings of tiredness were also not 
significantly different between the two groups at baseline t(24)=1.86, p=.08.  
A repeated measures ANOVA revealed no significant main effect of group 
(F(1,24)=.11, p=.75) on fatigue ratings. However, ratings were found to 
significantly increase when measured at the end of the study (F(1,24)=8.47, 
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p=.00). The interaction between time of measurement and group was not 
statistically significant (f(1,24)=2.86, p=.10).  
Ratings of tiredness significantly increased in the second measurement 
(F(1,24)=7.21, p=.01). There was also a significant interaction between time and 
group (F(1,24)=6.14, p=.02), although the main effect of group was not 
significant (F(1,24)=.42, p=.52). Further exploration using paired samples t-tests 
revealed no significant differences between pre- and post-fatigue ratings for the 
placebo group (t(11)=-1.55, p=.15), but a significant difference was found for the 
GBP group (t(13)=-3.7, p=.00).  
Correlations between percentage of change in fatigue/tiredness rating 
and percentage of change in MRS-GABA were also assessed using Pearson’s 
correlation co efficient. However, no significant correlations were found.  
 
7.4 Discussion 
 
Imbalances in glutamatergic (excitatory) and GABA (inhibitory) signalling 
within key brain networks are thought to underlie many brain disorders 
including: schizophrenia (Gonzalez-Burgos et al., 2010), depression (Kalueff & 
Nutt, 2007) and ‘hyperkinetic’ neurodevelopmental disorders such as TS (Clarke 
et al., 2012; Ramamoorthi & Lin, 2011). For this reason there is considerable 
current interest in the use of MRS to measure in vivo concentrations of brain 
molecules (e.g. GABA, glutamate, glutamine) that can be correlated with brain 
function and dysfunction. While it is tempting to equate the GABA measured 
using MRS (hereafter referred to as MRS-GABA) with neurotransmitter function, 
and with physiological or behavioural inhibition (e.g. Dharmadhikari et al. (2015); 
Haag et al. (2015)) it is important to note that at any point in time only a fraction 
of MRS-GABA will be neurotransmitter, and that increased MRS-GABA 
concentrations do not necessarily mean that there is increased physiological or 
behavioural inhibition (Rae, 2014). Furthermore, it is currently unclear whether 
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MRS-GABA represents the entire pool of GABA available for measurement (i.e., 
metabolic, intracellular, and extracellular GABA), or as some have argued, 
represents instead largely extracellular, extra-synaptic, GABA that is unrelated to 
the synaptic transmission of GABA (Rae, 2014; Stagg, 2014).  
In the current study we compared directly, in the same individuals, MRS-
GABA (and other important neurometabolites such as glutamate and glutamine) 
measured from a voxel located in the sensorimotor cortex against TMS measures 
of cortical excitability and GABA-mediated physiological inhibition measured 
from the hand area of motor cortex. We also used a placebo controlled drug 
manipulation to explore the effects GBP may have on TMS and MRS measures. It 
is important to note that using these techniques we obtained high-quality MRS 
data and replicated each of the previously reported TMS effects (i.e., TMS 
recruitment curves, 1ms SICI and 3ms SICI curves, and 10ms and 12ms ICF 
effects) that we set out to examine in this study. 
The main results of our study are summarised below.  
1. Individual concentrations of MRS-GABA were unrelated with any TMS 
measurements, including TMS measures of: general cortical excitability (i.e., TMS 
recruitment curve slopes); GABA mediated physiological inhibition (i.e., 3ms 
SICI), and TMS measures thought to be dependent upon the glutamatergic 
NMDA receptor (i.e., 10ms ICF and 12ms ICF).  
2. Individual levels of MRS-glutamate (Glu) were significantly negatively 
correlated with the plateau of the IO curve; a measure which is thought to reflect 
the balance of excitatory and inhibitory components of the corticospinal volley 
(Devanne et al., 1997). The relationship suggests that as levels of MRS-Glu 
increase the maximum MEP amplitude predicted by the model reduces. Multiple 
regression analysis revealed Glu/tCR to be the only significant predictor of this 
measure and, furthermore, Bayesian hypothesis tests provide very strong 
support in favour of the experimental hypothesis.  
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3. MRS-Glu was also found to be marginally correlated with 10ms but not 12ms 
ICF. The multiple regression analysis confirmed that Glu/tCR was a significant 
predictor of 10ms but not 12ms ICF. Bayesian hypothesis testing confirmed that 
there is substantial evidence in favour of the relationship.  
4. There was some evidence of correlation between glutamine (Gln) 
concentrations and median amplitude of the MEP response to TMS stimulation 
delivered at RMT. However, the Bayesian hypothesis test revealed only 
anecdotal support in favour of the relationship. This is possibly explained by the 
findings of the linear regression model which reveal that median MEP amplitude 
was found to be predicted by both the Gln/Glu and GABA/Glu ratios, but not 
significantly by Gln/tCR.  
5. Gabapentin did not significantly change MRS or TMS measures when 
compared with the placebo group. GBP also did not appear to significantly alter 
MRS measures of glutamate or glutamine.  
6. Levels of baseline MRS-GABA were significantly correlated with percentage 
change in MRS-GABA approximately 2 hours after participants received GBP, but 
not placebo. Those with the lowest levels of MRS-GABA at baseline saw the 
largest increases, however, those with initially high levels of MRS-GABA showed 
a decrease in the second scanning session. Bayesian hypothesis testing 
confirmed very strong support for the relationship in the GBP condition only.  
7. Baseline measures of 1ms SICI and 10ms ICF were found to be negatively 
correlated with subsequent change in these measures for both the GBP and 
placebo conditions.  
MRS-GABA and physiological inhibition  
Our finding, that individual concentrations of MRS-GABA are unrelated to 
GABA-mediated physiological inhibition, as measured by 3ms SICI, replicates 
previous reports for 3ms SICI (Tremblay et al., 2013) and 2.5ms SICI (Stagg et al., 
2011). The physiological mechanisms that underpin both 2.5ms and 3ms SICI 
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effects are well established and are thought to primarily involve post-synaptic 
inhibition mediated through GABA-A receptors (Ziemann et al., 2015). Although 
SICI has also been found to be modulated by neurotransmitters such as 
dopamine (Gilbert et al., 2006; Korchounov et al., 2007; Ziemann, Bruns, et al., 
1996), the contribution such neurotransmitters make to GABAergic 
neurotransmission is complex (see (Hasselmo, 1995) and beyond the scope of 
this study (Hasselmo, 1995). As a result, it is suggested that the lack of 
correlation between 3ms SICI and MRS-GABA observed in this study and others 
indicates that the primary source of MRS-GABA is unlikely to be that associated 
with GABAergic synaptic transmission, but instead most likely relates to 
concentrations of metabolic GABA and to levels of ambient extracellular GABA 
that contribute to tonic GABAergic activity and, therefore, to the GABAergic tone 
of a brain region (Rae, 2014; Stagg, 2014). 
 In a previous study, Stagg and colleagues (Stagg et al., 2011) reported a 
significant correlation between MRS-GABA concentrations and 1ms SICI slopes. It 
is important to note that the underlying physiological mechanisms for the 1ms 
SICI effect are thought to be distinct from those associated with longer ISIs such 
as the 3ms SICI effect (Cengiz et al., 2013; Fisher et al., 2002; Roshan et al., 
2003), however, the exact mechanisms underlying 1ms SICI are currently unclear. 
Some have proposed that the effects may relate to the refractory periods of 
inter-neurons (Cengiz et al., 2013; Fisher et al., 2002), whereas others have 
argued that synaptic processes may also play a role (Roshan et al., 2003; Vucic et 
al., 2009).  
Unfortunately, in this study the findings observed by Stagg et al. (2011) 
are not directly replicated and it is not fully clear why this would be. It is unlikely 
to be due to a lack of power, as the sample size used here was more than double 
that used previously (i.e., N=27 versus N=12). Similarly, it is also unlikely to be 
due to the efficacy of our TMS procedures as our 1ms SICI protocol was highly 
effective in producing effective inhibition and a 1ms SICI curve is clearly present. 
The main differences between the two studies were the nature of the MRS 
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protocol used (i.e. SPECIAL versus STEAM) and the field strength of the MR 
scanners (i.e., 3T versus 7T). Obviously it is difficult to conclude anything from a 
null effect, so at this point it is only possible to say that the previously observed 
relationship between 1ms SICI and MRS-GABA is not entirely reliable.  
MRS-glutamate and glutamine and cortical excitability  
TMS recruitment curves are thought to reflect cortical excitability more 
generally and the strength of cortico-spinal projections (Chen, 2000). However, 
different physiological processes may contribute to the TMS recruitment curve 
across the different stimulator intensities used, and various neuromodulators 
and neurotransmitters, including both GABA and Glu, may contribute to the 
effects observed (Ziemann, 2013). Furthermore, different aspects of the 
recruitment curve may relate to different mechanisms. For example, it may be 
that measures of the slope of the curve are distinct from measures of the plateau 
(Kouchtir-Devanne et al., 2012).  
Stagg et al. (2011) reported a significant correlation between cortical 
excitability, as indexed by the slope of the TMS recruitment curve, and MRS-
glutamate. This finding was not replicated in this study which in fact found quite 
the opposite, at least at first appearance. We found the plateau of the IO curve 
to be negatively correlated with Glu/tCr. We did not, however, find a relationship 
between IO curve and Glu/tCr. The most obvious differences between both 
protocols as mentioned are the differences between the sequences used to 
acquire MRS data, the scanner strength and the sample. Other possible 
explanations for the differences between these two studies may be the subtle 
differences between the protocols used for measuring TMS recruitment curves in 
each study. In this study we used a standard procedure; increasing the stimulator 
intensity in 10% increments proportional to an individual’s resting motor 
threshold. By contrast, Stagg et al. (2011) used a procedure in which the 
percentage of the intensity needed to yield an MEP of 1mV was tracked over 
time. This method ensures a similar degree of neuronal recruitment across 
participants’ mid-slope, whereas the method that we used ensures that this is 
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the case at 100% of RMT. However, it is important to note that despite these 
procedural differences, the IO curves themselves appear to be similar. In 
particular, the mean amplitude for MEPs in response to the highest stimulation 
was highly similar across both experiments (i.e., approximately 3: 3.5mV) 
indicating that the two methods were producing comparable effects. For this 
reason, we feel that the different results obtained in the two studies are unlikely 
to have resulted from procedural differences in TMS stimulation.  
At first glance our finding appears to be somewhat unorthodox, however, 
it highlights that what we are measuring with MRS (and TMS) is most probably 
not just “excitation” vs. “inhibition”. Initially a high plateau may indicate more 
excitation, in which case, we may expect more glutamate. This is simply not the 
case. Prior literature describes that the maximum plateau of a recruitment curve 
does not simply reflect the maximum output of the corticospinal system 
(Devanne et al., 1997; Houdayer et al., 2008; Kouchtir-Devanne et al., 2012). It 
may instead reflect the intrinsic balance of excitation and inhibition at M1 
(Devanne et al., 1997). Few articles discuss the cortical origins that lead to the 
plateau of a recruitment curve. One experiment shows that decreases in 
maximum plateau across different active muscle conditions is accompanied by 
reductions in SICI and LICI but not in ICF (Kouchtir-Devanne et al., 2012) and we 
have speculated that this may relate to the functional coupling between 
intracortical circuits within M1. At least one study has shown that slope and 
plateau do not always change together and that active high frequency rTMS can 
reduce plateau and increase slope (Houdayer et al., 2008), thus our findings may 
not be entirely incompatible with Stagg’s 2011 paper. Any conclusions from this 
finding can only be speculation on our part, particularly since to our knowledge 
there are no similar findings in the literature between IO plateau and glutamate 
(or any other neurometabolite). 
 A significant relationship was found between 10ms but not 12ms ICF and 
MRS-glutamate. The lack of a significant relationship with 12ms is consistent with 
the previous findings by Stagg et al (2011), however, the relationship with 10ms 
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ICF is novel as this was not measured in either of the previous TMS-MRS studies 
(Stagg et al., 2011; Tremblay et al., 2013). The mechanisms underlying ICF are 
not yet fully understood, however, ICF is generally thought to test the excitability 
of an excitatory neuronal motor network which is likely to be modulated by both 
glutamatergic and GABAergic mechanisms (Ziemann, 2013). ICF can be measured 
using ISIs of 7-20ms (Kujirai et al., 1993; Vucic et al., 2006) and although this is a 
relatively large range of effective ISIs, to our knowledge no clear distinction has 
been drawn between these parameters (unlike SICI). Therefore, although the 
results suggest support for the experimental hypothesis, further study and 
replication of this effect is warranted to draw strong conclusions about this 
relationship.  
Finally, it was demonstrated that individual MEP amplitudes were 
predicted by a linear combination of the ratios of glutamine/glutamate and 
GABA/glutamate. Glutamate exists in several metabolic pools in the brain and 
these pools serve as the source of glutamate for neurotransmission. Also, there 
is a balanced cycling between glutamate and glutamine that is essential for the 
normal operation of brain functions and the levels of these neurometabolites are 
highly correlated with one another in the healthy brain (Rae, 2014). Specifically, 
glutamate removed from the synaptic cleft is converted to glutamine within 
astrocytes and astrocyte-derived glutamine is then used as a precursor for the 
synthesis of glutamate or GABA within neurons. This cycling of glutamate and 
glutamine between cell types in the brain is highly dynamic and is thought to 
account for 80% of cerebral glucose consumption (Ramadan et al., 2013). For this 
reason it is very likely that TMS-induced changes in cortical excitability may be 
indexed by subtle changes in the balance between glutamate and glutamine.  
 
Effects of Gabapentin on TMS measures 
GBP was not found to significantly alter any of the TMS measures when 
compared with the placebo group. This was somewhat surprising as based on the 
previous literature (Rizzo et al., 2001; Ziemann, Lonnecker, et al., 1996) it was 
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expected that GBP would significantly increase SICI, and reduce ICF.  To our 
knowledge, this study is the first to use a double blind, sham controlled method 
to investigate the effects of GBP on TMS measures. This study also appears to be 
the first not to show a clear effect of GBP on TMS measures. It is not entirely 
clear why the present study failed to replicate previous findings, although it is 
possible that subtle differences between experimental designs may have 
contributed.  
Power seems an unlikely reason for the lack of observable effects, as our 
sample was substantially larger (N=15) than the first experiment conducted by 
Ziemann, Lonnecker, et al. (1996) (N=6) and slightly larger than that used by 
Rizzo et al. (2001) (N=11). Drug dosage also seems an unlikely reason for the lack 
of effects, as, although this study used a 900mg dose which was lower than that 
use by (Ziemann, Lonnecker, et al., 1996)(1200mg) it was higher than the 800mg 
used by Rizzo et al. (2001).  
Another possible reason for the lack of replication may be the timing 
between drug uptake and TMS measurement. On average the second TMS 
measurements were taken 3 hours after receiving GBP, however, this ranged 
from 2.36-3.25 hours between participants. In their study Rizzo et al. (2001) 
found increased SICI and decreased ICF 3 hours after participants received an 
800mg dose of GBP. This may suggest, that in this study the duration for drug 
uptake may have been too short for some individuals. However, Ziemann, 
Lonnecker, et al. (1996) found significant effects of SICI and ICF after just 2 hours. 
Unfortunately, as different doses and timings were used in all studies it is not 
possible to draw strong conclusions about the lack of effects seen here. If a 
similar study were to be conducted again it would be interesting to measure 
effects over a number of time points to map the time course of GBP and its peak 
effects.  
Pearson’s correlational analysis was used to explore any impact baseline 
may have on subsequent change in TMS measures. Although baseline was 
significantly correlated with measures including 1ms SICI slope and 10ms ICF, 
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these correlations were present for both GBP and control groups.  The pattern of 
results and the finding of similar correlations in both conditions strongly suggest 
a regression to mean type effect, and provides no further explanation for the 
lack of observable GBP effects on TMS measures.   
Effects of GBP on MRS measures 
Contrary to previous findings (Cai et al., 2012; Kuzniecky et al., 2002; 
Petroff et al., 1996) GBP did not significantly alter levels of MRS-GABA.  As was 
the case with the TMS measurements it is possible that the lack of replication in 
this study reflects the timing of the measures.  Approximately 2 hours elapsed 
between drug intake and scanning in this study, however, this ranged from 1.45-
2.23 hours. Interestingly, although Cai et al. (2012) found significantly elevated 
GABA levels 2.5 hours after drug uptake, similar effects were only found 6, but 
not 3 hours after intake by Kuzniecky et al. (2002).  Although the studies differ in 
a number of ways including the field strengths used to collect MRS data and the 
amount of gabapentin given to participants, these findings both suggests that 2 
hours may have been too early to see effects.  
In order to explore the potential effect baseline GABA levels may have on 
subsequent levels of change correlational analyses was conducted.  A significant 
correlation was found between baseline and subsequent % change following GBP 
(Figure 7.8) but not placebo (Figure 7.9). The correlation between baseline and 
change in GABA following GBP was also reported by Cai et al. (2012). However, 
unlike the relationship found by Cai et al. (2012) not all participants showed a 
percentage increase in GABA; in fact, some of those with higher baseline GABA 
levels showed a percentage decrease in the second MRS measurement. It is not 
entirely clear why this would be so, and although speculation regarding 
homeostatic mechanisms or regression to mean are possible, without further 
testing these explanations would be superfluous.     
There are a number of similarities between the present studies design 
and that used by Cai et al. (2012) including performing the study at 7T and using 
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a 900mg dose of gabapentin. However, there also remain a few key differences 
between the two. One potentially important difference is that in their study Cai 
et al. (2012) tested only male participants. The decision to do so appears to be 
related to previous findings that females show more variability in GABA level 
(Epperson et al., 2006), which can be particularly elevated during certain times of 
the menstrual cycle. Given the correlation between GABA level and increase 
following GBP (Cai et al., 2012) it could be that effects in females may be smaller 
if measured during such a time when GABA levels are elevated. Our sample size 
is too small to make strong claims about the potential differences between 
sexes, however, comparison of the percentage of change in GABA following GBP 
for males (N=7) and females (N=7) revealed no clear differences (data not 
shown). In addition to this the changes in MRS-GABA were found by Kuzniecky et 
al. (2002) whose participant sample include both males and females.  
Another difference between this study and those previously conducted, is 
that participants were able to eat immediately following drug consumption. 
Although this may seem problematic, there is little evidence that gabapentin 
absorption is negatively influenced by food. In fact, some studies have even 
found that foods with higher levels of protein such as a milk based breakfast 
option (Gidal et al., 1996) and chocolate pudding (Gidal et al., 1998) have been 
found to moderately enhance absorption. Nevertheless, it is true that 
participants did not consume exactly the same food so it cannot be ruled out 
that this increased variability within the effects.   
 The aims of this study were two-fold. Firstly, we aimed to investigate how 
levels of key neurometabolites (i.e., glutamate, glutamine and GABA) relate to 
TMS measures of cortical excitability and physiological inhibition (i.e., TMS 
recruitment curves, ICF and SICI). The results of this study reveal mixed support 
for the previous findings thus reported in the limited number of studies which 
have explored this relationship. Specifically, it was found that 3ms SICI and MRS 
measured GABA are uncorrelated. These findings appear to be consistent with 
the view that the GABA concentrations measured using MRS largely represent 
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pools of extracellular GABA that are linked to tonic rather than phasic inhibition 
and thus contribute to the inhibitory tone of a brain area rather than GABAergic 
synaptic transmission (Rae, 2014; Stagg, 2014). 
 The secondary aim of the study was to explore the effects GBP may have 
on TMS and MRS measures using a double blind, sham controlled design. The 
results showed no clear effects of GBP on either TMS or MRS measures and did 
not replicate previous findings. Although there is no clear, singular reason why 
GBP did not influence our TMS and MRS measures, it is possible that the 
duration between drug uptake and measurement was too short for clear effects 
to be observed. This may be particularly true for MRS measurements.  
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 General discussion 
 
Key words: transcranial direct current stimulation (tDCS), transcranial magnetic 
stimulation (TMS), magnetic resonance spectroscopy (MRS), Gilles de la 
Tourette’s syndrome, variability, reliability, therapy.  
 
The primary aim of this thesis was to explore the effects of tDCS and its 
therapeutic potential in the treatment of Tourette’s syndrome. A secondary aim 
of the thesis was to explore what is being measured with MRS, with particular 
reference to the inhibitory neurotransmitter GABA.  
In this chapter the key findings from each of the preceding experimental 
chapters will be discussed and reviewed. For clarity, they will be organized under 
the following titles: tDCS effects in neurologically typical individuals (Chapters 3 
and 4), tDCS effects and Tourette’s syndrome (Chapters 5 and 6) and exploring 
the origins of MRS measured GABA (Chapter 7). General conclusions and 
limitations of the work presented in this thesis will also be discussed.   
8.1 tDCS effects in neurologically typical individuals 
 
In Chapter 3 the time course of 1mA and 2mA tDCS effects were explored 
using TMS. Based on the general consensus of past literature, it was expected 
that 1mA anodal stimulation would produce an increase in cortical excitability (as 
indicated by increased MEP amplitudes), whereas, 1mA cathodal stimulation 
would produce a decrease. The predicted outcome of the 2mA condition was less 
well defined, due to more recent findings suggesting non-linear effects following 
2mA cathodal stimulation (Batsikadze et al., 2013).  
The initial aim of the study was to identify the optimal stimulation 
parameters for altering cortical excitability, with the hope that these could then 
be used to inform parameter selection in subsequent work. It was also hoped 
that the study would identify the time course of the effects and that this would 
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help inform when best to measure any therapeutic outcomes. Disappointingly, 
the results of the study failed to provide clear answers to either of these 
questions. 1mA stimulation was not found to significantly alter cortical 
excitability (as measured by TMS IO curves) in either anodal or cathodal 
conditions at any of the time points measured. The effects of 2mA tDCS were 
also disappointing, and only revealed one small effect of increased excitability 90 
minutes following anodal stimulation. 2mA cathodal stimulation did not 
significantly increase excitability, consequently, the study by Batsikadze et al. 
(2013) remains the only one which has reported this effect. 
 What was most apparent in Chapter 3 was the large amount of variability 
which occurred between participants in response to stimulation, even in 
conditions when a significant group level effect was found. At the time of 
conducting this research it became apparent that others were also experiencing 
high levels of variability within their own data (Wiethoff et al., 2014) and that the 
well accepted pattern of tDCS effects was starting to be questioned.  
In Chapter 4, I aimed to explore this variability using a variety of TMS 
measures. I was particularly interested in exploring the stability of tDCS effects 
within individuals, as finding intra-subject stability would suggest the possibility 
that anatomical features such as skull-cortex distance could be used to 
individualise stimulation parameters. In addition to this, if intra-subject stability 
were found, it may become possible to identify responders/non responders in a 
single pre-testing session. However, this was not to be.  
Despite making improvements to the experimental design used in Chapter 
3 (such as using anatomical brain scans for accurate TMS coil localization), no 
significant effects were found in TMS measures taken immediately after 2mA 
cathodal stimulation. Analysis of intra-subject reliability using interclass 
correlation coefficients (ICC) revealed poor inter-subject reliability across the 
four sessions tested. This was true of changes from baseline in IO curve, SICI and 
ICF measures. 
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The results of the 2mA anodal condition were more promising. At a group 
level there was a significant increase in IO curve measures, and some evidence of 
significant changes in 3ms SICI after stimulation. The increase in IO curves after 
anodal tDCS replicated previous findings (Nitsche & Paulus, 2000; Nitsche et al., 
2005), however, the 3ms SICI results were less clear. Although SICI was found to 
decrease after anodal stimulation in the majority of the 4 sessions, significant 
effects between baseline and post stimulation were only found for 2 of the 4 
sessions. Somewhat surprisingly, in one session the effects on 3ms SICI appeared 
to be reversed, revealing a significant increase after 2mA anodal stimulation, 
however, this can largely be accounted for by methodological issues relating to 
differences in test pulse intensity. Consequently, although the findings highlight 
the importance of vigilance when measuring SICI, the results were not in direct 
conflict with previous work in which SICI was reduced after anodal tDCS 
(Batsikadze et al., 2013; Kidgell et al., 2013; Nitsche et al., 2005). Hence the IO 
curve and SICI results largely support the previously reported findings that 
anodal tDCS increases overall cortical excitability, which may in part be mediated 
by a reduction in GABA.   
The findings of ICC analysis revealed that despite significant group level 
effects on IO curves these changes were unreliable within individuals across the 
different testing sessions. ICC analysis also revealed poor reliability for changes in 
3ms SICI, which conflicts with the previous findings of Lopez-Alonso et al. (2015). 
It is possible that the variability found in this measure could reflect 
methodological differences, although it should also be noted that Lopez-Alonso 
et al. (2015) failed to find any significant changes in SICI measures. 
Key findings from Chapters 3 and 4 
 To summarize, the findings of the experiments discussed in Chapters 3 
and 4 reveal some difficulty in replicating findings of tDCS induced changes in 
cortical excitability. In particular, both studies failed to find evidence of 
significant change in excitability following cathodal stimulation. Furthermore, the 
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studies revealed high levels of both inter and intra subject variability, even when 
group effects were significant.  
 
8.2 tDCS effects and Tourette’s Syndrome 
 
In Chapter 5 I aimed to explore the potential of tDCS to reduce tics in 
individuals with Tourette’s syndrome. Gilles de la Tourette’s syndrome (GTS) is a 
neurodevelopmental condition characterized by the presence of motor and 
phonic tics which occur for a minimum of 1 year (Leckman, 2002). These tics can 
be embarrassing, socially alienating and physically harmful, and can start to 
become apparent in children as young as 3 years old  (Leckman et al., 1998). The 
treatment options available for individuals with GTS are limited, and while 
behavioural interventions such as habit reversal training (HRT) do exist, they may 
not be accessible to all. Consequently, many individuals with GTS take 
medications including forms of antipsychotics, which may have a number of 
undesirable side effects (Kurlan, 2014). Of those taking medications many will be 
children, as tics are often at their worst when individuals are 10-12 years old 
(Bloch & Leckman, 2009). This makes it particularly pertinent that alternative 
avenues of treatment are explored, one of which may be the development of 
non-invasive brain stimulation techniques (NIBS) such as tDCS.  
Two small scale studies have reported significant reductions in tics 
following repeated sessions of cathodal stimulation (Carvalho et al., 2015; 
Mrakic-Sposta et al., 2008). These results are promising, however, the sample 
sizes in these studies were particularly small, and the findings limited to the 
effects of prolonged applications of stimulation. Therefore, despite disappointing 
results in healthy individuals regarding cathodal stimulation effects (Chapters 3 
and 4), I chose to extend the previous findings of others using a sham controlled 
design in which the immediate effects of tDCS were assessed using video 
recordings/ tic counts and TMS.  
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Although I had previously failed to find significant cathodal effects, I felt 
that methodological differences such as participant sample, outcome measures 
and stimulation site may result in different findings than those reported in 
Chapters 3 and 4. Disappointingly this was not to be, and no clear differences 
were observed between the sham and cathodal conditions in any measure.  
Analysis of the TMS data (both IO curves and SI1mv) revealed no significant 
change in cortical excitability following either sham or cathodal tDCS. These 
results may appear to replicate the lack of cathodal effects seen in Chapters 3 
and 4, however, one important methodological difference should be considered. 
Unlike the previous experiments, stimulation was applied to the SMA rather than 
directly to M1. Although work using TMS had demonstrated that stimulation to 
SMA can influence MEPs derived from M1 (Arai et al., 2012; Civardi et al., 2001; 
Oliveri et al., 2003) it may be that tDCS effects are simply too weak to do so. 
Furthermore, without individualized models of current flow it is not possible to 
know if tDCS had any direct influence on M1. As a result, although the findings 
yet again failed to show reduced cortical excitability following cathodal 
stimulation they are not directly comparable to those discussed in Chapters 3 
and 4.  
The lack of change in the amount of tics counted in the video data was 
particularly disappointing, as this was a far more direct measure of clinical 
outcome. However, significant changes in such measures have only previously 
been reported after prolonged periods of stimulation which are repeated over a 
number of days (Carvalho et al., 2015; Mrakic-Sposta et al., 2008). Therefore, it is 
possible that a single session of tDCS may not be enough to cause any clear 
effects on such a complex phenomenon as tics.  
In Chapter 6 an in-depth, sham controlled case study was presented in 
which the effects of 10 day tDCS applications (sham, 1mA and 1.5mA) were 
explored using a variety of measures.  This study not only tested the potential of 
tDCS to reduce tics, but also explored the feasibility of home use stimulation. 
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This posed a number of challenges, in particular with regard to data collection 
using video recordings.  
In phase 1 of the study a clear decrease in impairment scores measured 
using the YGTSS questionnaire was found. Although there was a decrease from 
baseline after 10 sessions of 1mA cathodal stimulation, there was also a decrease 
in the sham condition. Furthermore, the subscales of the YGTSS which relate 
specifically to motor and phonic tics did not show a clear reduction. The results 
of the 1.5mA cathodal intervention appeared to be far more successful. Scores 
on the YGTSS clearly reduce compared to baseline, including scores on the motor 
tic aspect of the measure. Following the 1.5mA cathodal intervention, the 
participant also reported experiencing positive effects which were far beyond 
those reported after sham and 1mA conditions.  
The video data failed to show any clear changes from baseline in the 
amount of tics counted during either the 1mA or 1.5mA interventions. Although 
this is disappointing and does not reflect the previous findings reported by 
Mrakic-Sposta et al. (2008), there remains a strong possibility that this was the 
result of a number of methodological issues caused by the home video data 
collection. If true, this may explain the discrepancy between the findings from 
the video data and the findings from the questionnaires.  
The results of the imaging data revealed widespread change in resting 
state connectivity, including between the baseline and post sham stimulation 
scans. As a result, it is difficult to interpret which changes between regions were 
the result of the cathodal stimulation. Nevertheless, a number of regions within 
the cerebellum were found to have significantly altered levels of connectivity 
from baseline in the scans taken shortly after 10 days of 1mA cathodal 
stimulation and 1 month later. These regions were not found to significantly alter 
in the sham condition. The cerebellum has been implicated in a number of 
studies exploring the neurophysiology of GTS (Bohlhalter et al., 2006; Lerner et 
al., 2012; McCairn et al., 2013; Pourfar et al., 2011; Tobe et al., 2010) and work 
by Carvalho et al. (2015) saw a decrease in this region following 10 sessions of 
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cathodal stimulation. This may suggest tDCS induced changes within the region, 
although it is clear that more comprehensive studies would be needed to 
confirm this. Unfortunately, the scans in phase 2 did not fully capture the 
cerebellum, although a number of significant differences were found between a 
second baseline condition and after 1.5mA tDCS applications.  
Although collecting data outside of the laboratory using video recordings 
proved difficult, compliance with tDCS application was good and none of the 30 
stimulation days were missed.  With regard to side effects the participant did 
report mild nausea and mild headache after stimulation, however, assessment of 
their personal notes revealed that this was no different in the sham and active 
condition during phase 1. In phase 2 daily notes were not recorded, however, the 
participant was told to inform the experimenter of any effects that they were 
concerned about; nothing was reported. The successful application and remote 
supervision of home use tDCS echoes the findings of a recent study by Kasschau 
et al. (2016)  which also found good compliance and adherence to treatment 
regimes in 20 participants when remote supervision was provided. This is 
particularly promising for tDCS, as it suggests that home use is a viable option.       
Key findings from Chapters 5 and 6 
 The results in Chapter 5 suggest that a single session of 1mA cathodal 
tDCS applied to the SMA is not sufficient to have an effect on tics in the period 
shortly after stimulation. Furthermore, the stimulation was not found to have 
any distinct effects on cortical excitability as measured by MEPs. Although the 
results are somewhat discouraging, it may be that a single session of stimulation 
is simply not enough to influence complex behaviours such as tics.  
The effects of repeated applications of cathodal tDCS were explored in 
Chapter 6 with some success. Although the results of the different measures 
were conflicting, the participant’s self-report of symptoms and the results from 
the YGTSS suggest that for this participant repeated sessions of 1.5mA cathodal 
tDCS may be beneficial in reducing tics. The imaging analysis also revealed 
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distinctive changes in regions of the cerebellum which were present after 1mA 
cathodal but not sham stimulation. Although the therapeutic outcomes of the 
case study are less clear than previous work (Carvalho et al., 2015; Mrakic-Sposta 
et al., 2008) the study does successfully demonstrate how home use of tDCS 
under remote supervision is possible.  
8.3 Exploring the origin of the MRS-GABA signal and the 
effects of Gabapentin  
 
A secondary aim within this thesis was to explore exactly what is being 
measured using MRS, particularly with reference to GABA. MRS is a useful tool 
which has been used to explore the biological basis of tDCS effects (Stagg et al., 
2009) and also to enhance understanding of the underlying neurobiology of GTS 
(Draper et al., 2014; Puts et al., 2015). However, the findings of such studies are 
limited by a lack of understanding regarding exactly where the MRS-GABA signal 
originates from. 
In Chapter 7, MRS-measured GABA and other metabolites were explored 
using TMS. The effects of gabapentin (GBP) were also explored. In line with 
previous studies (Stagg et al., 2011; Tremblay et al., 2013) there was no 
significant relationship between baseline MRS-GABA and later phases of SICI 
(thought to be primarily GABA-A receptor mediated (Ziemann, 2008)). This 
suggests that the primary source of MRS-GABA is not dependent on GABAergic 
synaptic transmission, instead it is more likely to reflect ambient extracellular 
levels of GABA which relate to tonic GABAergic inhibition.  
Unlike the findings in Stagg et al. (2011) baseline levels of MRS-GABA did 
not significantly correlate with 1ms SICI. The underlying mechanisms of 1ms SICI 
are somewhat unclear, and it is not fully apparent why this discrepancy between 
studies occurred. One possibility is that the use of different MRS protocols 
contributed, however, without directly comparing the sequences this can be 
nothing more than speculation.  
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The findings of MRS-Glu were somewhat mixed when compared with 
findings reported in the previous literature. Levels of MRS-Glu were found to 
significantly correlate with the plateau of the IO curve. However, unlike the 
findings of Stagg et al. (2011), no relationship was found between this measure 
and IO curve slope. Furthermore, although 12ms ICF was not found to be 
significantly related to MRS-Glu as found by Stagg et al. (2011), 10ms ICF was. As 
of yet no distinctions have been drawn between the mechanisms underlying 12 
and 10ms ICF, however, it remains possible that subtle differences between 
them may exist. Further exploration and replication would be needed to confirm 
this finding.  
Interestingly, despite in-depth exploration of the data, GBP failed to 
significantly alter either MRS or TMS measures. It is largely unclear why these 
findings reported in Chapter 7 differ to previous work exploring the effects of 
GBP (Cai et al., 2012; Kuzniecky et al., 2002; Rizzo et al., 2001; Ziemann, 
Lonnecker, et al., 1996). In the case of MRS, it could be that insufficient time was 
allowed between drug uptake and scanning to allow effects to be seen. However, 
the duration between drug administration and TMS measures was similar to 
Rizzo et al. (2001) and longer than Ziemann, Lonnecker, et al. (1996) ; therefore 
timing is an unlikely explanation for the lack of effects.  
Key findings from Chapters 7 
  Despite using a larger sample size than Stagg et al. (2011),  a relationship 
between 1ms SICI and MRS-GABA was not found. It is possible that this reflects 
differences in the scanning sequences used, nevertheless, it suggests that at best 
the relationship is unreliable and in need of further exploration.  
Although the findings differ slightly from previous work conducted by 
Stagg et al. (2011) and Tremblay et al. (2013), they are largely in agreement with 
the previous assertion that MRS measures pools of extracellular GABA. These 
pools of GABA are linked to tonic rather than phasic inhibition and thus 
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contribute to the inhibitory tone of a brain area rather than GABAergic synaptic 
transmission. 
 In light of previous work (Cai et al., 2012; Kuzniecky et al., 2002; Rizzo et 
al., 2001; Ziemann, Lonnecker, et al., 1996), it was surprising to find that GBP 
failed to influence either TMS or MRS measures. While the lack of change in MRS 
may reflect a timing issue, the timings of the TMS measures reflects those used 
in previous work (Rizzo et al., 2001; Ziemann, Lonnecker, et al., 1996). 
Furthermore, as this study was sham controlled and with a far larger sample than 
that used in previous TMS studies (Rizzo et al., 2001; Ziemann, Lonnecker, et al., 
1996), this raises questions regarding the ability of GBP to truly influence these 
measures. Hence raising questions about the underlying mechanisms of GBP.  In 
order to investigate the effects of GBP in more detail it may be necessary to 
include a physical measure of drug uptake (such as blood samples) which could 
be used to verify that enough time had elapsed and a suitable dose had been 
delivered. If this method were applied it may be possible to not only enhance 
understanding into the effects of the drug, but also to explore the origin of the 
MRS-GABA signal – in particular if a discrepancy between TMS and MRS results 
were identified.  
8.4 Limitations and suggestions for future research 
 
One of the fundamental problems with tDCS is that unlike TMS there is no 
established method for individualising and optimising stimulation parameters. In 
Chapters 3, 4, 5 and 6, the selection of stimulation parameters was based upon 
the findings of previous studies; these parameters were then used for all 
participants without exception. Although this is common practise within tDCS 
research, it is far from ideal. It is highly possible that this issue contributes to 
some of the inter-subject variability found in response to tDCS, which has been 
reported in this thesis and in the work of others (Labruna et al., 2016; Wiethoff 
et al., 2014).  
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It is becoming increasingly important that future tDCS research addresses 
the cause of inter-subject variability, as this may help to identify markers which 
could be used to predict responses. This could be particularly helpful in 
identifying individuals who may benefit therapeutically. Recently, associations 
between sensitivity to TMS measures and response to tDCS have been identified 
(Labruna et al., 2016; Strube et al., 2016; Wiethoff et al., 2014), although the 
results are not always synonymous. For example, Wiethoff et al. (2014) found a 
correlation between baseline MEP amplitude (in response to SI 1mV stimulation) 
and tDCS induced change. Specifically, individuals with smaller MEP amplitudes 
were found to be more prone to show increased cortical excitability following 
anodal or cathodal tDCS. Whereas Strube et al. (2016) found the opposite to be 
true. Interestingly, a recent study by Labruna et al. (2016) found that higher 
sensitivity to TMS (as indexed by lower thresholds for SI1mv) was related to 
larger MEP enhancement following anodal but not cathodal stimulation. These 
finding suggest that it may be possible to use TMS to predict responses to tDCS, 
although it is clear that further research is needed.  
Integrating computational modelling into future tDCS studies may help to 
optimise the selection of stimulation parameters with regard to electrode 
placement. It is known that differences in anatomical structure have critical 
effects on current flow (Bikson et al., 2012; Datta et al., 2012), and it has already 
been shown that subject-specific modelling can facilitate more effective use of 
tDCS (Datta et al., 2012). The utilization of such models is not yet commonplace 
in tDCS research, however, as more evidence amounts of their efficiency, they 
could prove a particularly useful tool with regard to the therapeutic use of the 
technique.  
In Chapter 4, high levels of intra-subject variability were found in response 
to 2mA tDCS. This poses another potential issue for the technique as it suggests 
that causes of variability may go beyond anatomy. For example, it may be that 
transient changes in cortical excitability and neurotransmitter levels also 
influence the effect. If so, this could make identifying individuals who may 
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benefit from the stimulation particularly difficult. However, it may also be that 
the methodological issues between different testing sessions contribute to 
findings, hence revealing more variability than there truly is. Replication of 
results and the use of multimodal techniques will be important in answering 
these questions. Furthermore, this may help to understand why some studies 
such as Lopez-Alonso et al. (2015) reported acceptable levels of intra-subject 
stability whereas Horvath et al. (2016) and the research reported in Chapter 4 
did not.  
The need to develop a multi-modal approach to investigate the biological 
underpinnings of tDCS is highlighted by the fact that the exact method used to 
measure the effects is likely to influence the outcome. For example, although 
TMS IO curves are thought to index global cortico-spinal excitability (Abbruzzese 
& Trompetto, 2002; Devanne et al., 1997) which is supposedly influenced by 
tDCS, a number of studies have now failed to find clear effects using IO curves 
(Batsikadze et al., 2013; Strube et al., 2016) despite finding significant changes in 
MEP amplitude when using SI 1mV. It is unclear exactly why this may be, 
however, the amount of TMS pulses given and the intensity at which these occur 
are possible explanations. This may explain why 2mA anodal tDCS was not found 
to significantly alter IO curves immediately after stimulation in Chapter 3, but did 
so in Chapter 4 in which higher TMS intensities were used.  
Methods such as MRS may be useful in providing a different perspective on 
tDCS. For example, significant alterations in MRS-GABA have previously been 
reported following tDCS (Kim et al., 2014; Stagg et al., 2009).  Based on the 
findings of Chapter 7 and those reported by Stagg et al. (2011) and Tremblay et 
al. (2013), it seems that MRS measures pools of extracellular GABA.  Hence, 
when combined with the wide ranging evidence that SICI is also altered by tDCS 
(Batsikadze et al., 2013; Cengiz et al., 2013; Kidgell et al., 2013; Nitsche et al., 
2005) it can be concluded that the effects of tDCS on GABA are widespread and 
not restricted to change at the synapse. MRS could prove useful in exploring 
intra-subject variability following stimulation. For example, tDCS induced 
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changes in neurotransmitter levels could be measured multiple times in the 
same individual (as in chapter 4). The results of this could then be used to 
confirm or refute that the lack of intra-subject stability found in Chapters 4 and 
by Horvath et al. (2016) was the result of methodological issues pertaining to the 
TMS protocols.  
To summarise, the main limitations of the work presented in this thesis are: 
 Limited ability to generalize findings of Chapters 3, 4, 5 and 6. It is likely 
that altering tDCS parameters (intensity, duration or electrode 
placement) would also alter the effects found. 
 Dependence on TMS alone to measure tDCS effects in Chapters 3 and 4. 
In Chapter 3 it is possible that changes in cortical excitability were missed 
due to inadequate outcome measures.  
 Issues with parameter selection and the lack of individualised protocols. 
The necessary stimulation parameters to cause significant physiological or 
behavioural change are likely to differ from person to person. This is 
apparent in Chapter 6, in which 1.5mA stimulation appeared to be more 
effective than 1mA.  
Future work should aim to: 
 Increase understanding of factors which may cause the inter and intra- 
subject variability often reported in tDCS studies.  
 Use multi-modal techniques to explore factors which may predict an 
individual’s response to tDCS. This is critical to developing methods 
which allow stimulation parameters to be tailored to each individual. 
This is likely to be an important step in improving efficiency and 
therapeutic outcomes.  
 Replicate previous findings and publish failures to replicate. This may be 
particularly important with regard to the effects of cathodal stimulation.  
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8.5 Conclusions 
 
tDCS effects proved to be more elusive than initially expected, and over the 
course of this thesis it became apparent that developing tDCS as an effective 
therapeutic intervention may be far more complex than initially anticipated.  
The findings in Chapters 3 and 4 suggest that although a number of studies 
have reported significant reductions in cortical excitability following cathodal 
stimulation (see Table 2.1), these effects are unreliable at best and can be 
difficult to replicate.  In Chapter 4, it was found that while 2mA anodal tDCS did 
successfully increase cortical excitability at a group level, there was substantial 
inter and intra-subject variability. This finding makes important contributions to 
the current literature and raises some real questions regarding the use of the 
technique and the reporting of experimental findings.  
The findings in Chapter 5 suggest that a single session of cathodal tDCS 
applied to the SMA has no clear effects on tics in individuals with Tourette’s 
syndrome. This is a novel finding, and suggests that the previous reports of tic 
reduction following stimulation (Carvalho et al., 2015; Mrakic-Sposta et al., 2008) 
are the result of accumulative tDCS effects. The findings in Chapter 6 offer some 
support for this hypothesis, as there was evidence of a meaningful reduction in 
tics after 10 days of 20-minute cathodal stimulation delivered at 1.5 mA. The 
findings in Chapter 6 also highlight the need to optimise stimulation parameters 
for each individual, as the effects following 1mA were not that distinctive from 
the sham condition.  
In Chapter 7, evidence was found which supports the previous assertion 
that MRS-GABA reflects extra-synaptic GABA tone (Stagg et al., 2011; Tremblay 
et al., 2013). The study also highlighted a number of interesting relationships 
between TMS and MRS measures, and raised some interesting questions 
regarding the ability of gabapentin to raise GABA levels in healthy participants.  
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To conclude, the field of non-invasive stimulation continues to grow and a 
substantial amount of progress has been made in recent years. The once widely 
held assertions of tDCS effects are recently being challenged, and it is being 
found that cathodal tDCS does not always reduce cortical excitability. 
Furthermore, recent work has focused on discussing and unpicking variability 
found in individual responses to the stimulation. The work presented in this 
thesis, contributes to this and suggest that the technique and its effects are far 
more variable and difficult to predict than might initially be expected. Despite 
this, the findings in Chapter 6 show that although tDCS effects may be variable, 
repeated applications of cathodal stimulation may still be effective in reducing 
tics in Tourette’s syndrome. Furthermore, the findings highlight that application 
of tDCS outside of the lab is possible with remote supervision. Although more 
work is clearly needed, tDCS has proved that it still has therapeutic potential, and 
perhaps with a little more research this potential will finally be reached.  
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Appendices 
Appendix i:  Effects of tDCS on MEPs (Ch.3) 
Repeated measures ANOVAs in which time and intensity served as within 
subject’s factors with 5 and 8 levels respectively. The analysis was run separately 
for each tDCS parameter (anodal, cathodal or sham, at 1mA or 2mA) to allow for 
in-depth exploration of changes from baseline.   Significant effects were further 
analysed using students t-tests (paired samples, two tailed, p<0.05). The 
Greenhouse-Geisser correction was used to correct for significant violations of 
sphericity.  
 
Polarity Factor d.f F P p² 
Anodal 1mA Time 2.45 .88 .44 .05 
 Intensity 1.27 29.6 .00* .64 
 Time*Intensity  2.91 .62 .60 .04 
Cathodal 1mA Time 2.35 1.3 .29 .07 
 Intensity 1.23 35.72 .00* .68 
 Time*Intensity  4.74 1.17 .33 .06 
Sham 1mA Time 2.52 .8 .48 .05 
 Intensity 1.40 40.56 .00* .71 
 Time*Intensity 5.55 .93 .48 .05 
Anodal 2mA Time 4 2.48 .05* .15 
 Intensity 1.33 40.22 .00* .74 
 Time*Intensity  5.39 2.46 .04* .15 
Cathodal 2mA Time 4 1.34 .27 .09 
 Intensity 1.37 48.01 .00* .77 
 Time*Intensity  5.2 .87 .51 .06 
Sham 2mA Time 2.08 1.69 .20 .11 
 Intensity 1.31 29.95 .00* .68 
 Time*Intensity 3.35 1.37 .26 .09 
 
Uncorrected paired samples t-tests were used to examine the significant 
interaction found for the 2mA anodal condition. At 130%RMT significant 
differences emerged between baseline (M=2216.71, SD=968.35) and 30 minutes 
post stimulation (M=3386.85, SD=2138.46) t=-2.758, p=.02; and also between 
baseline (M=2216.71, SD=968.35) and 60 minutes (M=3044.53, SD=1902.35), t=-
2.62, p=.02. No significant differences were found between baseline and 0 
minutes or baseline and 90 minutes after stimulation. No significant differences 
were found for lower intensities.  
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Appendix ii: Individual variability & 2mA anodal tDCS (Ch. 3) 
Although the results of the ANOVA suggest that 2mA anodal stimulation 
significantly increased MEP amplitudes 30 and 60 minutes following stimulation, 
there was substantial variability even within this condition. Figure below shows 
normalized MEP values from the 130% condition for each individual following 
2mA anodal stimulation.  
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Appendix iii: Effects of tDCS on raw IO curve slope (Ch. 3) 
Raw values from linear fitting were entered in to separate repeated 
measures (rm) ANOVAs, in which time was also included as an independent 
factor. Post hoc analysis were conducted using students t-tests (paired samples, 
two tailed, p<0.05). When necessary the Greenhouse-Geisser correction was 
applied.  
Rm ANOVAs revealed no significant effect of time for 1mA anodal tDCS 
F(2.17,38.92)=.246, p=.801. 1mA cathodal tDCS also failed to significantly alter 
slope at any time point, F(2.08,35.39)=1.234, p=.30; as did sham stimulation  
F(4,68)=.74, p=.57.  
Rm ANOVA revealed a significant effect of time in the 2mA anodal 
condition F(4,56)=4.28, p=.00. Uncorrected paired samples t-tests revealed a 
significant increase in IO curve slope at 30minutes post tDCS when compared to 
baseline t(15)= 2.37, p=.03. A significant increase 60minutes following tDCS was 
also apparent t(15)=2.46, p=.03. Time was did not significantly alter slope 
following cathodal F(4,56)=.26, p=.62 or sham stimulation F(2.05,28.67)=3.16, 
p=.31.   
To allow the different measures to be compared more directly the 
ANOVAs were run again with tDCS polarity included as a factor. No significant 
differences were found between baseline slopes in the 1mA conditions (all 
t=<1.89, all p>0.08). No significant effects were revealed – see table below. 
 
 
 
No significant differences between baseline slopes were found between 
the 2mA conditions (all t=<1.72, all p=>.28).  No significant effects of polarity 
were found, however, there was a significant main effect of time F(4,56)=2.82, 
p=0.34. This appears to be driven by an increase in slope from baseline at 
30minutes post stimulation (t(45)=2.29, p=0.03) and also a significant increase in 
slope from baseline at 60minutes (t(45)=2.48, p=0.2).  
 
 
  
Factor df F P 
Polarity 2,34 .64 .53 
Time 2.04 1.02 .37 
Polarity*Time  4.04, 68.61 .6 .67 
Factor df F P 
Polarity 1.4,19.76 .19 .75 
Time 4,56 2.82 .03* 
Polarity*Time 4.26,59.64 .891 .480 
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Appendix iv: Sigmoidal fitting with IO curve data (Ch. 4) 
Four-parameter sigmoidal fits were applied to the median MEP amplitude for 
each TMS intensity (100-150%). From this fitting the maximal slope and the 
plateau of the curve were calculated. The sigmoidal function used to fit curves to 
the individual datasets was: 
MEP𝑆 = 𝑦0 +  
MEPMAX
1 + 10(𝑆50−𝑆)𝑘
 
In which MEPMAX is the maximum MEP amplitude measured, S50 is the 
TMS intensity needed to produce 50% of the maximum MEP, k is the gradient of 
the maximum steepness of the curve and y0 is the minimal MEP response, which 
was set to 0. 
In some instances sigmoidal fitting yielded higher R² values than linear 
fitting, however, it also produced some surprisingly high predictions when 
looking at estimates of plateau, and revealed a number of outliers when fitting 
slopes. Outliers were identified and removed using Grubbs test (alpha 0.01) prior 
to analysis. For Slope values this resulted in the removal of 2 data sets from 
anodal, 1 from cathodal and 4 from sham conditions. For slope plateau this 
resulted in the removal of 8 data sets from the anodal, 5 from sham and 1 from 
the sham condition.  RmANOVAs were used to explore any significant change 
over time (pre/post) and across the four different sessions tested for each tDCS 
condition (anodal, cathodal, sham). Results for slope can be seen below. 
 
 
Measurement Factor d.f F P p² 
Anodal slope  Session 3 1.03 .4 .13 
 Time 1 .24 .64 .03 
 Session*Time  3 .92 .45 .12 
Cathodal slope Session 3 .52 .68 .06 
 Time 1 .18 .68 .02 
 Session*Time  3 .57 .64 .07 
Sham slope Session 1 .32 .6 .06 
 Time 1 .05 .84 .01 
 Session*Time  1 2.32 .19 .32 
Anodal plateau Session 3 3.34 .04* .36 
 Time 1 1.97 .21 .25 
 Session*Time  1.4 1.09 .35 .15 
Cathodal plateau Session 1.36 1.72 .23 .2 
 Time 1 1.54 .26 .18 
 Session*Time  3 .18 .91 .03 
Sham plateau Session 1 .01 .92 .00 
 Time 1 .63 .45 .08 
 Session*Time  1 .45 .52 .06 
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Justification for use of linear opposed to sigmoidal fits 
Although IO curves are reportedly sigmoidal in shape (Devanne et al., 1997; Hess 
et al., 1987), this is dependent on testing a large range of intenties to capture 
both the bias level and the top plateau after which increase in MEP amplitude 
slows dramatically. The parameters used in this study (100-150% RMT) are not 
necesserily broad enough to reveal either of these factors. Although linear fits 
are not prefect, they do appear to reflect the data well.   
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Appendix v: ICC analysis for Rush (Ch. 5) 
To assess the degree of reliability between primary and secondary coders 
ICC analysis was conducted. The ICC results are reported based upon Lahey et al. 
(1983), ICC values of <0.4 are considered to indicate poor intra-class reliability, 
values >0.4 and <0.59 are fair, values >0.6 and <0.74 are good, and values >0.74 
are excellent. 
ICC analysis was first carried out using the mean rush total score, which 
was calculated by averaging the total score per minute for each of the two 
minute video segments. This revealed excellent reliability between the primary 
coder (KD) and the secondary coder (ER) ICC(2,1)=.81. The reliability between the 
primary coder (KD) and the other secondary coder (KF) was also found to be 
excellent ICC(2,1)=.92.  
 
Further analysis on the individual components of the rush scale revealed 
different levels of reliability between the primary coder (KD) and secondary 
coder (ER) which are discussed below. As with the analysis of total score the 
average score across the two minute video clips was used.  ICC analysis revealed 
fair reliability for scores on the body areas component ICC(2,1)=.462. It was poor 
for motor tic frequency ICC(2,1)=.35; excellent for phonic tic frequency 
ICC(2,1)=.85; good for motor tic severity ICC(2,1)=.68 and excellent for phonic tic 
severity ICC(2,1)=7.42.  
 
For consistency, ICC analysis was also used to assess the agreement 
between the mean amount of tics per minute counted by each coder during the 
two minute video clips. Average tic score was assessed by calculating the mean 
amount of tics over the twelve 10S time segments.  
 
ICC analysis for average total tics revealed fair reliability between primary 
coder (KD) and secondary coder (ER) ICC(2,1)=.59. Reliability between primary 
coder and second coder (KF) was found to be excellent ICC(2,1)=.97. ICC analysis 
motor tics was fair between KD and ER, ICC(2,1)=.47; and excellent between KD 
and KF, ICC(2,1)=.96. ICC analysis for phonic tic scores revealed excellent 
reliability between scores of the primary coder (KD) and the secondary coder 
(ER) ICC(2,1)=.88; and also excellent reliability between the primary coder and 
secondary coder (KF) ICC(2,1)=.96.  
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Appendix vi: Sigmoidal curve fitting (Ch. 5) 
Four-parameter sigmoidal fits (as described in Appendix iv) were applied to 
the median MEP amplitude for each TMS intensity (100-150%). From this fitting 
the maximal slope and the plateau of the curve were calculated.  
Although the slope fits were generally very good (average R² values = 0.95), 
sigmoidal fitting resulted in some significant outliers which were detected using 
Grubbs test (using an alpha level of 0.01). This resulted in the removal of one 
data set from the pre sham, and one from the post sham condition for maximal 
slope value. A further data set was removed for the plateau calculation form the 
post sham condition.  This was not an issue when linear slope fits were used.  
A repeated measures ANOVA was calculated in which time (pre/ post) and 
tDCS type (sham/ Cathodal) served as independent factors. IO curve slope was 
entered as the dependent variable. No significant effects were revealed, see 
below. 
 
 
  
Measurement Factor d.f F P p² 
Slope plateau tDCS type 1,9 .97 .35 .097 
 Time 1,9 1.0 .35 .1 
 Type*Time  1,9 .99 .35 .1 
Maximal slope tDCS type 1,9 1.08 .33 .11 
 Time 1,9 .34 .57 .04 
 Type*Time  1,9 1.23 .3 .12 
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Appendix vii: Further analysis with RUSH score (Ch. 5) 
Repeated measures ANOVAs were calculated for each component of the RUSH to 
explore any effects of tDCS (sham/cathodal) and time (pre/post).  
 
  
Measurement Factor d.f F P p² 
Total 
impairment 
tDCS type 1,9 6.7 .03* .427 
 Time 1,9 1.25 .29 .12 
 Type*Time  1,9 .01 .93 .00 
Motor 
frequency 
tDCS type 1,9 1.98 .19 .18 
 Time 1,9 1.84 .21 .17 
 Type*Time  1,9 3.67 .09 .29 
Phonic 
frequency 
tDCS type 1,9 2.53 .15 .219 
 Time 1,9 .33 .58 .04 
 Type*Time  1,9 1.14 .31 .11 
Motor severity tDCS type 1,9 .33 .58 .04 
 Time 1,9 2.53 .15 .22 
 Type*Time  1,9 1.14 .31 .11 
Phonic severity tDCS type 1,9 .28 .61 .03 
 Time 1,9 .18 .68 .02 
 Type*Time  1,9 .26 .62 .03 
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Appendix viii: ROIs in Baseline/Sham comparisons (Ch. 6) 
ROIs identified as statistically different between Baseline and Sham scans 
using paired sample t-tests. R indicated right, L indicated left. **Indicates 
significantly difference at p=<0.01 (FDR corrected). ***Indicates significant at 
p=<0.001(FDR corrected), otherwise significant at p<0.05 (FDR corrected). 
Atlas no. Region 
1 
2 
Frontal pole R  
Frontal pole L ** 
5 Superior Frontal Gyrus R  
9 
11 
Inferior Frontal Gyrus, pars triangularis Right *** 
Inferior Frontal Gyrus, pars opercularis Right ** 
13 
14 
Precentral Gyrus R ** 
Precentral gyrus L *** 
17 
18 
20 
Superior Temporal Gyrus, anterior division R ** 
Superior Temporal Gyrus, anterior division L ** 
Superior Temporal Gyrus, posterior division L *** 
21 
22 
24 
25 
Middle Temporal Gyrus, anterior division R 
Middle Temporal Gyrus, anterior division L 
Middle Temporal Gyrus, posterior division L 
Middle Temporal Gyrus, temporooccipital part R 
27 Inferior Temporal Gyrus, anterior division Right 
30 
31 
32 
Inferior Temporal Gyrus, posterior division L ** 
Inferior Temporal Gyrus, temporooccipital part R ** 
Inferior Temporal Gyrus, temporooccipital part L *** 
33 Postcentral gyrus R ** 
38 
39 
40 
Supramarginal Gyrus, anterior division L 
Supramarginal Gyrus, posterior division R ** 
Supramarginal Gyrus, posterior division L 
41 Angular gyrus right 
49 Frontal Medial Cortex *** 
50 
51 
Supplementary motor area R ** 
Supplementary motor area L ** 
56 Cingulate Gyrus, posterior division ** 
57 Precuneous Cortex 
63 Parahippocampal Gyrus, anterior division L 
70 
71 
Temporal Fusiform Cortex, posterior division R  
Temporal fusiform cortex, posterior division L ** 
77 Frontal Operculum Cortex Left *** 
78 Central Opercular Cortex R 
81 Parietal Operculum Cortex R *** 
90 
91 
Occipital pole R 
Occipital pole L 
98 
99 
Palladium R ** 
Palladium L 
102 Amygdala R ** 
104 
105 
Accumbens R 
Accumbens L ** 
115 Cerebelum 6 L 
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Appendix ix: ROIs in Baseline/Active comparisons (Ch. 6) 
ROIs identified as statistically different between Baseline and Active scans 
using paired sample t-tests. R indicated right, L indicated left. **Indicates 
significantly difference at p=<0.01 (FDR corrected). ***Indicates significant at 
p=<0.001(FDR corrected), otherwise significant at p<0.05 (FDR corrected). 
Atlas no. Region 
1 
2 
Frontal pole R ** 
Frontal pole L 
5 Superior Frontal Gyrus R ** 
7 Middle frontal gyrus 
9 
11 
12 
Inferior Frontal Gyrus, pars triangularis R ** 
Inferior Frontal Gyrus, pars opercularis R ** 
Inferior Frontal Gyrus, pars opercularis L 
21 
23 
Middle Temporal Gyrus, anterior division R 
Middle Temporal Gyrus, posterior division R ** 
27 Inferior Temporal Gyrus, anterior division R ** 
39 Supramarginal Gyrus, posterior division R ** 
42 Angular gyrus L 
44 
45 
46 
Lateral Occipital Cortex, superoir division L ** 
Lateral Occipital Cortex, inferior division R 
Lateral Occipital Cortex, inferior division L 
47 Intracalcarine Cortex R 
49 Frontal medial cortex 
53 Paracingulate Gyrus Right ** 
55 
56 
Cingulate Gyrus, anterior division 
Cingulate Gyrus, posterior division 
57 Precuneous Cortex *** 
59 Cuneal Cortex L 
60 
61 
Frontal Orbital Cortex R *** 
Frontal Orbital Cortex L  
62 
64 
65 
Parahippocampal Gyrus, anterior division R 
Parahippocampal Gyrus, posterior division R 
Parahippocampal Gyrus, posterior division L ** 
67 Lingual Gyrus L 
69 Temporal Fusiform Cortex, anterior division L 
75 Occipital Fusiform Gyrus L 
79 Central Opercular Cortex L  
80 Parietal Operculum Cortex R ** 
86 Planum temporale R *** 
100 Hippocampus R 
104 Accumbens R 
106 Brain-Stem 
108 
111 
113 
114 
117 
120 
Cerebelum Crus1 R 
Cerebelum 3 L 
Cerebelum 4 5 L ** 
Cerebelum 4 5 R ** 
Cerebelum 7b L 
Cerebelum 8 R 
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Appendix x: ROIs in Active/Sham comparisons (Ch.6) 
ROIs identified as statistically different between Active and Sham scans using paired 
sample t-tests. R indicated right, L indicated left. **Indicates significantly difference at 
p=<0.01 (FDR corrected). ***Indicates significant at p=<0.001(FDR corrected), otherwise 
significant at p<0.05 (FDR corrected). 
Atlas no. Region 
1 Frontal pole R 
3 Insular cortex R ** 
5 Superior Frontal Gyrus R ** 
10 Inferior Frontal Gyrus, pars triangularis Left 
13 
14 
Precentral Gyrus R *** 
Precentral gyrus L ** 
18 Superior Temporal Gyrus, anterior division L ** 
20 Superior Temporal Gyrus, posterior division L *** 
23 
24 
Middle Temporal Gyrus, posterior division R 
Middle Temporal Gyrus, posterior division L **  
30 Inferior Temporal Gyrus, posterior division L *** 
32 Inferior Temporal Gyrus, temporooccipital part L ** 
33 
34 
Postcentral Gyrus R *** 
Postcentral Gyrus L 
37 Supramarginal Gyrus, anterior division R 
44 
45 
46 
Lateral Occipital Cortex, superoir division L ***  
Lateral Occipital Cortex, inferior division R *** 
Lateral Occipital Cortex, inferior division L *** 
47 
48 
Intracalcarine Cortex R 
Intracalcarine Cortex L 
50 
51 
Supplementary motor area R *** 
Supplementary motor area L *** 
55 Cingulate Gyrus, anterior division ** 
57 Precuneous cortex 
58 
59 
Cuneal cortex R ** 
Cuneal cortex L ** 
60 Frontal Orbital Cortex R ** 
62 
63 
64 
Parahippocampal Gyrus, anterior division R ** 
Parahippocampal Gyrus, anterior division L ** 
Parahippocampal Gyrus, posterior division R *** 
66 
67 
Lingual Gyrus R *** 
Lingual Gyrus L *** 
74 
75 
Occipital Fusiform Gyrus R *** 
Occipital Fusiform Gyrus L *** 
77 Frontal Operculum Cortex L 
78 
79 
Central Opercular Cortex R *** 
Central Opercular Cortex L *** 
80 
81 
Parietal Operculum Cortex R *** 
Parietal Operculum Cortex L *** 
84 
85 
Heschl''s Gyrus R ** 
Heschl''s Gyrus L ** 
86 
87 
Planum temporale R *** 
Planum temporale L ** 
88 Supracalcarine Cortex R 
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93 Thalamus L ** 
98 Palladium R ** 
100 
101 
Hippocampus R *** 
Hippocampus L  
102 
103 
Amygdala L ** 
Amygdala R 
105 Accumbens L 
106 Brain stem ** 
108 
111 
112 
114 
117 
Cerebelum Crus1 R 
Cerebelum 3 L ** 
Cerebelum 3R ** 
Cerebelum 4 5 R ** 
Cerebelum 7b L 
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Appendix xi: ROIs in Baseline2/Active2 conditions (Ch.6) 
Significant differences (p=<0.05, FDR corrected) in connectivity between 
Baseline2 and Active2. R = right, L = left. **Regions were significantly different at 
p=<0.01 (FDR corrected). *** p=<0.001(FDR corrected). 
Atlas no. Region 
2 Frontal pole L 
3 
4 
Insular cortex R 
Insular cortex L ** 
8 Middle front gyrus L 
12 Inferior frontal gyrus (pars opercularis) L ** 
13 Precentral gyrus R *** 
15 
16 
Temporal pole R ** 
Temporal pole L *** 
21 Middle temporal gyrus (anterior division) R 
25 
26 
Middle Temporal Gyrus, temporooccipital part R ** 
Middle Temporal Gyrus, temporooccipital part L *** 
29 
30 
31 
32 
Inferior Temporal Gyrus, posterior division R *** 
Inferior Temporal Gyrus, posterior division L *** 
Inferior Temporal Gyrus, temporooccipital part R ** 
Inferior Temporal Gyrus, temporooccipital part L *** 
33 
34 
Postcentral gyrus R ** 
Postcentral gyrus L ** 
37 Supramarginal Gyrus, anterior division R ** 
47 
48 
Intracalcarine Cortex R ** 
Intracalcarine Cortex L 
51 Juxtapositional Lobule Cortex/ SMA-L 
60 
61 
Frontal Orbital Cortex R ** 
Frontal Orbital Cortex L *** 
62 
63 
64 
Parahippocampal Gyrus, anterior division R ** 
Parahippocampal Gyrus, anterior division, L*** 
Parahippocampal Gyrus, posterior division R 
66 
67 
Lingual gyrus R ** 
Lingual gyrus L  
70 
71 
72 
73 
Temporal Fusiform Cortex, posterior division R *** 
Temporal fusiform cortex, posterior division L *** 
Temporal Occipital Fusiform Cortex R ** 
Temporal occipital fusiform cortex left ** 
77 Frontal operculum cortex L 
78 
79 
Central Opercular Cortex R 
Central Opercular Cortex L ** 
80 80: Parietal Operculum Cortex R ** 
82 
83 
Planum Polar R ** 
Planum polar L ** 
85 Heschl’s Gyrus L ** 
86 
87 
Planum temporale R 
Planum temporale L ** 
92 
93 
94 
Thalamus R 
Thalamus L *** 
Caudate R   ** 
99 Pallidum L 
102 
103 
Amygdala R 
Amygdala L 
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Appendix xii: ROIs implicated in Active-Baseline which are 
predictive of connectivity in Post condition (Ch.6) 
Atlas no. Region 
15 Temporal pole R 
17 
19 
Superior Temporal Gyrus, anterior division R 
Superior Temporal Gyrus, posterior division R 
27 
28 
32 
Inferior Temporal Gyrus, anterior division R 
Inferior Temporal Gyrus, anterior division L 
Inferior Temporal Gyrus, temporooccipital part L 
54 
56 
Paracingulate Gyrus L 
Cingulate gyrus posterior division 
60 
61 
Frontal Orbital Cortex R 
Frontal Orbital Cortex L  
62 Parahippocampal Gyrus, anterior division R 
68 Temporal Fusiform Cortex, anterior division R 
78 
79 
Central Opercular Cortex R 
Central Opercular Cortex L 
94 Caudate R 
98 Pallidum R  
104 Accumbens R   
109 
110 
111 
112 
119 
120 
Cerebellum Crus2 L 
Cerebellum Crus2 R 
Cerebellum 3 L 
Cerebellum 3 R 
Cerebellum 8 L 
Cerebellum 8 R  
125 
128 
Vermis 1 2 
Vermis 6 
 
